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MAYA EL-SABBAN. Elucidating the contribution of the BAF A12T mutation to cellular
mechanisms of premature aging. (Under the direction of PAULA TRAKTMAN)

Abstract
The nuclear envelope is a dynamic structure and organizing hub for cell structure
and function. The underlying nuclear lamina is composed of a thick network of
intermediate filaments, Lamin A/C and B, and inner nuclear membrane-associated
proteins such as Lap2, Emerin and Man1. BAF, a central organizing protein, is a small,
dimeric, essential protein that binds to dsDNA, proteins of the inner nuclear membrane
and Lamin A. Cells with perturbations of the nuclear lamina display dysmorphic nuclei
which have the potential to lead to altered gene expression, increased DNA damage
events, and premature cellular senescence. In this study, we address a single amino acid
substitution from Alanine 12 to Threonine (A12T) in BAF that gives rise to a nuclear
morphology defect. At the clinical level, patients who inherit a homozygous BAF A12T
mutation have a rare premature aging syndrome called Nestor Guillermo Progeria
Syndrome (NGPS) with symptoms such as osteolysis, adipolysis and craniofacial defects
that present at approximately two years of age and progress rapidly, ultimately shortening
patient lifespan significantly. Tissues of mesenchymal origin appear to be most severely
impacted in this disease, leading to the hypothesis that mesenchymal stem cells are
preferentially affected. To address the cellular and organismal pathology of NGPS, we
used CRISPR/Cas9 technology to establish BAFA12T/BAFA12T human induced pluripotent
stem cells (hiPSCs). A12T BAF iPSCs appeared normal, however when differentiated to
induced mesenchymal stem cells (iMSCs), A12T BAF cells exhibited a marked increase
in cellular senescence and an elevated cellular stress response. The mechanism of A12T
BAF’s contribution of this cell-type specific pathology was not well understood. Our data
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indicate that A12T BAF ‘s binding to Lamin A is greatly diminished, thereby weakening the
Lamin A network of the nuclear lamina and the structural integrity of the nuclear envelope.
Mechanosensitive iMSCs are unable to withstand this weakened network and the nuclei
appear to rupture, thereby causing cellular stress and ultimately, senescence. Our results
indicate that the A12T BAF mutation is necessary but not sufficient to cause premature
cellular aging. All cell types expressing BAFA12T/BAFA12T have dysmorphic nuclei, however
cells derived from BAFA12T/BAFA12T mice are viable and primary dermal fibroblasts are not
senescent, nor do they demonstrate elevated levels of DNA damage. Furthermore, A12T
BAF mice do not have shortened lifespans nor do they have defects in mesenchymal
derived tissue. These data highlight the nuances of this mutation’s effect both at the
cellular and organismal level and elucidates a new role for BAF at the nuclear envelope
as a key player in cell mechanosensitivity and the network of the nucleoskeleton and
cytoskeleton.
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Chapter 1: Introduction
As early as the first microscopic observations in the 18th century, the nucleus was
described as a central feature of the eukaryotic cell. Over 100 years later, Robert Brown
coined the term nucleus in 1831 and suggested that the nucleus played a key role in the
fertilization and development in plant cells (Brown, 1833). The late 1800’s saw a spike in
the study of the nucleus and its role in the heredity and development. By the early 1900s
there were extensive studies and observations about the discrete entities within the cell,
including the nucleus, and in 1964 Gall described the nuclear envelope using electron
microscopy. This final observation established the division between the nucleus and the
cytoplasm (Gall, 1964; Wilson, 1900). As time continues to press on, studies continue to
uncover the complexities of this organelle, revealing the intricate relationships between
chromatin, the nuclear envelope, the nuclear lamina and the nuclear substructures.
Overview of the Nucleus and its Substructures
The nucleus is one of the defining feature of eukaryotic cells. It encloses and
sequesters the entire genome and is delimited by two concentric lipid bilayers that are
punctuated by nuclear pores, which facilitate selective transport between the nucleus and
cytoplasm. The nucleus is the site of the major metabolic activities of the cell including
DNA replication and repair, gene transcription, RNA processing and ribosome maturation
and assembly. The limited nuclear space must contain within it: DNA, RNA, histones, nonhistone proteins, regulatory and processing enzymes, stable elements of the nuclear
envelope and nuclear pores, structural proteins, and the nuclear lamina. Spatio-temporal
regulation of this crowded nucleus is managed through the non-stochastic 3-D architecture
of chromatin into distinct territories determined by the association of chromatin domains
with other nuclear structures such as the nuclear envelope (Dekker & van Steensel, 2013).
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DNA Organization in the Nucleus
The majority of the nuclear volume is occupied by genetic material packaged into
high-order DNA-histone complexes called chromatin (Wolffe, 1998). The building blocks
of chromatin are discrete entities called nucleosomes, which consist of 160-200bp
stretches of DNA wrapped around an octamer of histones folded into a condensed
structure (Felsenfeld & McGhee, 1986; Kornberg & Lorch, 1999). Compacted chromatin
is transcriptionally repressed and chromatin is remodeled during replication and
transcription (Adams & Workman, 1993; Alexiadis, Varga‐Weisz, Bonte, Becker, & Gruss,
1998; Beato & Eisfeld, 1997; Kornberg & Lorch, 1991).
Histones:
Core histones are the main components of the nucleosome and are comprised of
histones H2A, H2B, H3 and H4. Core histones are regulated through post translational
modifications such as acetylation, methylation and phosphorylation which influence the
accessibility and remodeling of chromatin (Davie & Chadee, 1998; Wu, Panusz, Hatch, &
Bonner, 1986). The post translational modifications of histones are carried out by histone
modifiers, which are organized into subfamilies such as histone acetyltransferases (HATs)
and histone deacetylases (HDACs), histone methyltransferases (HMTs) and histone
demethylases (HDMs) and protein kinases. (Gilbert, Gilchrist, & Bickmore, 2004). The
function of the nucleosome is not only to act as a structural component but also as a
modulator of gene expression. Precise positioning across genes allows differential access
to transcription factors and are repositioned by chromatin remodeling complexes (Längst
& Becker, 2001; Simpson, 1991). Linker histones H1, H5 and H1° are located outside of
the nucleosome and are responsible for the condensation and the stabilization of the
chromatin fiber (Pruss, Hayes, & Wolffe, 1995; Thoma & Koller, 1977). Histone acetylation
2

is correlated with transcriptional activity, while methylation is correlated with transcriptional
repression (Hebbes, Thorne, & Crane‐Robinson, 1988)
Chromatin Compaction:
Interphase nuclei have two distinct chromatin organizations: heterochromatin and
euchromatin. Heterochromatin is highly condensed and euchromatin adopts an open
conformation.

Heterochromatin

is

further

subcategorized

into:

i)

constitutive

heterochromatin, which is comprised of tandem repeats that remain condensed
throughout the cell cycle, ii) facultative heterochromatin, which changes throughout
development and as a result of signaling and is therefore regulated in a temporal manner
and iii) senescence associated heterochromatin foci (SAHF) which accumulate throughout
the genome as cells undergo cellular aging (Gilbert et al., 2004). Interphase chromatin is
organized spatially into territories. Territories are discrete entities delimited by the
interchromatin domains (ICD) and their structured organization influences gene
expression

(Cremer & Cremer, 2001; Leitch, 2000). Chromosomes return to the

configuration in which they were found preceding anaphase, which is fixed during cell
cycle and can be arranged into similar patterns among similar species or cell type (Leitch,
2000). These data highlight the non-random positioning of chromatin within the nucleus.
Lamina Associated Chromatin:
An important substrate for the tethering of chromatin to specific localizations in the
nucleus is the nuclear envelope (Chubb, Boyle, Perry, & Bickmore, 2002; Heun, Laroche,
Shimada, Furrer, & Gasser, 2001). The regulation of transcription through chromatin
conformation is facilitated by long range interactions which form intrachromosomal loops
and contacts. The development of chromosome conformation capture allowed the
identification of subdomains within chromatin that associate spatio-temporally (Dekker,
3

Rippe, Dekker, & Kleckner, 2002). These interacting domains are called topology
associated domains, or TADs. Discrete TAD organization is subdivided into two major
compartments: the “A” compartment which correlates with proteins and histone
modifications that are involved with active transcription; and the “B” compartment which
correlates with repression of gene transcription (Dixon et al., 2012). Within the “B” type
compartment is a subset of TADs which associate with the nuclear envelope and the
underlying nuclear lamina, called lamina-associated domains (LADs) (Guelen et al., 2008;
Pickersgill et al., 2006).
The nucleolus:
The nucleolus is a nuclear body that forms around rRNA enriched gene loci called
“nucleolar organizer regions” (NORs). The function of the nucleolus is the synthesis of
rRNA and processing and assembly of the ribosomal subunits which are then exported
from the nucleolus to the cytoplasm to carry out their function of mRNA translation. The
nucleolus is divided into three subcategories: the fibrillary center, the dense fibrillary
component and the granular component. Each step of rRNA synthesis and maturation
occurs in a discrete nucleolar structure (Lamond & Sleeman, 2003).

4

Figure 1-1

Figure 1-1. The 3-D Organization of Chromatin in the Nucleus. Taken from
(Gonzalez-Sandoval & Gasser, 2016). Chromatin is highly organized within the cell, and
chromosome territories are conserved throughout the lifespan of the cell and across cell
type and species. Long rage chromatin interactions facilitate chromatin organization within
the nucleus. Topology associated domains are classified as transcriptionally active or
repressed (Compartment A or B respectively) and TADs associated with the nuclear
lamina, termed Lamina Associated Domains, LADs are generally associated with
transcriptional repression.
5

The Nuclear Envelope and Nuclear Lamina
The nuclear envelope (NE) is a dynamic structure that determines the overall
shape, size, and integrity of the nucleus. The NE is comprised of two lipid bilayers giving
rise to an outer nuclear membrane (ONM) and inner nuclear membrane (INM). The ONM
is continuous with the endoplasmic reticulum which allows for direct insertion of NE
proteins and the translocation of proteins into the perinuclear space; the INM contains
within it a population of stable membrane proteins that interact with chromatin and the
nuclear lamina (Schirmer, Florens, Guan, Yates, & Gerace, 2003; Schirmer & Gerace,
2005). The INM acts as the scaffolding for the intermediate filaments of the nucleoskeleton
which, in turn, provide critical stability, elasticity, rigidity, and organization to the structure
of the nucleus.
The INM and ONM fuse at the sites of nuclear pore complexes (NPC) which are
involved in the selective trafficking between the nucleus and cytoplasm. Pore density and
distribution varies greatly between different cell and tissue types and across development.
The membrane delimiting each pore is highly curved and studded with specific pore
proteins called Poms which facilitate the anchoring of nucleoporins (Nups), thus
generating a series of interactions contributing to the formation of the complex structure
of the NPC (Rout et al., 2000). High resolution structures for the Nups and their interaction
partners reveal a 9mm aqueous central channel that allows for the diffusion of small
molecules (<40kDa). Large proteins, RNA and other macromolecules are transported
across the membrane using facilitated transport
The NE further contains of the nuclear lamina (NL). The NL is comprised primarily
of type V intermediate filament proteins, termed lamins, which form a meshwork of
filamentous structures. They feature a central α-helical rod that is flanked by non-helical
6

head and tail domains organized in an Ig-like-β -fold that contains a nuclear localization
sequence, see Figure 1-3 (Brian Burke & Stewart, 2013). There are two major families of
lamins: Lamin A/C and Lamins B1 and B2. Lamin A and Lamin C are isoforms of the LMNA
gene that arise due to alternative splicing and that are only expressed in differentiated
cells. Lamins B1 and B2 are encoded by the LMNB1 and LMNB2 genes respectively, and
one or the other are expressed in all cells throughout development and differentiation
(Thomas Dechat et al., 2008). Lamin A and Lamins B1 and B2 contain a C-terminal CaaX
motif (Cys, aliphatic residue, aliphatic residue, and X, usually a Met), that defines the site
of farnesylation and carboxymethylation (Beck, Hosick, & Sinensky, 1990; Kitten & Nigg,
1991). Newly synthesized lamins are targeted to the nuclear envelope through
farnesylation and are associated with the INM. Once incorporated, Lamin A undergoes
proteolytic cleavage by ZMPSTE24 after Tyr646 to remove 15 amino acids from the Cterminus to give rise to mature Lamin A, whereas B-type Lamins remain farnesylated at
the INM (Pendás et al., 2002). The proper expression and processing of both A-type and
B-type lamins are critical to cell function and will be discussed in more detail later. Lamins
are integral to the organization of chromatin at the nuclear periphery. Analysis of NE and
NL-associated DNA indicates that for the most part, transcriptionally silent chromatin is
concentrated at the nuclear periphery, and genes move towards or away from the NP
based on repression or expression respectively, providing a mechanism for the spatial
control of DNA replication and transcription.
Resident proteins of the INM and underlying NL contribute to the regulation of
nuclear functions. A family of INM proteins that contain a 40 amino acid bi-helix motif,
LAP-2, Emerin, Man1 domain (LEM-D), share the ability to bind lamins and BAF at the
NP. LEM-D proteins interact with a diverse array of substrates, implicating them in
7

mechanotransduction, cellular and nuclear architecture, transcriptional regulation and
chromatin tethering (Barton, Soshnev, & Geyer, 2015). LEM-D proteins represent the most
studied subset of INM proteins and contribute to the organization of chromatin within the
nucleus by tethering genomic regions to the NP through direct interactions or through their
interactions with BAF and Lamin. LEM-D proteins also play a role in gene regulation
through histone mark regulation by interacting with histone deacetylases, or by direct
association with transcription factors (Barton et al., 2015). The mammalian genome
encodes 7 LEM-D proteins: LAP2α, Emerin, MAN1, LEM2, LMD1, Ankle1 and Ankle2
most of which contain transmembrane domains that tether them to the INM (Brachner &
Foisner, 2014).
Lamina associated peptide (LAP) 2α arises from the LAP2 gene which gives rise
to 6 LAP2 isoforms. The LAP isoforms share the first 187 N-terminal residues that contain
within them the LEM domain and a LEM-like motif which allows for direct DNA binding.
LAP2α differs from other LAP2 isoforms in that it is not stably anchored into the INM at its
C-terminal tail, whereas LAP2β, for example contains a C-terminal transmembrane
domain. LAP2α is distributed within the nucleoplasm and binds Lamin A, chromatin and
pRb (Gesson, Vidak, & Foisner, 2014). LAP2α’s association with the cell cycle regulator
pRb is suggestive of a role in cell cycle regulation. LAP2α preferentially interacts with
hypophosphorylated pRb and anchors it in the nucleus, thereby inhibiting the expression
of E2F target genes and inhibiting cell proliferation (Dorner et al., 2006). LAP2α is highly
dynamic and localizes throughout the nucleoplasm during interphase. During NEBD and
prophase, it disperses into the cytoplasm, and during late anaphase and telophase it
interacts with sub-telomeric regions and TRF1, a member of the Sheltrin complex (T.
Dechat et al., 2004). Furthermore, LAP2α plays a role in DNA repair pathways through its
8

association with DNA repair machinery, such as the Werner helicase (WRN) and Ku86, in
the context of non-homologous end joining (NHEJ), and with PARP to generate a docking
site for DNA damage repair proteins (Gagné et al., 2012; Lachapelle et al., 2011).
Emerin is an integral membrane protein that localizes to the INM and directly binds
BAF and lamins. Emerin is encoded by the EMD gene, which was identified during the
genetic mapping of Emery-Drifuss muscular dystrophy (EDMD) (Emery & Dreifuss, 1966).
EDMD is characterized by the progressive wasting of skeletal muscle and dilated
cardiomyopathy, which results in cardiac arrest (Dalton, Goldman, & Sampson, 2015).
The identification of Emerin as a nuclear membrane protein gave rise to the new category
of diseases termed laminopathies that are involved in the binding to and regulation of the
nuclear lamins (B. Burke & Stewart, 2006; Méndez-López & Worman, 2012).

9

Figure 1-2

Figure 1-2. Structure and processing of Lamin A, C and B1/2. Taken from (Thomas
Dechat et al., 2008). (A) Conserved structure between LMNA and LMNB1/2. Lamins are
type V intermediate filaments which contain an α-helical rod, nuclear localization signal
(NLS), an Ig-fold domain and a C-terminal CAAX domain. (B) The processing of pre-Lamin
involves farnesylation, trimming and carboyxymethylation, as shown. Lamins B1 and B2
remain farnesylated in their mature form, whereas pre-Lamin A is cleaved internally by
Zmptse24 to give rise to non-farnesylated, mature Lamin A. (C) Comparison of the nuclear
lamins structure at the C-terminus.
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The Nucleoskeleton and Mechanotransduction
The shape of the nucleus is regulated by the mechanical properties of the NE and
NL, but also by the attachments it makes to the cytoskeleton. Cellular and extracellular
mechanical forces are transduced at the cell periphery into signaling cascades that directly
affect cell function. Mechanical changes at the cell periphery can arise as a result of
changes to the extracellular matrix (ECM), changes in cell-cell junctions, or sheer and
mechanical forces. Membrane-bound mechanosensitive proteins, such as integrins and
cadherins, induce the reorganization of actin filaments, triggering downstream signaling
pathways (Bouzid et al., 2019). The nucleus and cytoskeleton are coupled through a
complex termed the Linker of Nucleoskeleton to the Cytoskeleton, or LINC complex.
The LINC complex is composed of two protein families that span the nuclear
envelope: Nesprin and SUN proteins. Nesprins are found at the nuclear envelope and
contain a variable N-terminal domain, a C-terminal transmembrane KASH domain and a
rod domain composed of a series of spectrin repeats (Lombardi & Lammerding, 2011).
Nesprin binds actin at the N-terminus and SUN proteins in the preinuclear space at the Cterminus. A SUN monomer is made up of Unc-84 and Sad1 homology domains and
assembles in a homotrimer (Malone, Fixsen, Horvitz, & Han, 1999). SUN interacts with
Lamin A at its nucleoplasm domain thereby linking the perinuclear space and the
nucleoplasm. The tethering of actin to Nesprin, Nesprin to SUN, and SUN to Lamin A,
therefore, connects the cellular periphery to the nucleus and integrates the forces of the
cytoskeleton and the nucleus. Cells require the LINC complex for migration and to
establish nuclear structure, function, shape and position (Lombardi & Lammerding, 2011).
Changes in nuclear shape affect gene expression and protein synthesis, and lamins are
upregulated and reorganized in response to mechanical stress (Lammerding et al., 2005).
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Nuclear shape is dependent on the rigidity of the underlying extracellular substrate: the
nucleus assumes a spherical shape on soft surfaces due to smaller actomyosin tension
and becomes flattened and ellipsoid on rigid substrates where the extracellular forces on
the cell are greater (Lovett, Shekhar, Nickerson, Roux, & Lele, 2013). Lamin A levels are
proportional to substrate rigidity, implicating Lamin A as a stabilizer for the nucleus under
mechanical stress (Swift et al., 2013).
The coupling of the nucleus with the surrounding cytoskeleton indirectly connects
the nucleus with the extracellular matrix and the surrounding cells. Mechanical
deformations within the tissue are transduced along the cytoskeleton to the nucleus and
influence nuclear function and gene expression. The interphase nucleus is a rigid, but
deformable structure and is 2-10 fold stiffer than the remainder of the surrounding cell
(Caille, Thoumine, Tardy, & Meister, 2002). The nuclear lamina and chromatin impart the
nuclear stiffness and cells deficient in Lamin A/C are softer and more fragile (Lammerding
et al., 2006). The interior of the nucleus can be characterized as being an aqueous,
compressible viscoelastic material that increases in stiffness when compressed (Dahl,
Engler, Pajerowski, & Discher, 2005). During cellular migration, the movement of the
nucleus is coordinated with the motile cytoskeleton, which results in complex changes in
both position and shape. Through the LINC complex, the nuclear lamina absorbs the
mechanical stresses and tensile forces acting on the nucleus (Broers et al., 2005). As
mentioned previously, the vast majority of the volume of the nucleus is comprised of
genetic material. An increase in the proportion of heterochromatin restricts chromatin
mobility and stiffens the nucleus (Pajerowski, Dahl, Zhong, Sammak, & Discher, 2007).
The nuclear lamins also contribute to the rigidity of the nuclear interior and provide
structure and organization between the nuclear interior and periphery (Broers et al., 2005).
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Figure 1-3

Figure 1-3. Nuclear deformations as a result of mechanical stress. Adapted from
(Ungricht & Kutay, 2017). The NE responds to force stiffening of the nuclear lamina which
results in the transduction of the signal from the cytoskeleton to the LINC complex, and in
turn the nucleoskeleton. (B) The balance between nuclear rigidity and flexibility is crucial
for cells to withstand mechanical forces on the nucleus. (C). Cells deform their nuclei to
migrate, or mechanosensitive cells under mechanical strain, can results in the loss of the
NE integrity and subsequent NE rupture and chromatin herniation. BAF is a component of
the nuclear rupture repair complex and acts by binding dsDNA at the site of rupture and
recruiting LEM-D proteins of the INM through the ESCRT-III machinery.
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Structure and Function of BAF
The Discovery of BAF
The integration of viral DNA, synthesized by reverse transcription, into the host
genome is essential for the retrovirus life cycle. Integration is carried out by a nucleoprotein
complex which directs viral DNA to integrate into the host chromosome rather than
undergoing self-destructive, self-integration. Viral nucleoprotein complexes isolated from
Moloney Murine Leukemia Virus (MoMLV) featured a host cellular component that
inhibited auto-integration (M. S. Lee & Craigie, 1994). Analysis of this host component
revealed a single protein that was termed Barrier to Autointegration Factor, or BAF.
Sequencing revealed an 89 amino acid protein highly conserved across species (Figure
1-4)
Structure Resolution of BAF
In 1998, the structure of BAF was solved by nuclear magnetic resonance (NMR),
which revealed that BAF is a globular shaped protein composed of 5 helices and a small
helical turn. The core is tightly packed and composed of hydrophobic residues. BAF forms
a stable dimer in solution with Gly 47 of each monomer in helix 3 forming the dimeric axis
(Cai et al., 1998). Importantly, helices 4 and 5 of BAF were thought to constitute a helixturn-helix (HTH) motif, where the small turn between helix 4 and helix 5 is three residues
in length beginning with a Gly, typical to HTH domains that recognize DNA. The Nterminus of helix 5, the DNA recognition helix of the HTH, appeared to readily fit into the
major groove of DNA, aligning the residues along the DNA and orienting residues of helix
1 to position along the phosphate backbone. These DNA-interacting residues comprise a
patch of positively charged residues on the surface of the protein and are highly conserved
between human, mouse and zebrafish. These NMR data were mostly validated by x-ray
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crystallography, confirming and refining the structure solution. The high-resolution
structure however, replaced the theory of an HTH domain facilitating DNA binding with
evidence of a helix-hairpin-helix (HhH), sequence-independent, DNA binding motif. An
HhH motif is defined as containing two helices connected by a reverse turn. DNA binding
occurs via hydrogen bonds formed between two adjacent phosphate groups of the DNA
backbone with the residues of the reverse turn and second helix of the HhH (Umland, Wei,
Craigie, & Davies, 2000). The dimerization of BAF at the third helix using the Gly47 notch
frees the HhH on either side of the dimer to bind distinct DNA strands, foreshadowing
BAF’s ability to cross-bridge DNA for the first time. Using 21-mer oligonucleotides, BAF
was observed to form discrete complexes with DNA and, extending the study of the role
of BAF from viral integration, revealing BAF’s extremely high affinity to dsDNA (Harris &
Engelman, 2000; R. Zheng et al., 2000). See Figure 1-4.
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Figure 1-4

Figure 1-4. BAF’s structure and Binding Surfaces. (A) The structure of the BAF dimer
(Red= BAF monomer 1 Blue=BAF monomer 2) creates a binding surface for the
interaction with LEM-D proteins (Green=LEM domain). Each BAF monomer binds dsDNA
in a sequence independent manner. BAF A12T mutation occurs on the binding surface on
the opposite pole of the LEM-D binding site (Pink Oval = surface of A12T mutation) (B)
Sequence alignment reveals that BAF is highly conserved among species. Important
resides are highlighted: Green box=sites of phosphorylation, red diamonds=interactions
with dsDNA, cyan arrow=site of A12T mutation, maroon boxes and yellow ovals= residues
that affect histone binding and chromatin compaction blue triangles= LEM-D binding,
purple rectangles= Lamin A IgFold binding
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BAF Protein Partners
In 1999, a yeast two-hybrid assay was performed to identify binding partners of
Lap2.

An 89 aa protein that localized to the nucleus was retrieved as a top hit; further

analysis revealed that the Lap2-binding protein was indeed BAF. The binding site for BAF
corresponded to the chromosome-binding site of Lap2. These data suggested, for the
first time, that BAF might play a role as an organizer of DNA within the nucleus. By
interacting with both DNA and proteins within the INM, it was postulated that BAF might
serve to tether DNA to the INM (Furukawa, 1999). Building on this, NMR analyses
elucidated the complex formed between BAF, DNA and Lap2’s LEM domain, a domain
shared, as discussed previously, with other components of the INM. A study in 2001
analyzed the contribution of the Emerin-BAF binding complex to chromosome dynamics
during mitosis and the reassembly of the nuclear envelope. BAF was implicated in the
assembly of the lamina and nuclear envelope at the end of mitosis, including the
recruitment of INM components to the newly forming nucleus (T. Haraguchi et al., 2001).
BAF has been shown to interact with pre-Lamin A and Progerin and influence
chromatin organization in the nucleus (Loi et al., 2016). Pre-Lamin accumulation affects
chromatin organization through HeK9me3 clustering. Furthermore, BAF was found to
regulate the distribution of Lamin A during nuclear envelope assembly implying its direct
interaction with it (Tokuko Haraguchi et al., 2008).
There is evidence that BAF interacts directly with transcriptional regulators to
influence gene expression, such as Crx to repress target gene activation (X. Wang et al.,
2002), LAP2ζ to repress LAP2β-mediated transcriptional repression (Shaklai et al., 2008),
and Sox2 to regulate stem cell fate in mouse embryonic stem cells (Mallanna et al., 2010).
Furthermore, BAF is thought to regulate gene expression epigenetically. Mapping of LAD
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sequences revealed that Lamins B1&2, Lamin A and BAF all interacted with the same
genomic regions at the NP forming a structural complex that modulates LAD positioning
(Kind & van Steensel, 2014). Furthermore, BAF interacts with a variety of histones
including H4 and the nucleosome core histones (De Oca, Lee, & Wilson, 2005; Rocío
Montes de Oca, Andreassen, & Wilson, 2011). BAF inhibits HAT-mediated acetylation of
H3 and H4, consistent with its ability to bind H3 by sterically inhibiting access of chromatin
regulators to the nucleosome (Rocío Montes de Oca et al., 2011). Furthermore, 3 specific
post translational modifications (PTMs) increase in the presence of BAF overexpression:
H3K4me2, H3K9me3 and H3K79me2. Paradoxically, H3K4me2 is associated with active
chromatin and H3K9me3 with transcriptional silencing. It is unclear how BAF influences
these PTMs and the downstream effects on gene expression (Rocío Montes de Oca et
al., 2011)
Moreover, BAF was found to bind to regulators of the DNA damage response.
PARP1 was found to bind to BAF and may implicate BAF in the repression of transcription
during the DDR. Additionally, BAF binds to damage-specific DNA binding protein (DDB2)
and CUL4A in a UV dependent manner. BAF is bound to DDB2 before the onset of DNA
damage. Once DNA damage is induced, BAF is released from DDB2 and binds CUL4A
until the damage process is complete (R. Montes de Oca, Shoemaker, Gucek, Cole, &
Wilson, 2009).
BAF’s interactions with LEM-D proteins, dsDNA and the nuclear lamina,
transcription factors, histones and other binding partners such as DNA damage effectors
highlights BAF’s role as a nuclear organizing hub that bridges a myriad of components of
the nucleus together. A summary of BAF function and interactions is represented in Figure
1-5.
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Figure 1-5

Figure 1-5. The Known Interactions of BAF. The BAF dimer is able to bind dsDNA in a
sequence independent manner, proteins of the INM that contain a LEM domain and the
Ig Fold of Lamin A. Furthermore, it has been show to play a role in the regulation of
transcription factors, histones and effectors of the DNA damage response pathway. BAF
is phosphorylated by VRK1 which regulates its interactions with its binding partners.
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BAF/VRK1 Signaling Axis and Mitosis
Our lab showed that BAF is phosphorylated preferentially on Serine 4 by Vaccinia
Related Kinase 1 (VRK1) which regulates its interactions and localization within the cell
(Bengtsson & Wilson, 2006; R.J. Nichols, M.S. Wiebe, & P. Traktman, 2006). Threonine
2 and 3 are weaker sites of phosphorylation. BAF is primarily localized at the INM but
there is also a cytoplasmic pool (Tokuko Haraguchi et al., 2007). BAF’s localization and
binding affinity to LEM-D proteins and DNA is reliant on its phosphorylation status: pBAF
increases the cytosolic fraction, and decreases BAF’s affinity to its interacting partners
(R.J. Nichols et al., 2006). In particular, the interaction between BAF and dsDNA is nearly
abrogated by phosphorylation.
The NE undergoes disassembly (NEBD) at the onset of mitosis. During NEBD,
nuclear integrity and compartmentalization is completely lost. NEBD marks the transition
from prophase to prometaphase and results in the retraction of the NE from chromatin,
NPC disassembly, and the mixing of the contents of the nucleoplasm and cytoplasm. The
components of the NE during this reorganization are released into the mitotic cytoplasm
and endoplasmic reticulum, either as individual proteins or stable subcomplexes (Hetzer,
Walther, & Mattaj, 2005; L. Yang, Guan, & Gerace, 1997). NEBD is regulated at multiple
levels by phosphorylation of NE- associated proteins, NPC proteins, lamins and other INM
proteins at the onset of mitosis (Anderson & Hetzer, 2008a). Cdk1/Cyclin B
phosphorylates lamins directly to trigger lamina depolymerization, Nup phosphorylation
initiates NPC disassembly, and other important phosphorylation events provide the
temporal signal for NEBD. Phosphorylation-mediated disruption of protein-protein
interactions at the NE leads to bulk disassociation (Buendia, Courvalin, & Collas, 2001;
Dephoure et al., 2008). BAF is hyperphosphorylated, by VRK1 at the onset of mitosis,
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which abrogates BAF binding to dsDNA and diminishes its interaction with the LEM-D
proteins, thereby releasing the chromatin from the nuclear lamina during mitosis
(Bengtsson & Wilson, 2006; T. P. Molitor & Traktman, 2014; R.J. Nichols et al., 2006).
Chromosomes aligned on the metaphase plate are membrane free and the proteins of the
NE reside in the mitotic ER, the precursor membrane of the interphase NE. At the end of
mitosis, BAF is dephosphorylated by PP4, and PP2A phosphatases, which reestablishes
its binding affinity to the LEM-D proteins of the INM to recruit membranes to chromosomes
through its interactions with dsDNA and the LEM domain-containing proteins (Asencio et
al., 2012; Gorjanacz, 2012; Gorjanacz et al., 2007). NE reformation and reconstitution
occurs by chromosomes binding to and targeting ER tubules and immobilizing them on
the chromosome surface which flattens and seals into a closed NE (Anderson & Hetzer,
2008b). The formation of flat membrane sheets on chromatin is initiated by the recruitment
of DNA-binding INM proteins or INM proteins containing a LEM domain bound to BAF
(Anderson & Hetzer, 2008b; Puhka, Vihinen, Joensuu, & Jokitalo, 2007; Samwer et al.,
2017). Depletion of BAF causes defects in chromatin segregation during mitosis and
subsequent nuclear envelope assembly (Furukawa et al., 2003; Gorjanacz et al., 2007),
and the expression of BAF is required for the reformation of a single nucleus at the end of
mitosis (Samwer et al., 2017).
BAF and Nuclear Rupture
Ruptures in interphase nuclei can occur as a result of migration through confined
spaces, weakening of the NE due to changes at the NP and mechanical strain and tension
(N. Y. Chen et al., 2018; Denais et al., 2016; Hatch & Hetzer, 2016). Repetitive nuclear
rupture causes loss of cellular compartmentalization and is a feature of laminopathies (De
Vos et al., 2011). Following NE rupture there are cellular consequences such as DNA
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damage, innate immune signaling, and mechanisms to functionally repair the rupture.
BAF’s predominantly non-phosphorylated pool of cytosolic BAF localizes to sites of
nuclear rupture to bind herniated dsDNA and recruits LEM-D with their associated
membranes proteins to functionally repair the NE (Halfmann et al., 2019; Young, Gunn, &
Hatch, 2020).
Overview of Cellular Aging and Progerias
The Hallmarks of Aging
Aging is characterized by the loss of physiologic integrity over time. The isolation
of longevity mutants in C. elegans by Klass in 1983 launched the study of genes
contributing to organismal aging (Klass, 1983). The study of the molecular basis of cellular
aging has become a widely studied field and has helped inform different areas of research
such as cancer biology and metabolism. There are nine hallmarks of aging that fill the
criteria of: i) manifesting during normal aging ii) aggravation accelerates aging iii)
amelioration retards the aging process and increases lifespan (both cellular and
organismal) (Lopez-Otin, Blasco, Partridge, Serrano, & Kroemer, 2013)
Genomic Instability:
The Disposable Soma model introduced the idea that aging is a consequence of
the investiture of energy required only to maintain the soma only long enough to
reproduce, and that the damage to cellular components is a consequence of this process
(Kirkwood & Holliday, 1979). DNA damage accumulates throughout the lifespan of a cell
and is likely one of the most critical contributors to the aging process (Moskalev et al.,
2013). The insults to DNA through exogenous damage, and endogenous stresses such
as replication errors, result in DNA lesions that require DNA repair. Insults to DNA repair
mechanisms cause premature aging syndromes, such as mutations in ATM, PARP-1,
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Ku86, DNA-PKcs, XPF, WRN and BLM (Espejel et al., 2004; H.-W. Lee et al., 1998;
Lombard et al., 2000).
Telomere Attrition:
Telomeric regions in the genome are highly susceptible to deterioration with each
round of replication, due to the inability of DNA polymerase to prime synthesis at the end
of linear DNA. Therefore, maintenance of telomere length during cellular DNA replication
relies on a specialized polymerase called telomerase (Blackburn, Greider, & Szostak,
2006). After birth, most somatic cells do not express telomerase, which causes the
progressive loss of telomeric sequences and eventually culminates in the inability of the
cell to replicate any further (Blackburn et al., 2006; Hayflick & Moorhead, 1961). Inducing
the expression of telomerase rescues cells from senescence and imparts cellular
immortality (Bodnar et al., 1998). Cells deficient in telomerase or components of the
telomeric complex results in cellular senescence and organismal aging (Armanios et al.,
2009).
Epigenetic Modifications:
Histone modifications can modulate gene expression through the methylation of
longevity-associated genes (Greer et al., 2010). Specifically, sirtuins, a family of histone
deacetylases, have been studied extensively because Sir2 overexpression increases the
lifespan of yeas, flies and worms (Guarente, 2011). In mammals Sirt1, Sirt3 and Sirt6
overexpression results in genomic stability and enhanced metabolic efficiency (Nogueiras
et al., 2012). Furthermore, DNA becomes hypermethylated with age and the patterns of
physiologic aging-driven hypermethylation of the genome is mirrored in premature aging
syndromes (Maegawa et al., 2010). Chromosome modifying proteins such as HP1α or
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members of the Polycomb or NuRD complexes all contribute to overall epigenetic
modifications that influence cellular aging (Pegoraro et al., 2009; Pollina & Brunet, 2011).
Loss of Proteostasis:
Impaired protein homeostasis is linked to aging. Endogenous and exogenous
insults to the cell leads to impaired protein folding during protein synthesis. The detection
of unfolded proteins is usually met either with refolding by heat-shock proteins or targeted
degradation through ubiquitin-mediated proteasomal or lysosomal pathways. Cells that
fail to clear unfolded proteins accumulate unfolded protein aggregates, with resultant
proteotoxicity (Powers, Morimoto, Dillin, Kelly, & Balch, 2009).
Deregulated Nutrient Sensing:
The IGF-1 pathway has been famously linked to aging through the identification of
C. elegans longevity mutants, and is one of the most conserved age-controlling pathway
between multiple species (Klass, 1983). Inhibition of IGF-1 signaling through caloric
restriction upregulates FoXO1, a tumor suppressor gene that mediates the observed
longevity effects (Yamaza et al., 2010). mTOR kinase downregulation also increases
longevity and mimics the effects of caloric restriction (Johnson, Rabinovitch, & Kaeberlein,
2013). The contributions of these two pathways indicate that reduced anabolic activity
mediates longevity.
Mitochondrial Dysfunction:
The free radical theory states that progressive aging results in the production of
reactive oxygen species (ROS) which leads to mitochondrial damage and global cellular
stress (Harman, 1965). Reduced mitochondrial biogenesis can occur as a result of
telomere attrition or p53 signaling but also occurs during physiologic aging (Bernardes de
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Jesus et al., 2012). Furthermore, the SIRT genes discussed above also modulate
mitochondrial biogenesis and can control the rate of ROS production by regulating the
antioxidant enzyme manganese superoxide (Qiu, Brown, Hirschey, Verdin, & Chen,
2010). Furthermore, the accumulation of mtDNA damage, the oxidation of mitochondrial
proteins or the destabilization of the electron transport change may all result in a decrease
in the proportion of healthy mitochondria and in turn contribute to cellular aging (K. Wang
& Klionsky, 2011).
Cellular Senescence:
Cellular senescence is the stable arrest of the cell cycle that is coupled with
phenotypic changes (Campisi, 2013). Senescence was first described by Hayflick while
culturing human fibroblasts, who noticed the inability of cells to progress past a certain
number of passages, termed the Hayflick number (Hayflick & Moorhead, 1961).
Senescence Associated β-Galactosidase is used to diagnose cellular senescence.
Senescent cells have an altered secretome, referred to as the senescence associated
secretory phenotype (SASP), which is a pro-inflammatory paracrine signaling pathway
that contributes to cellular aging and senescence (Campisi, 2013).
The accumulation of DNA damage and cellular stress responses results in the
induction of the p16INK4a/Rb and p19ARF/p53 pathways, which leads to cellular senescence
and contributes to physiologic aging (Baker et al., 2011). It is argued that cellular
senescence is a compensatory mechanism in response to the accumulation of damage,
and that senescence increases as cells exhaust their replicative capacity (Varela et al.,
2005).
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Stem Cell Exhaustion:
The loss of regenerative potential is an obvious characteristic of physiologic aging.
Functional attrition of stem cells from nearly every adult stem cell reservoir is exhibited as
aging progresses (Lopez-Otin et al., 2013). The accumulation of cellular damage,
telomere shortening and induction of cell cycle inhibitory proteins such as p16 or p53
contribute to the reduced self-renewal capacity of hematopoietic stem cells (HSCs)
(Janzen et al., 2006; Rossi et al., 2007). Stem cell exhaustion is likely the integrative
consequence of many age-related insults and is likely the definitive cellular defect that
underlies tissue and organismal aging.
Altered Intercellular Communication:
Alterations in intercellular communication modulate aging at a level beyond the
individual cell. Pro-inflammatory intercellular communication arises from inflammatory
tissue damage, chronic pathogen infection, dysfunctional immune signaling and the
activation of SASP, and age-associated inflammation reinforces the aging program
(Lopez-Otin et al., 2013; Salminen, Kaarniranta, & Kauppinen, 2012). The activation of
SASP causes a bystander effect in which senescent cells induce senescence in
neighboring cells through gap-junction mediating signaling, for example (Nelson et al.,
2012).
Conclusions:
The nine hallmarks of aging are divided into three subcategories: primary,
antagonistic and integrative. Primary hallmarks are unequivocally deleterious to the cell,
as is the case for DNA damage, telomere attrition, epigenetic alterations and defective
proteostasis. Conversely, antagonistic hallmarks are dependent on intensity: at low levels
they may be benign, but at high levels they impart damage to the cell. Examples of
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antagonistic hallmarks include senescence, ROS accumulation and elevated nutrient
sensing and metabolism. Lastly, integrative hallmarks such as stem cell exhaustion and
altered intercellular communication integrate some of the primary or antagonistic
hallmarks and in turn affect cellular and tissue homeostasis. Primary hallmarks are thought
to be the initiating hallmarks, which in turn lead to the antagonistic hallmarks, eventually
culminating in the integrative hallmarks that give rise to organismal aging (Lopez-Otin et
al., 2013). The hallmarks of aging are summarized in Figure 1-6.
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Figure 1-6

Figure 1-6. The Hallmarks of Aging. Taken from (Lopez-Otin et al., 2013). The nine
hallmarks of aging include: Genomic instability, telomere attrition, epigenetic alterations,
loss of proteostasis, deregulated nutrient-sensing, mitochondrial dysfunction, cellular
senescence, stem cell exhaustion and altered intercellular communication.
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The Aging Nucleus & Nuclear Envelopathies and Premature Aging Syndromes
They study of premature aging syndromes have been instrumental in elucidating
the molecular mechanisms behind physiologic aging. Moreover, the examination of
cellular aging is impossible without addressing the inextricable relationship between
cellular aging and nuclear structure and integrity.
Hutchinson Guilford Progeria Syndrome (HGPS)
The organization within the nucleus non-stochastic, and highly regulated into
functional neighborhoods of chromatin, subcompartments such as the nucleolus, and the
nuclear lamina. As described previously, the nuclear lamina is thought to act as the shield
that protects the genome from mechanical stress and as a regulator of chromatin
organization and gene expression. In 2003, the Collins and Levy labs identified mutations
in LMNA as the genetic cause for a premature aging syndrome termed Hutchinson-Gilford
progeria syndrome (HGPS) (Annachiara De Sandre-Giovannoli et al., 2003; Eriksson et
al., 2003). HGPS patients undergo normal embryonic development and appear normal at
birth and during infancy; however during childhood they begin to exhibit severe
degenerative symptoms such as failure to thrive, lipoatrophy, skeletal defects, osteolysis,
and alopecia. HGPS patients also suffer cardiovascular defects that lead to heart attack
and stroke, the ultimate cause of their extremely short lifespan. HGPS arises from the
Mendelian inheritance of a spontaneous C→T transition at position1824 of the LMNA
gene. Replacement of a single base produces a silent mutation which does not alter the
amino acid sequence (G608G). However, the mutation reveals a cryptic splice site within
LMNA; utilization of this splice site leads to an internal deletion of 50aa within the protein.
This deletion spans the Zmptse24 cleavage site. The resultant protein, termed Progerin,
therefore contains a 50 aa deletion and is permanently farnesylated at its C-terminus.
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HGPS is inherited as a heterozygous trait; Progerin exerts a dominant, negative effect
even in the presence of WT Lamin A (A. De Sandre-Giovannoli et al., 2003). Cells derived
from HGPS patients display irregular nuclear morphology, designating HGPS as a
laminopathy (Eriksson et al., 2003).
The expression of Progerin render cells more susceptible to damage by physical
stress because WT cells respond are thought to respond to mechanical stress by
redistributing Lamin A (Zhang et al., 2011). Progerin is found exclusively at the periphery
of the nucleus, unlike Lamin A. Moreover, HGPS nuclei exhibit a loss of LAD-associated
heterochromatin, a loss of overall repressive histone modifications and changes at the
level of chromatin-modifying complexes such as NuRD (Scaffidi & Misteli, 2005; Vidak &
Foisner, 2016). Progerin expression also affects genome stability by negatively affecting
DNA damage repair pathways. HGPS cells exhibit the accumulation of double strand
breaks as a result of impaired recruitment of DNA repair machinery such as 53BP1 and
Rad50/51. The accumulation and persistence of DNA damage leads to the induction of
p53 and promotes senescence (Brachner & Foisner, 2014).
HGPS preferentially targets tissue of mesenchymal origin, and evidence from the
literature indicates that the regulation and function of mesenchymal stem cells (MSCs) are
affected by Progerin expression (Gotzmann & Foisner, 2006). Low levels of Progerin are
observed during normal cellular aging, however, MSCs derived from HGPS patients
accumulate significant amounts of Progerin with passaging in vitro, and their self-renewal
and differentiation capacity are impaired (Wenzel et al., 2012).
Therapeutic treatment of HGPS was initially focused on repairing the mutant
protein with farnesyltransferase inhibitors, which improved some disease parameters such
as weight gain and bone structure (Cau et al., 2014; Gordon et al., 2012). Other
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approaches have included treatment with Rapamycin, an inhibitor of mTOR, which
relieves lobulated nuclei and clears DNA damage (Cao et al., 2011), Sulforaphane, an
antioxidant which enhances protein clearing and reverses some of the hallmarks of HGPS
(Gabriel, Roedl, Gordon, & Djabali, 2015), and Retinoids which showed promise by
decreasing Progerin levels (Kubben, Brimacombe, Donegan, Li, & Misteli, 2016).
Nestor Guillermo Progeria Syndrome (NGPS)
The homozygous inheritance of a single amino acid substitution from Alanine12 to
Threonine in BAF was identified as the cause of a novel progeria disease known as
Nestor-Guillermo Progeria Syndrome (NGPS) (R. Cabanillas et al., 2011). NGPS patients
share clinical features similar to those exhibited by HPGS patients, but lack cardiovascular
disease (R. Cabanillas et al., 2011). The clinical manifestations of NGPS do not begin until
approximately two years of age, when patients exhibit skin atrophy, general lipoatrophy
and severe osteoporosis with marked osteolysis (Puente et al., 2011). Craniofacial
abnormalities result from the atrophy of the facial subcutaneous fat and osteolysis of the
maxilla and mandible and incomplete closure of the cranial sutures. Diverging from HGPS,
NGPS patients retain eyebrows and eyelashes and, importantly do not exhibit cardiac
dysfunction, ischemia, atherosclerosis or metabolic syndromes (R. Cabanillas et al., 2011;
H. G. Fisher, N. Patni, & A. E. Scheuerle, 2020; Puente et al., 2011). The index patient
suffered of severe secondary pulmonary hypertension and subsequent heart failure as a
result of severe scoliosis (R. Cabanillas et al., 2011). Fibroblasts from NGPS patients
exhibit aberrant nuclear morphology which can was rescued by exogenous expression of
wild type BAF (R. Cabanillas et al., 2011; N. Paquet et al., 2014). A third NGPS patient
was recently identified in the US (Heather G. Fisher, Nivedita Patni, & Angela E.
Scheuerle, 2020)The literature has suggested that the A12T mutation in BAF does not
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affect interactions with LEM-D proteins or histone H3 (N. Paquet et al., 2014).
Interestingly, alanine12 is in close proximity to the BAF residues which have been
previously shown to affect in vitro chromatin condensation and histone binding (De Oca
et al., 2005), suggesting the possibility that A12T-expressing cells might exhibit defects in
chromatin condensation and histone binding, which could have negative consequence for
gene expression and eventual cellular dysfunction.
The ternary complex of BAF, a LEM-D domain and the IgF of Lamin A has shed
significant light the implications of the BAF A12T mutation. This report was the first to
demonstrate a direct interaction between BAF and the IgF of Lamin A and showed that
alanine12 is buried within the BAF: Lamin A interface. Moreover, this interface not only
contains alanine12, but contains several residues on the BAF-binding IgF surface of Lamin
A that are mutated in atypical progeria syndromes (Samson et al., 2018) (Figure 4-7 A).
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Figure 1-7

Figure 1-7. The Structure of the Nucleus and Aging. Cells that have undergone
physiologic aging or pathologic aging through the expression of progeria-associated
mutant proteins both undergo structural changes at the level of the nuclear envelope. The
integrity of the nuclear lamina is lost over time and nuclei develop dysmorphic nuclear
envelopes. Furthermore, these changes are met with the accumulation of DNA damage,
overall changes in the compaction of chromatin (including the formation of SAHF), and the
accumulation of stress responses like ROS accumulation and p53 signaling.
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Biochemical Characterization of BAF A12T
Dr. Aye Mon of the Traktman lab performed in depth biochemical comparison of
WT BAF and A12T BAF. To begin with, she established a model system in MCF10a cells
by expressing shRNA resistant 3XF-BAF or 3XF-A12T (discussed in Chapter 3) and then
depleting endogenous BAF. This approach established a close-to homozygous
expression system. In so doing, she observed that 3XF-A12T expressing cells exhibited
aberrant nuclear morphology, an observation that was also reproduced in this study. She
determined that 83% of 3XF-BAFexpressing cells exhibited normal nuclear morphology
whereas only 53% of 3XF-A12T-BAF-expressing cells had normal nuclear envelopes
(data not shown).
The first published study of the biochemical properties of A12T BAF noted that
cells derived from NGPS patients had lower steady state levels of BAF as analyzed by
immunoblot analysis (Puente et al., 2011). Based on this finding, the authors posited that
the stability of A12T was diminished and that this contributed to the molecular mechanism
behind the disease state. Using the model described above, Dr. Mon metabolically labeled
cells with

S-methionine and performed pulse chase experiments to analyze the half-life

35

of the protein. BAF is an extremely stable protein with a half-life of 35h; importantly, the
introduction of A12T did not alter the half-life (Fig 1-9 A).
The functional unit of BAF is a homodimer, through which it is able to associate
with its binding partners. The next question that was asked was whether A12T is able to
dimerize to the same efficiency of WT BAF. Recombinant BAF was purified and its
dimerization state analyzed using a size exclusion column: BAF dimers elute at
approximately 20 kDA, whereas monomers eluate at approximate 10 kDA. Analysis of the

34

gel filtration fractions that corresponded to these molecular masses indicated that the
A12T mutation does not affect dimerization (Fig 1-9-B).
BAF is rapidly and efficiently phosphorylated by VRK1 at Serine 4 and more slowly
at Threonine 2& 3 (R. J. Nichols, M. S. Wiebe, & P. Traktman, 2006). In vitro kinase assays
performed with recombinant WT or A12 BAF and purified VRK1 indicated that A12T does
not prevent the phosphorylation of BAF. In fact, A12T BAF appeared to be phosphorylated
more rapidly than WT BA (Fig 1-9-C). This result was intriguing, and led us to question of
whether threonine12 generated a novel phosphorylation site. To address this question,
T2, T3 and S4 were mutated to Alanine to generate a BAF phospho-null mutant or a BAF
A12T phospho-null mutant (R.J. Nichols et al., 2006). In vitro kinase assays indicated that
neither of these mutants were phosphorylated by VRK1, thereby showing that the
introduction of threonine as a result of the A12T mutation did not result in a novel
phosphorylation site. It is possible that the A12T mutation leads to a slight alteration in the
folding of the BAF protein that makes ser4 more accessible to VRK1.
The BAF homodimer binds dsDNA on either side with high affinity, and cross
bridges DNA into higher order structures. Paquet et al. found that A12T bound to dsDNA
with a lower affinity than WT BAF (Nicolas Paquet et al., 2014), as assessed by
electrophoretic mobility shift assays (EMSAs). Dr. Mon performed similar assays using
P-radiolabeled dsDNA oligonucleotide probes and purified recombinant WT or A12T
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BAF dimers. In these experiments, BAF and A12T had comparable DNA binding activity
in vitro (Fig 1-9 D).

Interestingly, a very recent 2021 paper (Marcelot et al., 2021)

assessed DNA binding in another manner, and their work demonstrated that the dsDNA
binding activity of WT and A12T BAF are indistinguishable.
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Cumulatively, these data indicate that the previously known biochemical functions
of BAF were unperturbed by the introduction of the A12T mutation. Therefore, this study
aimed to elucidate the molecular impact of the A12T mutation on BAF function in the
context of the nuclear envelope, and the overarching effects that these effects would have
at the level of the cell and the organism.
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Figure 1-8
A

B
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Figure 1-9. The Biochemical Characterization of BAF A12T. Aye Mon 2018Unpublished. (A) Assessment of the stability of WT and BAF A12T. (Top) MCF10a cells
that stably express 3XF-WTBAF and 3XF-A12TBAF were pulsed with 35S-met containing
DMEM medium for 2 h. Cells were washed and chased with DMEM complete media for 8
to 48 h. The 3XF-BAF proteins (WT and A12T) were retrieved by immunoprecipitation and
analyzed by SDS-PAGE \ and phosphorimager analysis. Black diamond indicates the
residual BAF protein during the chase. Bottom: Data were plotted; the half-lives of the two
proteins were indistinguishable (n = 3). (B) Dimerization of BAF is not perturbed by the
A12T mutation. The elution profile of gel filtration standards is shown. Lanes 6 -10
correspond to the protein standards of thyroglobulin and bovine γ-globulin with the
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molecular weights of 670 kDa and 158 kDa respectively; Lanes 11 – 21 correspond to the
ovalbumin protein standard with the molecular weight of 44 kDa; Lanes 22 – 36
correspond to the myoglobin protein standard with the molecular weight of 17 kDa. Black
diamond indicates the myoglobin with 17 kDa (bottom left and right) Size exclusion
chromatography of WT BAF dimers (bottom left) and A12T BAF dimers (bottom right).
Black diamonds indicate WTBAF and A12TBAF dimers. WTBAF and A12TBAF dimers
have the molecular weight of approximately 20 kDa, and were resolved from the size
exclusion column in the same fractions as the myoglobin standard (17 kDa). (C) VRK1
phosphorylates BAF A12T at least as well as WT BAF, and threonine 12 is not a new site
of phosphorylation. VRK1 kinase (10 nM) was incubated with WT or A12T BAF dimers
(1.5 μM) in the presence of [γ-32P] ATP for 0-10 min at room temperature. Reaction
products were resolved by SDS-PAGE and analyzed by silver staining (top) and
autoradiography (middle panel). In top panel, black diamond indicates the equal input of
BAF dimeric protein. On autoradiography, gray triangle indicates the phosphorylated BAF
proteins. Bottom panel: phosphorylated products were quantified and plotted; linear
regression analysis was performed to determine the slopes of WTBAF and A12TBAF. The
slope ratio

𝐴𝐴12𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠
𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠

indicates the difference in the rate of phosphorylation of WTBAF

and A12TBAF by VRK1. (n = 3) (D) BAF A12T and WT BAF exhibit comparable DNA
binding. Top: EMSA was performed using 100 nM of a 21-mer dsDNA probe and purified
recombinant WT and A12T BAF dimers at 66 nM, 100 nM, and 133 nM. Reaction products
were resolved on 4-10% acrylamide gel; a representative gel is shown. Black diamond
represents the free dsDNA probes, and gray triangle indicates dsDNA bound to BAF.
Quantitation of BAF binding to dsDNA. Calculation was performed using the formula
(

𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏
𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏+𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓

× 100), in which bound means dsDNA + BAF, and free means dsDNA.
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Chapter 2: Materials and Methods
Cell Culture Methods
All cells were cultured at 37°C in the presence of 5% CO2.
Harvest and Culture of Primary Mouse Dermal Fibroblasts
48-well dishes for culture were prepared by coating with 0.1% Gelatin solution (Life
Technologies #S006100) and incubating for 30-60min at room temperature. After
incubation, the remaining gelatin was aspirated and replaced with 250uL of warm mPEF
medium described in Table 2-1. Plates were left in the incubator while explants were
harvested in the mouse facility. In order to harvest ear punches, each mouse was
restrained in one hand and was placed inside the tissue culture hood. The ears, head and
face were sterilized using 70% ethanol. After the ear was sufficiently dry from the ethanol,
an ear puncher was used to generate a 1mm circular punch. Each individual punch was
placed in 500uL of ice cold mPEF medium on ice. Instruments were heat sterilized and
appropriately cooled between each mouse. After the harvesting was complete, the ear
punches were brought back to the tissue culture room on ice. The collection medium was
carefully aspirated and each punch was placed forcefully using sharp, sterile, forceps on
the gelatin at the bottom of the well, ensuring that the forceps were heat sterilized and
appropriately cooled between each ear punch
The 48-well dish was placed in the incubator and monitored daily. 100uL of fresh
media was added to each well every three to four days to compensate for evaporation.
After approximately two weeks, the volume of media was increased to 500uL/well and the
medium was carefully changed every three to four days without disturbing the ear punch.
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Once fibroblasts were confluent in each well, they were detached using 0.05%
Trypsin Ethylenediaminetatracetic acid (EDTA) (Life Technologies #15400054). They
were passaged at a 1:2 ratio until cells were comfortably doubling every 24-48 hours. The
subsequent passaging dishes did not need to be coated with gelatin. Once at least 5x107
cells were obtained, at least three vials were frozen in 10% Dimethylsulfoxside (DMSO)
with complete medium at a density of 1x106 cells/vial. Fibroblasts were kept relatively
confluent and passaged at a ratio of 1:3 to 1:5.
Stem Cell Culture
Culture of Induced Pluripotent Stem Cells
Induced pluripotent stem cells were cultured on human embryonic stem cell
(hESC) qualified Matrigel (Corning #8774552). Culture dishes are prepared by diluting the
Matrigel in DMEM/F12 (Life Technologies #1330057) at the appropriate ratio specified by
the manufacturer based on lot number. Dishes were then left to incubate one hour at room
temperature and stored for up to one week at 4°C. Coated dishes were then warmed for
one hour at 37°C before use. iPSCs were subcultured at a ratio of no less than 1:5 and
the medium was changed daily (see Table 2-1). iPSCs were subcultured by aspirating
media, washing twice with PBS, and adding Versene (Life Technologies #15040066),
formulated with 0.48mM EDTA in PBS, in order to gently lift the iPSCs in the absence of
proteases. Cells were then allowed to gently lift for 2-3 minutes at room temperature, the
Versene was aspirated and fresh media was added to the culture dish. Cells were gently
scraped in the fresh media using a cell scraper and, without dissociating the intact
colonies, transferred to a new Matrigel coated dish containing fresh medium.
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Differentiation and Culture of Induced Pluripotent Stem Cells to Induced Mesenchymal
Stem Cells
In order to differentiate iPSCs into induced mesenchymal stem cells (iMSCs),
iPSCs were plated on Matrigel coated dishes at a confluence of approximately 25%. Cells
were cultured in iPSC media for three to five days before switching the media to iMSC
media (see Table 2-1). Media was changed every three days for a total of 21 days. After
the 21st day, cells were passaged on to dishes coated with 0.1% gelatin (Attachment
Factor, Life Technologies #S006100) using 0.25% Trypsin EDTA (Life Technologies
#15400054), a concentration five-fold higher than generally used in cell subculturing. The
cells were subcultured at a ratio of 1:4 on gelatin for a total of three passages, each
passage using 0.25% Trypsin to lift the cells. On the fourth passage after gelatin, cells
were plated on uncoated tissue culture dishes, deemed passage zero. Subsequent
passaging of the cells occurred using 0.025% Trypsin EDTA and cells were always
subcultured at a ratio of 1:4. The success of this protocol is measured by the ability of the
cells to continue to proliferate on uncoated culture dishes.
Differentiation of Induced Mesenchymal Stem Cells to Lineage Cells
In order to determine whether the iMSCs are functional, they must be differentiated into
lineage cells such as osteoblasts and pre-adipocytes. To do this, iMSCs were plated in
24-well dishes at a density of 1x104 cells/cm2. Cells are cultured for three days in MSC
media, and then switched to either StemPro Osteogenesis Differentiation Medium (Life
Technologies #A1007201) or StemPro Adipogenesis Differentiation Medium (Life
Technologies #A1007001). The medium was changed every three days for a total of 28
days. Every seven days, cells were assessed for lineage staining: Alizarin Red (abcam

43

#146374) for osteoblasts, and Oil Red O (Simga Aldrich #O0625) for pre-adipocytes
(protocol outlined below). Pre-adipocytes and osteoblasts were not subcultured.
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Table 2-1 Table of Cell Culture Media
Cell Line

Cell
Line
Description

Base Media

Supplements

Source

mPEF

Primary
Mouse
Dermal Fibroblast

DMEM
(Sigma
Aldrich #D5796)
containing 4,500
mg/L
glucose,
4mM L-Glutamine
and NaHCO3 (no
Sodium Pyruvate,
no HEPES)

20% Fetal Bovine
Serum

Derived
from
mouse ears in
house

h-iPSC

Human
Induced
Pluripotent
Stem
Cells

mTesR1 defined
medium
containing zbFGF

Zebrafish derived

Bought
from
Applied Stem Cell

iMSC

Induced
Mesenchymal
Stem Cells

DMEM containing
(Sigma
Aldrich
#D5546)
containing 1,000
mg/L
glucose,
NaHCO3,
and
sodium pyruvate
(no L-Glutamine)

10% Fetal Bovine
Serum, 2mM LGlutamine (added
fresh).

Differentiated in
house from iPSCs

hASC

Human
Adipose
Derived
Mesenchymal
Stem Cells

DMEM containing
(Sigma
Aldrich
#D5546)
containing 1,000
mg/L
glucose,
NaHCO3,
and
sodium pyruvate
(no L-Glutamine)

10% Fetal Bovine
Serum, 2mM LGlutamine (added
fresh).

Bought
LaCell

Hek293T

Human Embryonic
Kidney
Cells
Expressing
TAntigen

DMEM
(Sigma
Aldrich #D5796)
containing 4,500
mg/L
glucose,
4mM L-Glutamine
and NaHCO3 (no
Sodium Pyruvate,
no HEPES)

10% Fetal Bovine
Serum

Bought
from
American
Type
Culture Collection
(ATCC)

MCF-10a

Human Mammary
Epithelial Cells

DMEM-F:12 (Life
Technologies
#
11330057)
containing 2.5mM
L-Glutamine and
15mM HEPES

5% Horse Serum,
500ng/mL
hydrocortisone,
100ng/mL Cholera
Toxin,
10ug/mL
human insulin and
20ng/mL epidermal
growth factor (EGF)

Bought
ATCC
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from

from

Established Cell Lines
Previously established cell lines were cultured in media according to Table 2-1.
Cells that were genetically manipulated to generate stable cell lines were cultured in the
presence of antibiotic selection that corresponded to the gene of interest, see Table 2-2.
Molecular Biology Methods
Generation of lentiviral particles for transduction of shRNA
A variant of the pHAGE lentiviral from containing a multiple cloning site (MCS) was
used to generate replication-deficient viral particles for stable transduction of cDNA.
pHAGE-PUROR-MCS (pPM), as described in Molitor & Traktman 2014 (T. P. Molitor &
Traktman, 2014). pPM was used to generate replication deficient lentivirus for shRNA
mediated depletion of target proteins were generated by transfecting HEK293T cells with
2ug of helper plasmids pRRE and pRSV-REV, 4ug of pVSVG and 12ug of the target
shRNA plasmid of interest using Lipofectamine 2000 transfection reagent (Life
Technologies #11668019). 24h after transfection, the medium was replaced with a
lentiviral harvest media containing: DMEM (Sigma Aldrich #5546), 10% Fetal Bovine
Serum (FBS), 0.5% bovine serum albumin (BSA), 10mM HEPES (4-(2-hydroxyethyl)-1piperazineethanesulfonic acid) and 2.5mM sodium butyrate. Following a 24h incubation in
harvest medium, the supernatant containing lentiviral particles was filtered using a 45um
filter and then treated with 8ug/mL of polybrene. Target cells were transduced with 1mL
of viral particles for 8-10h at 37°C, then media was replaced with the appropriate standard
media. After approximately 48h, cells were placed under selection appropriate to the
transfer plasmid at a concentration of 7.5ug/mL. Assays performed on these cell lines
were performed after selection and within 30 days post infection.
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Table 2-2 Table of Generated Cell Lines
Cell Line

Expression
Outcome

Expression
System

Genomic
Insertion

Promoter

Antibiotic
Selection

MCF-10a pHM

Empty Vector

Lentiviral
Transduction

Multiple
Random

CMV

Hygromycin

MCF-10a 3XFVRK1

3XF-VRK1

Lentiviral
Transduction

Multiple
Random

CMV

Hygromycin

MCF-10a 3XFVRK1 D177A

3XF-VRK1
D177A

Lentiviral
Transduction

Multiple
Random

CMV

Hygromycin

MCF-10a Scrm

Scramble
Control

Lentiviral
Transduction

Multiple
Random

Pol II

Puromycin

MCF-10a
shVRK1 (L1)

Silenced
VRK1

Lentiviral
Transduction

Multiple
Random

Pol II

Puromycin

MCF-10a
shVRK1 (KK2)

Silenced
VRK1

Lentiviral
Transduction

Multiple
Random

Pol II

Puromycin

MCF-10a
BAF

WT

3XF-BAF

Lentiviral
Transduction

Multiple
Random

CMV

Hygromycin

MCF-10a BAF
A12T

3XF-BAF
A12T

Lentiviral
Transduction

Multiple
Random

CMV

Hygromycin

MCF-10a
BAF_shBAF

3XF-BAF (sh
Resistant) _
Silenced
endogenous
BAF

Lentiviral
Transduction

Multiple
Random

CMV & Pol II

Hygromycin
& Puromycin

MCF-10a
A12T_shBAF

3XF-BAF
A12T
(sh
Resistant) _
Silenced
endogenous
BAF

Lentiviral
Transduction

Multiple
Random

CMV & Pol II

Hygromycin
& Puromycin

MCF-10a
BAF_shBAF _
H2B GFP

3XF-BAF (sh
Resistant) _
Silenced
endogenous
BAF_ GFP
H2B histones

Lentiviral
Transduction

Multiple
Random

CMV & Pol II

Hygromycin,
Puromycin &
Zeocin

MCF-10a BAF
A12T_shBAF
_ H2B GFP

3XF-BAF
A12T
(sh
Resistant) _
Silenced
endogenous
BAF_ GFP
H2B histones

Lentiviral
Transduction

Multiple
Random

CMV & Pol II

Hygromycin,
Puromycin &
Zeocin
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Generation of lentiviral particles for stable expression of transgenes
To generate lentiviral particles for expression of transgenes, 0.5ug of helper
plasmids pREV, pGAG/Pol, and pTAT, 1ug of VSVG and 12ug of a hygromycin-resistance
cassette, pHAGE-HYGR-MCS (pHM) (T. P. Molitor & Traktman, 2014) containing the
target gene of interest was used to transfect HEK293T cells at approximately 70%
confluence. The harvest of viral particles was performed as described above. Stable cell
lines were placed under selection using hygromycin at a concentration of 50ug/mL.
Transient Transfection
Cells were subjected to transient transfection using Lipofectamine 2000 (Life
Technologies #11668019) according to the manufacturer’s instructions. Plasmids that
were introduced to cells using transient transfection can be found in Table x.
Biochemical Methods
Purification of pGEX-Lamin A proteins
pGEX-Lamin A Ig fold constructs were generously gifted to us by the Zinn Justin Lab
(Institut de Biologie Intégrative de la Cellule, University of Paris) (Samson et al., 2018).
BL21-DE3 cells expressing pGEX-Lamin A IG fold (WT, R453C or R527H) were grown to
an OD550 of 0.5-0.7. in Luria-Bertani (LB) medium supplemented with 100ug/mL of
ampicillin at 37°C. Cultures were induced by the addition of Isopropyl-b-D-1thiogalactopyranoside (IPTG) to a final concentration of 1mM for three hours at 37°C. Cells
were harvested by centrifugation at 4,000xg for 30 minutes. Cells were suspended in PBS
containing: 1ug/mL Leupeptin, 1ug/mL Pepstatin and 0.2mM PMSF and subjected to
sonication 15 times per sample. After sonication, Triton-X 100 was added to a final
concentration of 1% and gently mixed and incubated on ice for 30 minutes. Lysates were
then clarified by centrifugation at 10,000xg for 20 minutes at 4°C. The resulting
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supernatant contained the soluble fraction of the pGEX-Lamin fusion proteins. In Vitro
Lamin-A and BAF binding assays were performed on the crude soluble lysate achieved in
this step.
Visualization of Proteins by Silver Staining of SDS-PAGE
In order to visualize and quantify protein content after induction or purification of
recombinant proteins, silver staining was performed on SDS-PAGE resolved protein
samples. BSA was serially diluted to 50ng, 100ng, 200ng, 400ng and 800ng, and utilized
as a protein standard for comparison. The gels were dehydrated by soaking in methanol
then incubated with 10uM DTT and stained with 0.1% (w/v) Silver Nitrate solution (Sigma
Aldrich #209139). Gels were placed in developer solution containing 6% sodium
carbonate (w/v) until protein bands were detectable. The developing reaction was
quenched by the addition of citric acid. Cells were then fixed using a solution of 50%
methanol and 10% acetic acid and then dried between two pieces of cellophane.
Co-Immunoprecipitation of GST-Lamin A with BAF
In order to assess the interaction of BAF with the Ig Fold of Lamin A, in vitro coimmunoprecipitation was performed. Crude GST-Lamin A (WT, R453C or R527H) lysates
were incubated with Glutathione sepharose beads (GE Healthcare #52-2303-00 AK) for
two hours at 4°C with end over end rotation in PBS containing the protease inhibitors
described above. Samples were washed twice and then 2ug of purified BAF WT or BAF
A12T were added to the samples. Samples were re-incubated for two hours at 4°C with
end over end rotation. Samples were boiled in sample buffer containing: 1% SDS, 1% bMercaptoethanol, 50mM Tris (pH 6.8), 6.5% glycerol, and bromophenol blue. Eluate was
subjected to SDS-PAGE alongside inputs, and samples were either subjected to silver
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staining or transferred on to nitrocellulose membrane and subjected to immunoblot
analysis to detect GST or BAF.
Cell Biology Methods
Growth curve assay and doubling time
Cells were detached from their dishes using 0.05% Trypsin EDTA and collected in
an equal amount of complete medium, then spun at 673xg for 5 minutes at room
temperature. The trypsin-containing media was then aspirated and the cells were flicked
to dissociate the pellet and resuspended into a single cell suspension in 1-2mL of
complete media. An aliquot of cells was taken and diluted 1:1 with 5% Trypan Blue. The
number of live cells in each of the outer quadrants of a hematocytometer were counted
and the average cell number per quadrant was taken. This number was multiplied by the
dilution factor of Trypan blue and the number of cells per mL was determined. Equal
densities of cells were plated in a 24-well plate in technical triplicate for each desired time
point. Cells were then counted using the same method described above at each desired
time point. The number of cells was plotted against the time elapsed, generating a growth
curve. To assess the apparent doubling time, cells were plated at equal densities and
counted 48h after plating. To determine the number of doublings, the equation
2x=nfinal/ninitial, where x equals the number of doublings and n equals the number of cells.
The apparent doubling time is then determined by h/x where h equals the number of hours
after seeding and x is the number of doublings calculated in the previous formula.
MTT Assay and Cell Titer Glo Assay
In order to generate a growth curve based on the metabolic activity of cells, an
MTT assay, a colorimetric assay based on the formation of insoluble formazan in viable
cells, was used. Cells were plated at a density of 5×103 cells per well of a 96-well dish
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and incubated for a desired period of time (usually 0, 24, 48, 72 and 96 hours). At each
desired

time

point,

tetrazolium

dye

MTT

3-(4,5-dimethylthiazol-2-yl)-

2,5,diphenyltetrazolium bromide (MTT) was added to a final concentration of 250ug/mL
per well, and incubation continued for three additional hours at 37°C. After three hours,
the plate was removed and 100uL of Stop Solution containing 20% Sodium dodecyl sulfate
(SDS) and 50% dimethylformamide (DMF) in dH2O was added to each well and the plate
was rocked at room temperature for one hour. After one hour, the plate was read on a
multi-well spectrophotometer at 570nm. The absorbance was plotted against the elapsed
time to generate a growth curve.
An alternative method to assess cell viability is the use of Cell Titer Glo (Promega
#G9241). Cell Titer Glo is a luminescent assay that measures ATP. The monooxygenation of luciferin by luciferase in the presence of Mg2+, molecular oxygen and ATP,
which is contributed by viable cells, results in a luminescent signal that is measured on a
spectrophotometer. Cells were plated at a density of 5×103 cells per well of a black walled,
clear bottom, 96-well dish and incubated for a desired period of time (usually 0, 24, 48, 72
and 96 hours). Cell Titer Glo reagent was added to each well and incubated for 10 minutes
at room temperature. Luminescence was measured on a multi-well spectrophotometer
and was plotted against the elapsed time to generate a growth curve.
Preparation of Cell Lysates and Immunoblotting
Medium was aspirated from dishes and cells were washed twice with ice cold
1xPBS, then lysed directly in the dish using “phospho-lysis buffer” (PLB) containing: 0.01M
NaPO4 (pH7.4), 0.1M NaCl, 1% Triton X-100, 2% SDS and 0.5% Deoxycholate
supplemented with protease and phosphatase inhibitors at a concentration of 1ug/mL of
Pepstatin, 1ug/mL of Leupeptin, 1mM PMSF, 1mM NaF, 5nM Calyculin A and 25 U/mL of
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Benzonase (Sigma Aldrich #E1014). Cells were scraped in the lysis buffer and transferred
to 1.5mL tubes and incubated on ice for 30 minutes. Lysates were cleared by spinning at
600xg at 4°C for 15 minutes. The supernatant was collected into a fresh tube. Protein
concentration was quantified using a Thermo Pierce BCA assay (#PI23227). 25-50ug of
protein was resolved by SDS-PAGE at 1W/cm between electrodes and then transferred
onto nitrocellulose membranes. Antibodies used in this study are described in Table 2-1.
Immunoblots were developed using Super Signal West Pico Chemiluminescence
Substrate (Thermo Pierce #PI34578) and developed on a FluorChem HD2 Imaging
Platform from Protein Simple. To quantify signal, densitometry was performed using the
protein simple quantification software (Alpha View).
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Table 2-3- Table of Antibodies
Antibody

Product
Number

Host

IF

WB

-Dilution

Dilution

Santa
Cruz
Biotechnology

sc-22760

Rabbit

Human,
Mouse

1:200

--

APO-B
(LDL20/17)

MabTech

3715-3-250

Mouse

Human

--

1:500

ATR

Santa
Cruz
Biotechnology

sc-515173

Mouse

Human,
Mouse

--

1:200

BAF (A-11)

Santa
Cruz
Biotechnology

Mouse

Human

--

1:1000

BAF

Abcam

ab129184

Rabbit

Human

1:200

1:1000

Calnexin

Enzo
Life
Sciences

ADI-SPA860-F

Rabbit

Human,
Mouse

--

1:1000

Chk-1

Santa
Cruz
Biotechnology

sc-8408

Mouse

Human,
Mouse

--

1:1000

E-Cadherin

BD
Biosciences

610181

Rabbit

Human,
Mouse

1:250

1:500

Emerin (FL254)

Santa
Cruz
Biotechnology

15378

Rabbit

Human,
Mouse

1:100

1:1000

Fibrillarin

Novus
Biologics

NB300-269

Mouse

Human,
Mouse

1:50

1:500

Flag (M2)

Sigma Aldrich

F1804

Mouse

--

1:200

1:2000

GAPDH
(EPR6256)

Abcam

ab128915

Rabbit

Human

--

1:1000

GFP
(EPR14104)

Abcam

ab183734

Rabbit

--

1:200

1:1000

H3K9me3

Abcam

ab8898

Rabbit

Human,
Mouse

1:200

1:1000

HNF4a (H1)

Santa
Cruz
Biotechnology

sc-374229

Mouse

Human,
Mouse

--

1:500

Mouse

Human,
Mouse

--

1:200

Mouse

Human,
Mouse

1:200

1:1000

53BP1
300)

(H-

Manufacturer

Reactivity

GST
H2B

Ku70
Lamin A/C
(2E8.2)

Millipore

7538
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Antibody

Manufacturer

Product
Number

Host

Reactivity

IF

WB

-Dilution

Dilution

Lamin B1

Abcam

ab16048

Rabbit

Human,
Mouse

1:200

1:1000

Nucleolin
(D4C70)

Cell Signaling
Technologies

14574S

Rabbit

Human,
Mouse

1:100

1:1000

p53 (DO-1)

Santa
Cruz
Biotechnology

sc-126

Mouse

Human,
Mouse

1:200

1:1000

p65
(D14E12)

Cell Signaling
Technologies

8242S

Rabbit

Human,
Mouse

1:100

1:1000

PARP
(46D11)

Cell Signaling
Technologies

9532S

Rabbit

Human,
Mouse

--

1:1000

p-Chk1

Cell Signaling
Technologies

2348S

Mouse

Human,
Mouse

--

1:1000

p-p53 (Thr18)

Santa
Cruz
Biotechnology

16716R

Rabbit

Human

--

1:1000

p-p65 (Ser536)

Cell Signaling
Technologies

3031S

Rabbit

Human,
Mouse

--

1:1000

Mouse

Human,
Mouse

--

1:1000

RPA
V5

Invitrogen

R960-25

Mouse

--

1:100

1:1000

Vimentin

Abcam

ab92547

Rabbit

Human,
Mouse

1:200

1:1000

VRK1

Sigma Aldrich

HPA017929

Rabbit

Human,
Mouse

--

1:1000

γH2AX
(Ser-139)

Cell Signaling
Technologies

2577S

Rabbit

Human,
Mouse

--

1:1000

γH2AX

Millipore

05636

Mouse

Human

1:200

1:1000
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Co-Immunoprecipitation of Flag-Tagged Proteins
Cells were harvested by lysing directly in the dish using “flag-lysis buffer”
containing: 150mM NaCl, 25mM Tris pH 7.4, 50mM EDTA, 0.1% Triton X-100, 0.01%
NP40 and 0.1% Tween. Protease and phosphatase inhibitors were supplemented in the
lysis buffer at a concentration of 1ug/mL of Pepstatin, 1ug/mL of Leupeptin, 1mM PMSF,
1mM NaF, 5nM Calyculin A and 25 U/mL of Benzonase (Sigma Aldrich #E1014). Cells
were incubated with magnetic Flag-conjugated beads (Sigma Aldrich #M8823) according
to the manufacturer’s instructions. Lysates were incubated with beads for four hours at
4°C with end over end rotation. Elution was performed by boiling samples for 10 minutes
in sample buffer containing: 1% SDS, 1% b-Mercaptoethanol, 50mM Tris (pH 6.8), 6.5%
glycerol, and bromophenol blue. Eluant was subjected to SDS-PAGE alongside inputs,
transferred on to nitrocellulose membrane and immunoblots against Flag and the protein
of interest were performed according to the specifications in Table 2-3.
Immunofluorescence
Cells were plated at equal densities on either four- or eight-well chamber slides
(NUNC Inc. #154526 or #154534 respectively) or 35mm (20mm imaging area) glass
bottom culture dishes (Mattek Corporation #NC9650104) either in the presence or
absence of a substrate coating of gelatin or Matrigel described above. If no substrate was
present, a Poly L-Lysine (Simga Aldrich #P8920) layer was coated on the glass. Cells
were treated as desired and then fixed for 15 minutes with 4% paraformaldehyde in PBS
(Electron Microscopy Sciences #15710) in dH2O on ice. Following PBS washes, cells were
permeabilized with 0.2% Triton-X 100 for five minutes on ice or, using “Hetzer Buffer”
containing: 0.1% Triton-X 100, 0.02% SDS and 10mg/mL of bovine serum albumin (BSA),
for 30 minutes at room temperature. The latter was only used when nucleolar structures
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were under investigation. Samples were then incubated for one hour at room temperature
with antibodies in 3% BSA (w/v), (or Hetzer buffer when appropriate) at concentrations
outlined in Table 2-3. Cells were then washed and incubated for one hour at room
temperature with secondary antibodies conjugated to Alexa Fluor 488 or 596 (Life
Technologies, 488: #A11034, 594: #A11037), or, when visualizing actin, phalloidin
conjugated to rhodamine (Life Technologies #A12381) was used. DNA was visualized by
staining with 4’,6’-diamidino-2-phenylindole (DAPI). Cells were then imaged on a Nikon
Eclipse Ti microscope.
Analysis of Nuclear Morphology
In

order

to

define

nuclear

morphology,

cells

were

analyzed

by

immunofluorescence as described above. Specifically, Lamin A/C was used to visualize
the nuclear envelope and DAPI to visualize the nucleus. Based on previously published
scoring methodologies (T. P. Molitor & Traktman, 2014) in each population of cells, the
nuclear envelope morphology was ascribed a score from one to six. Normal nuclei= 1,
invaginated= 2, highly invaginated= 3, pinched off= 4, blebbed= 5 and multi-nucleated= 6.
Live Imaging for Nuclear Rupture
Flow Cytometry to Assess Mesenchymal Stem Cell Surface Markers
Mesenchymal stem cell surface marker expression was assessed by flow cytometry using
an MSC Phenotyping Kit (Miltenyi Biotec #130-125-285). Samples were fixed using 4%
paraformaldehyde (Electron Microscopy Sciences #15710) at room temperature for 15
minutes. Cells were washed with PBS and then resuspended in “FACS Buffer” containing
0.5% BSA and 2mM EDTA in PBS, and the phenotyping cocktail provided by the kit. The
phenotyping cocktail contains positive surface markers: anti-CD73 conjugated to
allophycocyanin (APC), anti-CD105 conjugated to phycoerythrin (PE), anti-CD 90
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conjugated to fluorescein isothiocyanate (FITC); and negative surface markers: anti-CD
34, anti- CD45, anti-CD20, anti- CD14 all conjugated to PerCP-Cy5.5. Cells were
incubated with the phenotyping cocktail for 15 minutes at 4°C. Cells were analyzed on a
BD Fortessa X-20 Analytical Flow Cytometer. 10,000 events for each sample were
collected, and only live, individual cells were gated on. Samples were analyzed using the
FACSDiva software (BD Biosciences).
Metabolic Labeling of Cells to Assess Protein Synthesis
Cells were plated at a density of 1.5x105 cells in a 35mm culture dish. 48 hours
later, cells were washed with methionine free media, and then labeled with 100uCi/mL of
35S-methionine (Perkin Elmer #NEG709A500UC) for 45 minutes. As a control, cells were
pre-treated with cycloheximide for 20 minutes at a concentration of 50ug/mL. Cells were
harvested by scraping in ice cold PBS and lysed in lysis buffer containing 1% SDS, 1% bMercaptoethanol, 50mM Tris (pH 6.8), 6.5% glycerol, bromophenol blue and 2.5U of
Benzonase. Samples were incubated on ice for 30 minutes and then boiled for 5 minutes.
10% (for autoradiography) and 50% (for western blotting) of each sample was loaded and
run on a 7%-17% SDS-PAGE. For autoradiography: the gel was fixed in a solution of 50%
Methanol, 10% Acetic Acid and 40% dH2O, then dried between two sheets of cellophane.
The dried gel was then exposed on a phosphor-screen overnight and exposed on a
Typhoon for quantification. For western blotting: the gel was transferred overnight on to a
nitrocellulose membrane at 4°C at 35V then subjected to western blotting.
Senescence Associated b-Galactosidase Staining
Senescence associated b-galactosidase was used in order to detect βgalactosidase activity at a pH of 6, a characteristic of senescent cells. This was done by
examining the hydrolysis of 5-bromo-4-chloro-3-indolyl-b-d-galactopyranoside (BCIG or
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X-gal) by β-galactosidase yielding an insoluble blue byproduct visible to the naked eye
and by microscopy. A b-galactosidase staining kit from Cell Signaling Technology (Cell
Signaling Technology # 9860) was used. Cells were plated on four-chamber microscopy
slides (NUNC Inc. #154526) or 35mm (20mm imaging area) glass bottom petri dishes
(Mattek Corporation #NC9650104). Growth media was removed from the dishes and cells
were washed with PBS then fixed in situ using a proprietary fixative solution provided in
the components of the kit. Next, cells were washed and then overlayed with a βgalactosidase staining solution containing proprietary buffers and 10mg/mL of X-gal. Cells
were incubated at 37°C overnight and then imaged by phase microscopy. Quantification
of β-Galactosidase staining was performed by generating a scoring mechanism where 0=
absence of blue staining in the cell, 1= partial blue staining of the perinuclear area of the
cell and 2= complete blue staining of the perinuclear area and cytoplasm of the cell.
Senescence was reported as the number of cells falling into one of the three categories
described above divided by the total number of cells per condition.
Detection of Reactive Oxygen Species
The accumulation of reactive oxygen species (ROS) generates an oxidative
environment within the cell. 2’,7’-Dichlorofluorescin diacetate (DCFDA), a non-fluorescent
probe, is permeable across the plasma membrane. In the presence of oxidative
conditions, DCFDA is de-esterified and becomes highly fluorescent and trapped within the
cell. Cells were plated in 96-well tissue culture dishes. Cells were washed with serum free
media prior to the addition of DCFDA (Sigma #D6883). A solution of 2.5uM of DCFDA in
serum free media was added to the cells and incubated for 30 minutes at 37°C. Cells were
then washed and then analyzed for fluorescence intensity at 488nm on a
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spectrophotometric plate reader. As a positive control, cells were treated with 10uM
hydrogen peroxide (H2O2) for 30 minutes prior to the addition of DCFDA.
Comet Assay
Cells were plated at an equal density in 60mm dishes and incubated for 48h. Cells
were then treated with 50uM Etoposide for one hour. Samples were collected by scraping
gently in 1mL PBS and then counted on a hematocytometer and diluted to 1x105 cells/mL.
Comet assays were performed according to the Comet Assay Kit from TREVIGEN (2350050-K). Briefly, cells were combined with low-melt agarose and spread on a microscope
slide by using the side of a pipet tip. Slides were then gently immersed in the provided
lysis solution overnight in the dark. The next day slides were then aligned equidistant from
electrodes and subjected to electrophoresis at a voltage of 1 volt/cm (between electrodes)
at 4°C. The DNA was then ethanol precipitated in situ, then dried and stained with DAPI.
Slides were imaged at 10X magnification and comet moment was quantified by measuring
the vector length from the center of the comet head to the end of the comet tail.
Assessment of Lineage Differentiation Using Histologic Stains
In order to assess efficiency of lineage differentiation from mesenchymal stem cells
to osteoblasts and pre-adipocytes histologic stains against a specific cell types were used.
All samples were fixed in situ using 4% paraformaldehyde (Electron Microscopy Sciences
#15710) for 15 minutes at room temperature. Samples were plated in duplicate in order to
be stained with Crystal Violet as a positive stain for all cells, and to be used to calculate
the percentage of cells that stain positive for the lineage specific markers. For osteoblasts,
Alizarin Red (abcam #146374) was used at a concentration of 40mM. Pre-adipocytes were
stained with Oil Red O (Simga Aldrich #O0625) at 0.5% in methanol. All samples were
stained for 30 minutes at room temperature and then washed with dH2O and imaged on a
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light microscope. Following microscopy, samples were solubilized for quantitative
analysis. Samples stained with Crystal Violet were solubilized with 100% methanol,
samples stained with Alizarin Red were solubilized with 10% Cetylpyridinium chloride
(CPC) and samples stained with Oil Red O were solubilized with 100% Isopropanol.
Solubilized samples were then transferred to a clear-bottom 96-well dish in triplicate and
read on a spectrophotometer at 590mm absorption for Crystal Violet, 570mm absorption
for Oil Red O and 540mm absorption for Alizarin Red.
ATAC-Seq
ATAC-Seq is a method for mapping chromatin accessibility throughout the
genome. ATAC-Seq employs the use of hyperactive transposases that insert adapter
sequences into accessible areas of the genome; the presence of these integrated
adapters can then be assessed by sequence analysis (Buenrostro, Wu, Chang, &
Greenleaf, 2015). Cell pellets prepared from in duplicate for ATAC-Seq analysis at Active
Motif. Three analyses were used to assess differences in the accessibility of chromatin in
these cells. The preliminary analysis was performed by using a genome browser and
manually identifying peaks that exhibited at least a two-fold difference between the
samples. Secondly, we examined whether there were observable differences in chromatin
accessibility specifically at any of the following regions: distal intergenic, intronic, exonic,
3’UTR, 5’UTR, or any promoters ranging from <1kb to 5kb. These analyses were
performed on raw sequencing files. Following this, we filtered our reads and used Partek
Flow Software to call peaks that specifically align at transcription start sites.
Electron microscopy.
Confluent 60mm dishes of confluent cells were washed with Sorensen’s buffer
containing: 133mM Na2HPO4, 133mM KH2PO4 pH7.2, and fixed in situ with 1%
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glutaraldehyde in Sorensen’s buffer for 30min at room temperature. Cells were collected
by centrifugation at 800 x g for 7min and fresh fixative was added. Cells were then
processed for conventional electron microscopy and embedded in Embed 810 resin
(Electron Microscopy Sciences, Hatfield, PA). Thin sections were examined on a JEOL
JEM-1010 microscope and images were taken using a Hamamatsu camera.
Mouse Methods
All animal procedures were performed in accordance with the protocols approved
by the Medical University of South Carolina Institutional Animal Care and Use Committee
(IACUC).
Generating BANF1 A12T/+ mice
To generate a BANF1 A12T/+ mice, Applied Stem Cell generated an allele which
replaced a single codon in the second exon of the BANF1 gene. The codon encoding
Alanine 12, GCA, was replaced using CRISPR/Cas9 technology, and the resultant codon,
ACC, gave rise to a Threonine at position 12, thereby generating an A12T mutation in the
BAF protein.
Applied Stem Cell generated a six-mouse colony comprising three heterozygous (A12T/+)
females and three heterozygous males. Subsequent colony expansion was performed inhouse.
Genotyping BANF1 A12T Mice
In the WT BANF1 allele, the codon for the 12th amino acid, alanine, is GCA. To
generate the A12T amino acid substitution in our mice, the codon was changed from GCA
to ACC. This codon substitution generates two de novo restriction enzyme sites. The
BANF1 WT coding sequence contains two HPY 188III and one TSP 45I restriction enzyme
sites whereas the mutant allele generates a novel HPY 188III and TSP 45I restriction
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enzyme proximal to the mutation. We utilized the introduction of this unique restriction
enzyme site in order to genotype the mice.
Tail clips were obtained from mice at weaning by restraining the mouse in one
hand, introducing an ear tag, and using a fresh razor, cutting 1mm from the tip of the tail,
caudal to the end of the tail vein. Tail clips were maintained in 1.5mL tubes on ice until all
clips were complete.
Tail clips were subjected to an alkaline DNA extraction by incubating them in of
Alkaline Lysis Buffer containing: 25mM NaOH and 0.25mM EDTA in dH2O for 45 minutes
at 100°C. Extracted DNA was subjected to polymerase chain reaction (PCR) to amplify
exon two of the BANF1 coding sequence. Forward and reverse primers were designed
against the flanking regions of Exon 2. Once PCR was complete, restriction enzyme
digestion was performed on the PCR products. HPY 188III (NEB #R0622) and TSP 45I
(NEB #R0583) were individually incubated with the amplified BANF1 Exon 2 PCR product
for 2h according to the manufacturer’s instructions. Undigested and digested DNA were
electophoretically resolved using a 20% polyacrylamide gel cast in TBE at 250V. Bands
were subsequently visualized by staining with SYBR Gold (Life Technologies #S11494).
Genotypes were analyzed based on the banding patterns described in Figure 5-2.
X-Ray Imaging and Analysis of Mouse Skeleton
Mice were subjected to anesthesia using 20% Isoflurane by nose cone inhalation.
Mice were then laid on their left lateral side inside the imaging chamber of a Faxitron LX60 Cabinet X-Ray System. Mice were subjected to 40 kV of energy or 40 seconds and
then x-rays were developed. Mice were revived from anesthesia spontaneously under a
warming lamp. Skeletal measurements were taken based on anatomical landmarks.
Measurements taken include: length of nasal bone, distance between nasomaxillary point
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to superior incisor point, mandible length, menton to mandibular condyle, cranial length,
occipital bone to coronal suture, coronal suture to tip of nasal bone, body length (from
nose to anus), femur length, tibia length, humerus length, the height and width of the fifth
lumbosacral vertebra, the distance between the top of the fourth lumbosacral vertebra to
the bottom of the sixth lumbosacral vertebra, and the kyphosis index which is measured
by taking the distance between the bottom of the sixth cervical vertebra to the bottom of
the sixth lumbosacral vertebra (line AB) and the distance from the highest point in the
curvature of the spine down to line AB, generating line CD. The ratio of line AB to line CD
is deemed the kyphosis index. Figure x depicts the measurements made for each x-ray
taken.
Full Body Mouse Necropsy and Histologic Analysis
In order to perform histopathologic studies on the mice, full body necropsies were
performed by euthanizing mice using CO2 inhalation followed by secondary cervical
dislocation. All organs were harvested and maintained in 10% neutral buffered formalin
(Sigma Aldrich #HT501128). Samples were then submitted to the Division of Laboratory
Animal Resources, Veterinary Pathology Services at the Medical University of South
Carolina. Briefly, samples were subjected to either Hematoxylin & Eosin staining or
Masson’s Trichrome staining in order visualize microscopic substructures.
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Chapter 3: The Effect of BAF and BAF A12T Overexpression in Mammary
Epithelial Cells
Introduction
As discussed extensively in Chapter 1, the nuclear envelope is a highly-organized
structure which provides a barrier between the cytoplasm and the nucleus while still
allowing for highly regulated communication between the two cellular compartments
(Hetzer, 2010). BAF acts as a bridge between the nuclear lamina and chromatin and
creates an interface between the two. In addition to regulating nuclear structure, BAF is
involved in the disassembly and reassembly of the nuclear envelope in mitosis. It is also
thought to play a unique role in gene expression in two ways: the first is through
transcriptional regulation, and the second through epigenetic organization of chromatin.
At the transcriptional level, BAF has been shown to associate with multiple transcription
factors, pointing at a potential for regulating gene expression. At the epigenetic level, BAF
has been shown to bind histones and chromatin, thereby modifying overall chromatin
organization. Although BAF binds dsDNA in a sequence independent manner, it also binds
histones H3 and H1.1, and affects accessibility to chromatin through these interactions (T.
Chandra et al., 2015; R. Montes de Oca, Lee, & Wilson, 2005; Ronglang Zheng et al.,
2000). These findings indicated to us that BAF has the capacity to influence
chromatin organization and epigenetic regulation of gene expression.
Rationale
BAF is an essential protein that bridges the nuclear lamina and chromatin and
regulates nuclear structure. Phosphorylation of BAF by VKR1 regulates its interactions
with dsDNA, and LEM-D proteins and alters its subcellular localization (R.J. Nichols et al.,
2006). Molitor and Traktman demonstrated in 2014 that the depletion of VRK1 resulted in
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nuclear dysmorphia in MCF-10a cells and decreased the fraction of mobile BAF (T. P.
Molitor & Traktman, 2014). Molitor and Traktman also published that the depletion of
VRK1 slowed the doubling time of breast cancer cells and reduced the instances of distal
metastases in a breast cancer model (T.P. Molitor & Traktman, 2013). Moreover, the
homozygous inheritance of a missense mutation in BAF from Alanine 12 to Threonine
results in a premature aging syndrome termed NGPS; patient-derived cells exhibit
aberrant nuclear envelope structure, thereby designating it as a laminopathy (Puente et
al., 2011). We hypothesized that the hypophosphorylation of BAF contributed to the
nuclear envelope defect observed in VRK1-depleted cells and that the discovery of the
A12T mutation could further inform the model generated by Molitor and Traktman and help
elucidate the molecular mechanisms underlying these observations.
The BAF A12T mutation is not predicted to alter in the overall secondary structure
of the protein: A12 is not localized in the dimerization interface of BAF, and dimerization
is not disrupted in vitro (Nicolas Paquet et al., 2014). Furthermore, A12T mutation did not
compromise binding to known protein partners such as Emerin, Lamin and histone H3
protein, however purified protein exhibited decreases DNA binding (Nicolas Paquet et al.,
2014). Before the publication of the paper identifying the binding interface between BAF
and Lamin A, the surface was thought as being important in chromatin condensation and
histone binding (R. Montes de Oca et al., 2005; Samson et al., 2018; Segura-Totten,
Kowalski, Craigie, & Wilson, 2002). We posited that the mutation had implications in
chromatin structure and organization. Knowing that BAF may be involved in the regulation
of higher order chromatin organization, we hypothesized that the spatial organization
of the nucleus would be disrupted and that there might be an overall loss of
heterochromatin. We further hypothesize that the loss of higher order structure in the
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nucleus would cause a shift in gene expression profiles, which is a contributing
factor the development of the disease phenotype.
Chromatin conformation is tightly orchestrated spatially and temporally within the
nucleus (Harr, Gonzalez-Sandoval, & Gasser, 2016). In an extensive review (Harr et al.,
2016), a compilation of the histone associated proteins of the nuclear envelope revealed
the extent to which the INM proteins participated in the coordination of chromatin
organization through histone modifications. Although BAF has been fairly well
characterized, the role it plays in higher order chromatin organization has not yet been
well parsed out in interphase nuclei. Given what is known about tissue-specific chromatin
organization, we aimed to characterize the role of WT BAF and BAF A12T on higher order
chromatin structure. Chromatin can be classified in two compartments, open,
euchromatin,

and

closed,

heterochromatin.

Whether

the

overall

chromatin

organization in NGPS is altered has yet to be seen and characterizing the structural
differences of chromatin in BAF A12T cells will provide insight into the contribution
of higher order chromatin organization to the disease phenotype.
Results
Generating a Stable Mammary Epithelial Cell Line That Constitutively Expresses 3XFBAF or 3XF-BAF A12T Depleted for Endogenous BAF
The clinical manifestation of NGPS results from the homozygous inheritance of the
BAF A12T allele (Puente et al., 2011). To examine the impact of the BAF A12T mutation
in a close-to homozygous setting, we generated MCF-10a cells that constitutively
overexpress 3XF-BAF or 3XF-BAF A12T through a lentiviral transduction system, while
also introducing shRNA that targets endogenous BAF. Control cells were transduced with
a corresponding empty lentiviral vector. In order to silence endogenous BAF but not the
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BAF introduced by the lentiviral expression system, the 3XF-BAF and 3XF-BAF A12T
constructs had mutations introduced into the shRNA recognition sites in the 3’
untranslated region (UTR). Lentiviral mediated transduction of MCF-10a cells with both
expression vectors resulted in modest overexpression of 3XF-BAF to an average of twofold the levels of endogenous BAF while in turn depleting the levels of endogenous BAF.
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Figure 3-1. Generating a Stable Mammary Epithelial Cell Line That Constitutively
Expresses 3XF-BAF or 3XF-BAF A12T Depleted for Endogenous BAF. The first lane
represents parental MCF-10a cells, unmodified by lentiviral transduction, the vector
control lane represents MCF-10a cells transduced with an empty pHM vector that does
not encode for any mammalian protein, the remaining two lanes represent MCF-10a cells
transduced with lentiviruses encoding shRNA resistant 3XF-BAF or 3XF-A12T in order to
introduce exogenous BAF protein. Endogenous BAF was then depleted using lentiviral
mediated-transduction of shBAF targeting the endogenous (but not exogenous) protein.
This model achieves near homozygous expression of either WT BAF or A12T, allowing
the study of the effects of this recessive mutation in this model.
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The Expression of Wild Type 3XF-BAF or 3XF-BAF A12T Does Not Alter the Doubling
Time or Growth of Cells Compared to Vector Control
When MCF10a cells are depleted of VRK1, the kinase responsible for
phosphorylating BAF, the apparent doubling time increases (T.P. Molitor & Traktman,
2013). In order to ask the question whether MCF-10a cells expressing 3XF-BAF or 3XFBAF A12T in a close-to homozygous background also have an altered doubling time, we
performed four different assessments: analysis of apparent doubling time, growth by
counting cells on a hemocytometer, MTT assay and Cell Titer Glo assay. In all cases,
proliferation between vector control cells and cells overexpressing 3XF-BAF or 3XF-BAF
A12T showed no significant difference. Statistical significance was determined by
performing a student’s t-test for the assessment of apparent doubling time and non-linear
regression and multiple t-tests for the growth curves.
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Figure 3-2
A

B

C

D
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Figure 3-2. Assessment of Proliferation in 3XF-BAF or 3XF-A12T Expressing Cells.
(A) Apparent doubling time of vector control cells is approximately 18h, whereas cells
expressing either 3XF-BAF or 3XF-A12T have a doubling time of approximately 20h, an
apparent doubling time of 2h greater than vector control, but not different between the
homozygous expression of WT 3XF-BAF and 3XF-A12T as described in Chapter 2. (B)
Cells were seeded at equal densities and counted every day for 4 days by staining with
Trypan Blue and counting live cells. This was repeated in 5 independent experiments and
cell number was plotted against time to generate a growth curve. (C) Cells were plated at
equal densities and then subjected to MTT analysis across 4 days as described in Chapter
2. This represents 6 independent experiments. 570nm absorbance was measured on a
spectrophotometer and plotted against time to generate a growth curve. There was no
significant difference between the rate of proliferation of 3XF-BAF expressing cells and
3XF-A12T expressing cells. (D) Cells were plated at equal densities and then subjected
to Cell Titer Glo analysis as described in Chapter 2. This represents 6 independent
experiments. Luminescence was

measured by spectrophotometer and plotted against

time to generate a growth curve. Statistical analysis revealed no significant difference
between the growth curves of cells expressing 3XF-BAF or 3XF-A12T.
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The Homozygous Expression of 3XF-BAF A12T Results in Aberrant Nuclear Morphology
Cells derived from patients afflicted with NGPS display a clear change in nuclear
morphology that is characteristic of all premature aging syndromes arising from mutations
in the components of the nuclear periphery. Expression of 3XF-BAF A12T results in the
deformation of the shape of the nucleus. Cells were stained using a Lamin A antibody and
were assessed by fluorescence microscopy as described above. Approximately 50% of
the cells expressing 3XF-BAF A12T display some amount of nuclear envelopathy.
Furthermore, using the scoring scheme described in Moltior & Traktman 2014 (T. P.
Molitor & Traktman, 2014) the distribution of the severity of the nuclear dysmorphia was
analyzed. Whereas vector control cells and cells overexpressing 3XF-BAF WT displayed
normal nuclei at a frequency of 83% and 79% respectively, only 51% of cells expressing
3XF-BAF A12T displayed a normal nuclear morphology. 35% of 3XF-BAF A12T
expressing cells had nuclei that were assigned a score of 2 and 8% were assigned a score
of 3.
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Figure 3-3. Homozygous Expression of 3XF-A12T Results in Aberrant Nuclear
Morphology. (A) Cells were analyzed by immunofluorescence of Lamin A to for nuclear
morphology abnormalities. Normal nuclei were defined by a score of 1 based on the scale
defined in Molitor & Traktman 2014, and aberrant nuclei were defined by a score >1. 50%
of the cells expressing 3XF-A12T exhibited dysmorphic nuclei. (B) Cells expressing 3XFBAF appear to have well rounded, smooth nuclei when analyzed by immunofluorescence
of Lamin A; meanwhile, cells expressing 3XF-A12T exhibit dysmorphic nuclei that contain
invaginations, blebs and in some cases multinuclei. (C) Using the scoring scheme defined
in Molitor and Traktman 2014, cell nuclei were assigned a score of 1-6, with 1 defined as
smooth round nuclei, and 6 as multinucleated and blebbed. Vector expressing cells and
3XF-BAF expressing cells both exhibited approximately 80% normal nuclei, whereas cells
expressing 3XF-A12T had a majority of their nuclei with a score of 2 or greater.
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The Homozygous Expression of 3XF-BAF A12T Does Not Alter the Steady State Levels
of Proteins of the Nucleus
BAF interacts with many different binding partners within the nucleus, including the
nuclear lamins and proteins with a conserved LEM domain. We used immunoblotting and
band analysis, in order to ask whether the steady state levels of components of the nuclear
periphery were altered during 3XF-BAF A12T expression. The proteins of the nuclear
lamina, together with BAF, organize the nuclear periphery to provide structure and
modulate the functions of the nucleus. Any alterations in the steady state levels of these
proteins could point at a loss of interaction or organization at the nuclear periphery and
may be a contributing factor to the formation of dysmorphic nuclei in the presences of a
homozygous expression of 3XF-A12T. Using immunoblotting and immunofluorescence,
we assayed steady state levels and distribution of Emerin, Lamin A/C and Lamin B, and
found that they were unchanged in the presence of homozygous 3XF-BAF A12T.
Additionally, cells that exhibit premature aging phenotypes have an increased
amount of heterochromatin and as such, an increase in the amount of tri-methylated
histone 3 at lysine 9 (H3K9me3). H3K9me3 is found at sites of physiologic
heterochromatin but also is a component of senescence associated heterochromatin foci
(SAHF) in the context of cellular aging (Romero-Bueno, de la Cruz Ruiz, Artal-Sanz,
Askjaer, & Dobrzynska, 2019). While senescent cells can exhibit dynamic signaling
changes such as the upregulation of senescence associated secretory phenotype (SASP)
components, once SAHFs have been formed, the heterochromatic structures are largely
static and organized into repressive layers that are spatially distinct from transcriptionally
active chromatin (Tamir Chandra & Narita, 2013). The use of H3K9me3 for analysis by
immunofluorescence to analyze distribution and by immunoblotting to assess steady state
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levels are, therefore, straightforward methodologies to ask whether SAHF are being
formed in association with cellular senescence. Steady state levels of H3K9me3 were
unaltered in the presence of homozygous expression of 3XF-A12T, and the distribution of
H3K9me3 foci was undistinguishable between cells expression 3XF-BAF and 3XF-A12T.

76

Figure 3-4
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Figure 3-4. Nuclear Protein Expression and Distribution Is Unaltered by The
Expression of 3XF-A12T. (A) Steady state levels of Lamin A/C, Lamin B and Emerin
were analyzed by immunoblotting. Band analysis and quantification revealed no
significant differences between the steady state levels of these NP proteins in 3XF-BAF
expressing cells compared to 3XF-A12T expressing cells. This experiment is
representative of 4 independent experiments. Statistical analysis was done by individual
student’s T-tests between conditions (B) Immunofluorescence for H3K9me3 was
performed to compare the distribution of heterochromatin foci in cells expressing 3XF-BAF
or 3XF-A12T. The number of foci and fluorescence intensity were no different between
cells expressing 3XF-BAF and 3XF-A12T indicating no changes in the formation of SAHF.
(C) Immunoblot analysis of the steady state levels of H3K9me3 further indicate that the
expression of 3XF-A12T does not result in the accumulation of H3K9me3 in the nucleus.
Band analysis and Student’s T-tests were used to determine no significant differences
between samples.

78

The Homozygous Expression of 3XF-BAF A12T Results in Minor Alterations in the
Nucleus
The nucleolus is a nuclear substructure in which the transcription of ribosomal RNA
(rRNA) occurs. The nucleolus is a dynamic structure that responds to cellular signaling,
stress, and metabolism.(Boulon, Westman, Hutten, Boisvert, & Lamond, 2010). Previous
studies have shown that in normal cells, nucleolar size and function are tightly regulated
by the Lamin A meshwork, whereas in the context of HGPS, the Lamin A meshwork is lost
and in turn nucleolar expansion and rRNA production increases. These phenomena result
in an increase in nascent protein synthesis. (Buchwalter & Hetzer, 2017). Furthermore,
nucleolar size inversely correlates with longevity. Tiku et al. demonstrated that C. elegans
longevity mutants have reduced ribosome biogenesis, smaller nucleoli, and decreased
protein synthesis (Tiku et al., 2017). Owing to the idea that nucleolar size can indicate
changes in rRNA synthesis and in turn nascent protein synthesis, we asked whether
steady state levels of a nucleolar marker, nucleolin, were altered and whether nucleolar
number or size were altered in the context of 3XF-A12T homozygous expression.
Measuring these nucleolar parameters was performed by fluorescence microscopy.
Nucleoli were visualized by immunostaining for nucleolin, and DAPI was used to
counterstain the DNA. The area of the nuclei and nucleoli were measured based on DAPI
staining and nucleolin staining respectively and the area and the number of nucleoli were
quantified.
Whereas cells expressing 3XF-BAF A12T had a slightly increased nuclear area,
the nucleolar area was decreased, and the number of nucleoli was not altered. These data
suggest that the area occupied by the nucleoli within the nucleus is significantly smaller in
cells expressing 3XF-BAF A12T as compared to cells with wild type BAF expression. The
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decreased occupancy of the nucleolus within the 3XF-A12T nucleus could imply variations
in the amount of rRNA production and overall nascent protein synthesis. The inversion of
the phenotype, however, is intriguing. While HGPS cells exhibit nucleolar expansion, the
homozygous expression of 3XF-A12T leads to a decrease in nucleolar area and nuclear
occupancy. Whether these slight variations have a biological influence on the behavior of
the cells would be determined by the overall protein turnover as assessed by metabolic
labeling and analysis of nascent protein synthesis.
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Figure 3-5
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Figure 3-5. Assessment of Nucleoli in 3XF-BAF and 3XF-A12T Expressing Cells. (A)
Cells were immunostained with antibodies directed against Fibrillarin, a marker of the
fibrillar component of the nucleolus and Nucleolin, a nucleolar marker, and counterstained
with DAPI (for DNA). Representative images are shown; 3 independent experiments were
performed and approximately 10 fields/experiment were analyzed. (B) Nuclear size was
analyzed by taking the total area of positive DAPI staining per cell; approximately 500 cells
from 3 independent experiments were analyzed. Statistical significance was determined
by multiple Student’s T-tests. The average area of vector and 3XF-BAF expressing cells
is approximately 500um2 , whereas the average nuclear area of 3XF-A12T-expressing
cells is approximately 600um2. (C) Nucleolar area was determined by measuring the total
area of Nucleolin staining that is delimited by a strong outer ring, and that colocalizes with
Fibrillarin staining. The nucleolar area is the measurement of each nucleolus in the cell,
not the average nucleolar area per cell. Approximately 1000 nucleoli were analyzed from
3 independent experiments and statistical significance was determined by multiple
Students T-tests. The average nucleolar area of 3XF-BAF expressing cells and vector
control cells is 30um2, whereas the average nucleolar area of 3XF-A12T expressing cells
is 20um2. (D) The number of nucleoli per cell was counted by indexing any structures that
contained were delimited by a strong outer ring of Nucleolin and that co-localized with
Fibrillarin. The number of nucleoli per cell was taken by analyzing 50 nuclei from 3
independent experiments. There are approximately 3 nucleoli per cell in all conditions. In
all measurements, the mean and standard error of the mean were plotted. (E) Immunoblot
analysis of the steady state levels of Nucleolin reveal no alterations between any of the
conditions. Band analysis reveals no significant differences in the relative expression
levels of Nucleolin.
83

Nascent Protein Synthesis Was Unaltered in Cells Expressing 3XF-BAF A12T
Based on the observation that the nucleolar area was significantly smaller in cells
expressing 3XF-BAF A12T, we asked whether the rate of nascent protein synthesis was
altered. One of the nine hallmarks of aging is the loss of proteostasis, with a concomitant
increase in nascent protein synthesis (Buchwalter & Hetzer, 2017; Lopez-Otin et al.,
2013). To ask whether there were alterations in protein synthesis in cells expressing 3XFBAF A12T, we performed metabolic labeling using

S-methionine/cysteine. Protein

35

synthesis remained unaltered in cells expressing 3XF-BAF A12T as compared to cells
expressing wild type BAF. Therefore, even though we observed differences in nucleolar
occupancy in the nucleus, this did not correlate to changes in protein synthesis.
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Figure 3-6. Nascent Protein Synthesis is Unaltered in Cells Expressing 3XF-A12T.
The production of nascent proteins was analyzed by pulsing the cells with

S-
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methionine/cysteine. Samples were resolved by SDS-PAGE and subjected to
phosphorimager analysis (left). Protein synthesis was unaltered in cells expressing 3XFA12T compared to 3XF-BAF or vector control. These data are representative of 3
independent experiments. Band analysis was performed, and statistical analysis was
based on multiple student T-tests.
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Cells Expressing 3XF-BAF A12T Exhibited an Increase in the Accumulation of DNA
Double Strand Breaks, but Do Not Accumulate Reactive Oxygen Species as a Measure
of Cellular Stress
The accumulation of DNA damage is one of the hallmarks of aging (Lopez-Otin et
al., 2013). The accumulation of dsDNA breaks results in genomic instability and in some
cases, a subsequent arrest in cell proliferation (Efeyan & Serrano, 2007). To measure
DNA damage, we assessed the levels of RPA, p53 and gamma-H2AX steady state levels
in cells expressing 3XF-BAF A12T as compared to those expressing wild type 3XF-BAF
or vector controls. As a positive control, cells were treated with the DNA damaging agent
Etoposide at a concentration of 100µM for one hour. Interestingly, cells expressing 3XFBAF A12T exhibited an increase in the steady state levels of gamma-H2AX in the absence
of any exogenous DNA damaging agents, whereas the steady state levels of RPA and
p53 remained unaltered. These results were intriguing, since the constitutive
phosphorylation-mediated activation of histone H2AX normally leads to the activation of
the DNA damage response pathway, and to the resolution of dsDNA breaks or cell cycle
arrest (Itahana, Dimri, & Campisi, 2001; Jakob et al., 2011). However, as indicated by
figure 3-2, proliferation was unaltered in these cells, indicating an ability for these cells to
bypass the presumed accumulation of DNA damage. To further assess whether the
activation of H2AX was truly a result of the accumulation of dsDNA breaks, we performed
a comet assay. Single cell DNA electrophoresis indicated that there was, in fact, an
increase in the number of DNA double strand breaks per cell in cells expressing 3XF-BAF
A12T, as indicated by the vector length of the comet tails generated by resolved dsDNA
on slides coated with agarose and then stained with DAPI. The presence of “basal” DNA
damage in 3XF-A12T cells is clear, what remains unclear is the biological significance.
The cells do not exhibit slowed proliferation, nor do they have increased levels of p53.
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To assess whether the genotoxic stress present in these cells results in the
accumulation of other stress responses, we next asked whether there was an
accumulation of reactive oxygen species. We posited that cells may accumulate reactive
oxygen species as a result of cellular stress. Furthermore, one of the nine hallmarks of
aging is mitochondrial dysfunction (Lopez-Otin et al., 2013). The accumulation of genomic
stress and reactive oxygen species is also a phenomenon observed in prematurely aged
cells. In order to measure whether cells accumulated reactive oxygen species, they were
treated with DCFDA. ROS lead to the esterification of the substrate DCFDA, which can be
measured by the emission of light at 488nm. As a positive control, cells were treated with
hydrogen peroxide for one hour prior to the assay. Cells expressing 3XF-BAF A12T did
not have a noticeable accumulation of ROS as compared to cells expressing 3XF-BAF
WT, and both conditions had a negligible accumulation of ROS as compared to cells
treated with H2O2. Therefore, even though genomic instability was present in these cells,
the accumulation of ROS and eventual mitochondrial dysfunction was not observed.
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Figure 3-7
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Figure 3-7. DNA Damage Analysis of Cells Expressing 3XF-A12T. (A) Immunoblot
analysis of DNA damage response proteins RPA and p53 in the presence and absence
of 100uM Etoposide for 1h. Steady state levels of RPA and p53 were not different between
cells expressing 3XF-BAF or 3XF-A12T, nor were there differences in the response to
exogenous DNA damage (increased levels). (B) Immunoblot analysis of γH2AX in the
presence and absence of 100uM Etoposide was performed. The steady state level in the
absence of exogenous DNA damage is 2-fold higher in cells expressing 3XF-A12T BAF
in comparison to cells expressing 3XF-BAF or Vector control cells. The level of γH2AX
increases approximately 2-fold in the presence of etoposide in control cells, whereas it
appears that there is no further induction of this damage response in 3XF-A12T
expressing cells. (C) A comet assay was performed on cells expressing 3XF-BAF or 3XFA12T in the absence and presence of 100uM Etoposide. Single cell electrophoresis was
followed by DAPI staining to visualize DNA. Vector tail lengths were measured and plotted.
This image is representative of approximately 25 fields per experiment, 3 independent
experiments. Quantification was performed on approximately 500 cells, and multiple
Students T-tests were used for statistical analysis. In each cell line the vector length of
each comet tail increased in the presence of Etoposide, however the comet tail vector
length was significantly greater in cells expressing 3XF-A12T in the absence of Etoposide
compared to cells expressing 3XF-BAF.
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Figure 3-8

Figure 3-8. DCFDA Analysis of ROS. Cells were treated with DCFDA in order to measure
the accumulation of reactive oxygen species in the cells. Vector control cells were treated
with H2O2 as a positive control prior to DCFDA treatment. Vector control cells, 3XF-BAF
and 3XF-A12T cells alike had a fluorescence intensity of about 300 A.U. whereas H2O2
treated cells had a fluorescence intensity of greater than 1500 A.U., a massive increase
compared to the rest of the cells.
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ATAC-Seq Analysis Reveals No Overall Alterations in Gene Accessibility in Cells
Expressing BAF A12T
ATAC-Seq is a method for mapping chromatin accessibility throughout the
genome. ATAC-Seq employs the use of hyperactive transposases that insert adapter
sequences into accessible areas of the genome; the presence of these integrated
adapters can then be assessed by sequence analysis (Buenrostro et al., 2015). Proteins
of the nuclear periphery participate directly in chromatin organization, and in the context
of HGPS, the expression of Progerin results in differences in gene accessibility and altered
gene expression. BAF, which directly binds to dsDNA, acts as an organizational hub at
the nuclear periphery. We therefore posited that chromatin conformation might be altered
in cells expressing BAF A12T, and that such changes might result in altered gene
accessibility. As a first test of this hypothesis, cells were subjected to ATAC-Seq. Cell
pellets prepared from our vector control, 3XF-BAF wild type or 3XF-BAF A12T cell lines
were submitted in duplicate for ATAC-Seq analysis. After ATAC-Seq was performed (see
Chapter 2 for details) three analyses were used to assess differences in the accessibility
of chromatin in these cells. The preliminary analysis was performed by using a genome
browser and manually identifying peaks that exhibited at least a two-fold difference
between the samples. At the time of this preliminary analysis, we did not ask whether
these peaks fell within exonic, intronic, genic, intergenic, proximal or distal promoter
regions or other regulatory regions within the genome. Our preliminary analysis indicated
that there were no overall differences in the accessibility the genome. In order to ask
whether differences might be revealed with a more precise analysis, we examined whether
there were observable differences in chromatin accessibility based on specifically
annotated chromatin regions. When organized into these categories, we were unable to
observe gross alterations in chromatin accessibility at any of the following regions: distal
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intergenic, intronic, exonic, 3’UTR, 5’UTR, or any promoters ranging from <1kb to 5kb.
Knowing that these categories did not necessarily encompass all the important regions for
gene accessibility and expression, we further asked whether there might be alterations in
accessibility specifically at transcription start sites. Mapping these regions and peak
annotations revealed no gross alterations in the accessibility of chromatin at transcription
start sites overall. Taken together, these data, ranging from broad analysis down to
detailed annotation, indicate no changes in the accessibility of chromatin based on the
homozygous expression of BAF A12T in mammary epithelial cells.
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Figure 3-9
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Figure 3-9. ATAC Seq Analysis on 3XF-BAF and 3XF-A12T Expressing Cells. (A)
Schematic of ATAC Seq methodology taken from (Buenrostro et al., 2015) depicting
transposes attacking accessible areas of the genome that insert adapter sequences in
open chromatin that are then amplified and sequenced. (B) Analysis of peaks of open and
accessible chromatin organized by their genome designation. There are no differences
between the accessibility of chromatin in cells expressing 3XF-BAF or 3XF-A12T
regardless of their location in the genome. (C) Analysis of accessibility at the average of
all transcription start sites. Vector control cells had a lower accessibility at transcription
start sites in comparison to 3XF-BAF or 3XF-A12T expressing cells, however there is no
marked difference between the accessibility at transcription start sites between 3XF-BAF
and 3XF-A12T expressing cells.
93

Overall Heterochromatin and Euchromatin Distribution is Unaltered in Cells Expressing
BAF A12T
Another measure of overall chromatin organization and compaction is the ratio of
heterochromatin to euchromatin within the cell and the amount of heterochromatin at the
nuclear periphery. Chromatin that is associated with the lamina is often times compacted
into foci of heterochromatin that are directly bound to Lamin A or to other components of
the nuclear periphery; these are called Lamina Associated Domains (LADs). While cells
expressing 3XF-BAF and 3XF-A12T did not exhibit variations in the levels and distribution
of H3K9me3, nor were there observable differences in overall chromatin accessibility, the
use of electron microscopy offers a unique and direct visualization of the chromatin within
the nucleus. MCF-10a cells expressing Vector control, 3XF-BAF, or 3XF-BAF A12T were
subjected to glutaraldehyde fixation and processed for electron microscopy. The area of
the nucleus was analyzed at 2,000x magnification and the respective areas of
heterochromatin and euchromatin were measured. The ratio of heterochromatin to
euchromatin was calculated, revealing that the overall distribution of heterochromatin to
euchromatin was largely unchanged in cells expressing 3XF-A12T compared to vector
control. The heterochromatin at the nuclear periphery is associated with lamina associated
domains, which, as discussed above, are generally sites of silenced genes tethered to the
nuclear lamina. The thickness of heterochromatin was measured, and the average
thickness of the heterochromatin at the NP was 0.002 um (+/- 0.001). There were no
significant differences in the overall thickness of the heterochromatin at the nuclear
periphery indicating no gross changes in the quantity of lamina associated domains in
cells

expressing

homozygous
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3XF-A12T.
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Figure 3-10. Electron Microscope Analysis of 3XF-BAF and 3XF-A12T Expressing
Cells. (A) Cells pellets were processed for transmission electron microscopy; images were
taken at a magnification of 2,000x. Approximately 5 fields per condition were analyzed.
(B) The ratio of heterochromatin to euchromatin was analyzed by taking the overall nuclear
area, and using automated measurement of heterochromatin area vs euchromatin area
based on the pixel density. (C) Peripheral heterochromatin was measured by measuring
the vector length between the edge of the nucleus and the end of any peripheral
heterochromatin. Student’s T-tests were performed to determine statistical significance.
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Discussion
Here, we have demonstrated that the expression of BAF A12T causes a nuclear
envelopathy in MCF10a cells. Since the BAF A12T allele is associated with a premature
aging syndrome, our goal was to determine if this envelopathy was correlated with
agreed-upon hallmarks of cellular aging. As described in detail in Chapter 1, the hallmarks
of aging are: genomic instability, telomere attrition, epigenetic alterations, loss of
proteostasis,

deregulated

nutrient

signaling,

mitochondrial

dysfunction,

cellular

senescence, stem cell exhaustion and altered intercellular communication (Lopez-Otin et
al., 2013). We asked about epigenetic alterations and the alteration of nuclear
substructures and found that there were no significant changes in the steady state levels
of the nuclear periphery proteins, histone modifications, or the substructures of the
nucleus. We did find a decreased area occupied by the nucleoli; however, this was not
met with any changes in de novo protein synthesis, indicating that there were no gross
alterations in protein synthesis. We addressed the question of cellular senescence and
exhaustion by asking whether the growth curves or doubling times were altered in BAF
A12T expressing cells and found no variation in cell proliferation. We asked whether there
was genomic instability in these cells by examining the cells for double strand break
accumulation. While we did see an increase in the accumulation of double strand breaks,
the remaining data indicate that these double strand breaks did not result in an increase
in cellular stress responses. We addressed the question of mitochondrial dysfunction by
examining the accumulation of ROS and found that cells did not accumulate ROS nor did
they accumulate other cellular stress responses.
Furthermore, we asked whether premature aging in this model might manifest with
gross alterations at the level of euchromatin and heterochromatin organization. By using
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two high resolution methodologies: electron microscopy and ATAC-Seq, we were unable
to distinguish changes in overall nuclear organization.
All these data together highlight that while the homozygous expression of BAF
A12T causes a human premature aging disease, the expression of BAF A12T in an
epithelial cell line does not recapitulate the hallmarks of cellular premature aging. It also
highlights that while BAF A12T causes a nuclear envelopathy, nuclear envelopathies are
not sufficient to result in a model of cellular aging and dysfunction. While on the surface
this may appear to be a limitation, we find that a model of nuclear envelopathies lacking a
premature aging phenotype actually presents itself as a powerful tool for the
understanding of nuclear envelope dynamics without the downstream sequalae that arise
from cellular stress responses.
We posited that, since the BAF A12T-associated progeria primarily affects tissues
of mesenchymal origin, the use of a mammary epithelial cell line might not recapitulate
some of the cellular features of the disease. Furthermore, the model of lentiviral
transduction to overexpress shRNA resistant 3XF-BAF or 3XF-A12T followed by the
depletion of endogenous BAF is a somewhat complex approach to modeling a
homozygous expression system. Therefore, we sought to address these limitations by
generating a CRISPR/Cas9 mouse model that introduces A12T into the endogenous BAF
locus. Generating a mouse model allows for the examination of different tissue to ask
about cell type specificity, and the impact of the disease at the organismal level.
Importantly, primary cells derived from these mice may also provide valuable insight into
the etiology of the disease phenotype.
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Chapter 4: The Characterization of a Novel NGPS Mouse Model
Introduction
Background on Murine Models of Progeria
Aging at the cellular level is defined by nine hallmarks (outlined in Chapter 1). At
the organismal level, aging is characterized by the loss of function of physiologic systems
over time, and the inability to maintain homeostasis (Blair, 1990). Clearly, the
accumulation of cellular aging culminates in organismal aging and the sites of age-related
pathologies are also the sites of the accumulation of senescent cells (Jeyapalan & Sedivy,
2008). Several studies have identified genes in which mutations arise that either
accelerate or delay the effects of aging, indicating a genetic component to this physiologic
phenomenon (Liao & Kennedy, 2014).
Mouse models for accelerated aging, or progeroid models, are not defined solely
by a shortened life span, but rather must encompass the accumulation of age-associated
pathologies. As of 2014, nine categories of genes whose alteration result in premature
aging and/or shortened life span were established: Lamin A processing, the somatotropic
axis, DNA repair, DNA replication, oxidative stress, sirtuins, hormones, genes involved in
inflammation, and tumor suppressor genes. The existing mouse models for premature
aging syndromes arising from nuclear envelopathies (see Chapter 1) all fall under the
category of Lamin A processing mutations, thereby mirroring human HGPS (Liao &
Kennedy, 2014). Patients with HGPS exhibit accelerated aging that involves the
degeneration of tissues of mesenchymal origin including osteolysis and joint contracture,
musculoskeletal disorders, severe craniofacial deformities, lipodystrophy, alopecia,
thinning skin. Interestingly, HGPS patients also exhibit cardiovascular defects which
ultimately results in heart attack or stroke and death, with the lifespan of HGPS patients
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averaging merely 13 years (Tsiligiri, Fekos, Theodoridou, & Lavdaniti, 2014). A range of
murine models of LMNA derived mutations have been generated in order to study the
mechanisms of disease progression and to generate novel therapies. As detailed in
Chapter 1, HGPS arises from a mutation in Lamin A resulting in a mutant protein termed
Progerin. Progerin is unable to undergo cleavage by the endopeptidase ZMPTSE24,
resulting in Progerin’s permanent farnesylation and accumulation at the NE (Goldman et
al., 2004). Mice with mutations in, LMNA or the deletion of ZMPTSE24 both recapitulate
the phenotypes observed in HGPS in humans including failure to thrive, loss of adipose
tissue, craniofacial defects, musculoskeletal abnormalities, nuclear envelopathies, and
premature death as a result of dilated cardiomyopathy (Navarro et al., 2004; Pendás et
al., 2002). Interestingly, while HGPS is associated with a heterozygous mutation in LMNA,
specifically LMNA G608G/+, in order to recapitulate the progeria syndrome in mice, the
paralogous LMNA G609G mutation is best modeled using a homozygous LMNA
G609G/G609G model of inheritance, highlighting an important difference between human
manifestation of HGPS and the murine model (Fernando G. Osorio et al., 2011).
Werner’s syndrome is a progeria syndrome arising from mutations in the WRN
gene (Oshima, Martin, & Hisama, 1993), which encodes a protein involved in DNA repair.
The Werner’s helicase contributes to the resolution of double strand breaks through
homologous recombination and non-homologous end joining (NHEJ) (Thompson &
Schild, 2002). To recapitulate this premature aging syndrome using a mouse model,
Lombard et al. generated a WRN knockout mouse; however the WRN -/- mouse does not
exhibit the features or clinical phenotypes of premature aging (Lombard et al., 2000).
However, when WRN -/- mice were crossed with mice deficient for Terc, a component of
the telomerase complex, the mice began to develop key premature aging phenotypes at
100

the organismal level, such as alopecia and osteoporosis, and at the cellular level such as
replicative senescence and accumulation of genotoxic stress (Chang et al., 2004). This
model is highlighted because it required a “double hit” model to capture the premature
aging syndrome in mice, whereas the human disease results from a “single hit”.
There are key differences between the clinical manifestation of human progeria
syndromes and the parallel mouse models aiming to recapitulate these diseases. These
differences highlight the complexity of developing a mouse model in order to study a
disease state at the organismal level.
The Study of Progeroid Primary Cells
Organismal aging is the culmination of cellular aging and replicative senescence
(Campisi, 1998). The use of primary cells is therefore a useful methodology for the study
of premature aging at the molecular and cellular levels. The first studies of HGPS patientderived dermal fibroblasts revealed a reduced capacity for proliferation due to a steady
decline of the fraction of proliferating cells over time with each passage (Kill, Faragher,
Lawrence, & Shall, 1994; Martin, Sprague, & Epstein, 1970). The presence of abnormal
nuclei is characteristic of cells expressing mutant Lamin A, and the discovery of these
dysmorphic nuclei pointed at the molecular etiology of the disease phenotype (Annachiara
De Sandre-Giovannoli et al., 2003; Eriksson et al., 2003). Further, another study indicated
that the fraction of cells with dysmorphic nuclei increases with both cellular and organismal
age (Bridger & Kill, 2004). Together these data helped inform the subsequent studies that
revealed the molecular pathways of cellular aging, especially those arising from insults to
the nuclear envelope. Furthermore, the study of fibroblasts from elderly patients compared
to HGPS-derived fibroblasts has been an excellent method of comparison between
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physiologic and pathologic aging (Cao, Capell, Erdos, Djabali, & Collins, 2007; Scaffidi &
Misteli, 2006).
While the study of patient-derived cells has been valuable in the analysis of
premature aging syndromes, especially in the context of treatment prospects, the use of
reprogrammed patient cells has been an important tool in analyzing the differences
between normal cellular aging and premature cellular aging as well (Carrero et al., 2016).
Induced pluripotent stem cells (iPSCs) derived from patient fibroblasts have provided a
mechanism to understand the process of differentiation and the upstream mechanisms
leading to cells prone to premature aging phenotypes. For example, in the case of
Werner’s syndrome (WS), patient-derived fibroblasts that were reprogrammed to iPSCs
had telomere length elongation, and restoration of cellular function, whereas when they
were differentiated to mesenchymal stem cells they exhibited the hallmarks of premature
aging once again (Cheung et al., 2014; Shimamoto et al., 2014).
In parallel to patient derived cells, primary cells derived from mouse models have
also been valuable for the study of premature aging syndromes at the cellular level. The
study of cells derived from ZMPTSE24 null mice established that the accumulation of
Progerin damages the nuclear envelope, a critical and central feature of HGPS (Varela et
al., 2005). Analysis of these cells also revealed other pathways involved in the pathologic
aging phenotype including upregulation of p53 signaling, stem cell dysfunction and DNA
repair defects (Liu et al., 2005; Fernando G. Osorio et al., 2011; Varela et al., 2005).
Measuring Aging in Mice
Premature aging syndromes arising from components of the nuclear lamina
manifest at the cellular level with nuclear morphology defects, as outlined in Chapter 1.
However, based on this study and others (T. P. Molitor & Traktman, 2014) a nuclear
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envelopathy is not sufficient to generate a premature aging phenotype. Therefore, the
measurement of premature aging in mice must rely on the accumulation of tissue
degeneration and organ system dysfunction. Previous models of mouse aging syndromes,
both arising as a result of LMNA mutations or other etiologies, use an array of
measurements to assess the progression of premature aging.
Clearly, as defined by shortened lifespans, published characterizations of
premature aging syndrome report survival. For example, the LMNA G609/G609 murine
model of HGPS has an average lifespan of 125 days, approximately four months,
compared to 242 days, approximately 8 months in LMNA G609G/+ mice and the 24 month
life span of a healthy mouse (Flurkey, Currer, & Harrison, 2007; Fernando G. Osorio et
al., 2011). Consistent with human phenotypes, mice expressing progeria-inducing genetic
mutations exhibit reduced growth rates and significantly lower weights compared to their
wild type counterparts (Navarro et al., 2004; F. G. Osorio et al., 2011; Pendás et al., 2002;
Santiago-Fernández et al., 2019).
As mentioned previously, premature aging syndromes specifically target the
degeneration of tissues of mesenchymal origin. Importantly, these include the bones,
cartilage, muscle and adipose tissue. Skeletal aging specifically is defined by the
progressive loss of function in the bone and articular cartilage. The most common clinical
manifestations include osteoporosis and osteoarthritis (Hambright, Niedernhofer, Huard,
& Robbins, 2019). Osteoporosis is characterized by reduced bone mass resulting from a
loss in the balance between bone formation and resorption resulting in increased porosity,
trabecular erosion and an increased incidence in fractures (Demontiero, Vidal, & Duque,
2012). The many murine models of HGPS all exhibit skeletal aging features including
osteoporosis, kyphosis, and spontaneous fractures resulting in craniofacial defects due to
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inappropriate healing (Bergo et al., 2002; Kuro-o et al., 1997; Pendás et al., 2002). X-ray
analysis of the entire skeleton elucidates overall skeletal defects such as kyphosis, and
fractures whereas micro-computed tomography (uCT) is used to assess bone density and
volume, trabeculae number and other high-resolution analyses (Shazeeb et al., 2018). On
the histological level, murine progeria syndromes arising from a LMNA processing
mutation, and cells exhibit a classic nuclear envelopathy as expected, but also exhibit an
increase in nuclear stress and cellular senescence markers, and defects at the
microscopic level in structures of the skin, muscle, bone, cartilage and the aortic arch.
Nestor Guillermo Progeria Syndrome: Clinical Manifestation
As previously described above, the discovery of the BAF A12T mutation in patients
provided insight into BAF’s role in aging. The clinical manifestations closely mirror those
of HGPS with one marked difference: patients expressing BAF A12T do not suffer from
the cardiovascular defects that results in the premature death of HGPS patients. As
addressed before, the clinical manifestations of NGPS do not begin until approximately
two years of age. Patients present with failure to thrive, skin atrophy, general lipoatrophy
and severe osteoporosis with marked osteolysis (Puente et al., 2011). Craniofacial
abnormalities result from the atrophy of the facial subcutaneous fat and osteolysis of the
maxilla and mandible and incomplete closure of the cranial sutures, see figure 4-1.
Diverging from HGPS, NGPS patients retain eyebrows and eyelashes and, importantly do
not exhibit cardiac dysfunction, ischemia, atherosclerosis or metabolic syndromes (R.
Cabanillas et al., 2011; H. G. Fisher et al., 2020; Puente et al., 2011). The index patient
suffered of severe secondary pulmonary hypertension and subsequent heart failure as a
result of severe scoliosis (R. Cabanillas et al., 2011).
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Rationale
Patients with NGPS had progressive and dramatic skeletal degeneration. Studies
of murine models have been used to elucidate fundamental mechanisms of disease
progression in a tissue-specific, systems-based approach. Based on the ability to replicate
progeria syndromes in mice, albeit with some limitations and shortcomings, we aimed to
generate the first murine model of NGPS to assess a number of parameters.

105

Figure 4-1

Figure 4-1. Craniofacial Defects in Patients with NGPS. Adapted from R. Cabanillas et
al. 2011 (Rubén Cabanillas et al., 2011). Depicted in photographs and computed
tomography reconstructions, patients with the homozygous inheritance of BAF A12T have
severe craniofacial defects: the skull retains open cranial sutures, the facial bones
undergo osteolysis with complete mandibular resorption, and they exhibit a marked loss
of subcutaneous adipose tissue.
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Results
The Generation of a BANF A12T/+ Mouse Colony and Genotyping BANF1 Mice
To generate a BANF1 A12T/+ mice, Applied Stem Cell generated an allele
which inserted the NGPS associated mutation into the second exon of the BANF1 gene,
see Figure 4-2. Applied Stem Cell generated a six-mouse colony comprised of three
heterozygous (A12T/+) females and three heterozygous males in a C57/B6 background.
Subsequent colony expansion was performed in-house by mating heterozygous sires and
dams. The colony was subsequently inbred and maintained over 6 generations and
resulted in approximately 330 mice. Genotyping was performed at weaning.
In the WT BANF1 allele, the codon for the 12th amino acid, alanine, is GCA. To
generate the A12T amino acid substitution in our mice, the codon encoding Alanine 12
was changed from GCA to ACC. This codon substitution generates two de novo restriction
enzyme sites. The BANF1 WT coding sequence contains two HPY 188III and one TSP
45I restriction enzyme sites, whereas the mutant allele generates a novel HPY 188III and
a novel TSP 45I restriction enzyme proximal to the mutation (Figure 4-3 C). We took
advantage of the introduction of this unique restriction enzyme site in order to genotype
the mice. Genotyping PCR amplified exon two of the BANF1 coding sequence followed
by restriction enzyme digestion of the PCR products using HPY 188III and TSP 45I.
Undigested and digested DNA were resolved on a 20% polyacrylamide gel. Genotypes
were analyzed based on the banding patterns described in Figure 4-3 A, B.
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Figure 4-2

Figure 4-2. Alignment of human BAF and mouse BAF protein sequences. BAF is
highly conserved between human and murine BAF sequences. Only 3 of the 89aa differ
(blue and green). Ser4, the predominant phosphorylation site is underlined in red. A12
(red box) is mutated to a Threonine with a single codon change.
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Figure 4-3

Banding Pattern Based on Genotype Using Restriction Enzyme Digest
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Homozygous Mutant (A12T/A12T)

132, 90, 57 and 33

Heterozygous (A12T/+)

140 and 82

Wild Type (+/+)

140, 49 and 33

Homozygous Mutant (A12T/A12T)

140, 82, 49 and 33
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Figure 4-3. Genotyping BAF A12T Mice. The BANF1 WT coding sequence contains two
HPY 188III and one TSP 45I restriction enzyme sites. The BANF1 A12T mutant allele
generates a novel HPY 188-III and TSP 45-I restriction enzyme site that digests six basepairs downstream of the mutation. (A) DNA electrophoresis of uncut or restriction enzyme
digested samples reveal a unique banding pattern based on mouse genotype. Lanes 4
and 7 indicate a WT genotype based on the appearance of 2 distinct bands at 132bp and
90bp in HPY188-III digested and at 140bp mutant allele, giving rise to new bands of 33bp
and 57bp in the presence of HPY 188-III and bands of 49bp and 33bp in the presence of
TSP45-I. The heterozygous mice have the appearance of all the bands due to the
existence of one WT allele and one A12T allele. (B) Table describing the banding patterns
based on genotype (C) Primer target for PCR amplification of exon 2 of BAF. The amplified
PCR product in the WT allele contains pre-existing HPY188-III and TSP 45-I restriction
enzyme digest sites. However, in the mutant allele, GCA (blue box top) is mutated to ACC
(blue box bottom) to give rise to the A12T mutation which generates a de novo restriction
enzyme site for both HPY 188-III and TSP45-I (red star).
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Distribution of Phenotype and Analysis of Fertility
We first sought to characterize the distribution of males and females, and to
determine whether the distribution of the mutation followed Mendelian patterns of
inheritance. Matings were maintained between heterozygous mice, and the distribution of
male and female mice was evenly distributed at an approximate ratio of 1:1 (Figure 4-4
A). Furthermore, the distribution of wild type, heterozygous and homozygous mutant mice
was distributed at approximately 25:50:25 as predicted by Mendelian patterns of
inheritance. Next, we test-mated homozygous mutant males and females by mating
A12T/A12T males with WT females or A12T/A12T females with WT males followed by
crossing A12T/A12T females with A12T/A12T males, in order to ask whether they were
fertile. Data from our lab have shown that VRK1 hypomorphic mice are infertile as a result
of the progressive loss of spermatogonia in the testes and defects in oocyte maturation
(Wiebe, Nichols, Molitor, Lindgren, & Traktman, 2010) and (Traktman unpublished).
Therefore, it was an important question to ask whether a mutation in VRK1’s target, BAF,
also resulted in defects in fertility. We assessed 15 litters per group, and we found that
heterozygous and homozygous females both produced an average litter size of
approximately 5 mice per litter as compared to an average of 7 pups per litter in their wild
type counterparts (Figure 4-4 B). Pups from all groups grew and weaned appropriately
and there was no increase in the pre-weaning mortality of heterozygous or homozygous
mutant pups. Therefore, there were no detectable defects in fertility as a result of A12T
expression, and A12T/+ and A12T/A12T distribution is based on classic genetic ratios.
To the best of our ability, we counted the number of pups born at day p=0-1 and
then matched the number of pups at weaning. This information indicated to us that there
was no death previous to weaning, however the loss of any pups before detection of
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parturition could be a confounding factor since mothers scavenge dead pups. Taken
together, these data indicate that heterozygous and homozygous A12T mice do not have
defects in fertility and that there is no early loss of pups at a young age.
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Figure 4-4

Total Number of
Mutant Mice

Total Number of
Heterozygous Mice
150

98

96

50

0

Number of Mice

ns

10

15

16

10
5

6
4
2

al
es

WT Het Mut

Fe
m

al
es

Fe
m

M
al
es

8

0

0
M
al
es

Number of Mice

Average Litter Size

20
18

100

B

Number of Pups

A

Figure 4-4. Distribution of Genotype and Analysis of Litter Size. (A) The distribution
of genotypes among BANF1 mouse colony. There was a similar distribution of
heterozygous and homozygous mice among males and females alike. (B) Average litter
size between Dam genotypes were not statistically different (p=0.1871 n=15 litters each)
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Characterization of Lifespan and Growth
The average lifespan for C57/B6 mice 18-22 months, or 540 to 660 days. In HGPS
mice, LMNA G609G/+ and G609/G609 mice have dramatically shorter lifespans of
approximately 250 days and 100 days respectively (Fernando G. Osorio et al., 2011; VillaBellosta et al., 2013). The lifespan of A12T/A12T mice is equal in length to wild type mice
(Figure 5-5 A). We allowed the lifespan study to continue for 670 days before euthanizing
the mice for endpoint analysis. Necropsy of the mice revealed no gross anatomical
differences or gross abnormalities in either WT or A12T/A12T mice.
HGPS mice exhibit failure to thrive and exhibit body weights approximately 1/3 of
their wild type counterparts (Zaghini et al., 2020). Therefore, we next measured the body
weight of mice consistently between 3 and 12 weeks of age (Figure 4-6 A). No significant
difference was observed in the growth rate between wild type and mutant mice.
Furthermore, body weight was re-measured at 9 months of age and no significant
difference was observed between wild type and mutant mice see Figure 4-6 A. During
necropsy at end point analysis at 9 months of age, weights of heart, spleen, kidneys, liver,
and lungs were all measured. No statistical significance was observed in organ weight,
including liver weight, between wild type and mutant mice. Further, when liver weights
were normalized to body weights, the differences between the groups was even smaller.
These data suggest that there is no growth defect between in A12T/A12T mice and that
they thrive comparably to wild type controls (Figure 4-6 B).
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Figure 4-5
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Figure 4-5. Survival Curve of BAF A12T Mice. Litter mates were maintained in a survival
study across 670 days. The end point of this study was 22 months of age. The mice were
then euthanized for further analysis. The p value between the survival curves is >0.9999.
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Figure 4-6
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Figure 4-6. Analysis of BAF A12T Mice Growth. (A) Mouse body weight was measured
over time from 3 weeks of age to 12 weeks of age (left panel) n=6 per group. No significant
difference was observed in the growth rate between wild type and mutant mice (p=0.572).
Body weight between mice was taken at 9mo of age and no significant difference was
observed between wild type and mutant mice (right panel) n=3 per group. (B) Liver weights
were taken at 9mo of age after end point euthanasia. No statistical significance was
observed between wild type and mutant mice. Further, when liver weights were
normalized to body weights, the differences between the groups was even smaller. We
did not observe a difference in the weights of other organs including heart, spleen, kidney,
and lungs.

118

Radiographic Analysis of BANF A12T/A12T Mice
Mice that exhibit premature aging syndromes such as HGPS exhibit severe
skeletal defects such as osteoporosis, craniofacial defects, and severe kyphosis (F. G.
Osorio et al., 2011; Zaghini et al., 2020). In order to ask whether the mice expressing
A12T/A12T developed craniofacial or skeletal defects we used radiographic analysis to
measure different skeletal parameters. At 9 months of age, mice were anesthetized using
isoflurane and laid on their left lateral side inside the imaging chamber of a Faxitron LX60 Cabinet X-Ray System. Skeletal measurements were taken based on anatomical
landmarks. Measurements taken include: length of nasal bone, distance between
nasomaxillary point to superior incisor point, mandible length, menton to mandibular
condyle, cranial length, occipital bone to coronal suture, coronal suture to tip of nasal bone
(Figure 4-8), and body length (from nose to anus), femur length, tibia length, humerus
length, the height and width of the fifth lumbosacral vertebra, the distance between the
top of the fourth lumbosacral vertebra to the bottom of the sixth lumbosacral vertebra, and
the kyphosis index (Figure 4-7) which is measured by taking the distance between the
bottom of the sixth cervical vertebra to the bottom of the sixth lumbosacral vertebra (line
AB) and the distance from the highest point in the curvature of the spine down to line AB,
generating line CD. The ratio of line AB to line CD is deemed the kyphosis index. There
were no obvious defects in the living animals and the radiographic analysis revealed no
significant differences between the measurements of the skeleton indicating that there
were no underlying skeletal defects.
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Figure 4-7. Radiographic Analysis of the Skeleton. (A) Full body x-ray imaging was
performed on 9mo old mice (n=3 per group) by irradiating at 60kV for 60 seconds. (B)
Body length, tibia, humerus, femur and cranial lengths were all measured. No significant
differences were observed between wild type and mutant mice except femur length
(p=0.0335). (C) The kyphosis index is measured by taking the distance from the C7
vertebra to the wing of the ilium (line AB); and the distance from the point of maximum
curvature of the spine to the intersection of line AB (line CD); The kyphosis index (KI) is
the ratio of line AB to line CD: (KI=AB/CD). No significant difference in the KI was found
between wild type and mutant mice. Other spinal measurements such as the distance
from L4-L6 and the height and width of L5 were assessed and no differences in these
measures were observed.
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Figure 4-8
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Figure 4-8. Radiographic Analysis of the Head. X-ray analysis was performed on the
heads using cranial landmarks. (A) Close up images from the full body x-rays seen in
figure 5. (B) The ratio of cranial length normalized to body length was not significantly
different between wild type and mutant mice, nor were the lengths of the mandible, nasal
bone or the ratio of the mandible to the cranial length. (C) No differences were observed
in any of the cranial structures and distances including the distance between the sutures
and other cranial landmarks.
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Histologic Analysis of BANF A12T/A12T Mice
Histologic analysis of LMNA G609G/G609G mice reveals a loss of subcutaneous
adipose tissue, reduced hair follicle distribution and thinning of the dermal layer (S. H.
Yang et al., 2006; Zaghini et al., 2020). Tissues derived from mesenchymal origin are
preferentially affected by both HGPS and NGPS; therefore, we recovered tissue from the
same mice on which radiographic analysis was performed. Tissue samples from skin,
long bone, and joints were sectioned and stained with H&E as described in Chapter 2.
Histologic analysis of skin sections from A12T/A12T mice were assessed by measuring
the subcutaneous fat thickness and the dermal thickness. There were no measurable
differences in the distribution of the layers of the skin. Further, while there were no gross
skeletal abnormalities between wild type and A12T/A12T mice, we looked at the structures
of the bone and cartilage at the microscopic level. The thickness of the epiphyseal line
was also measured alongside other bone parameters including overall organization of
trabeculae, compact bone, and cartilage distribution. There were no differences in the
overall histology of the long bones between wild type and A12T/A12T mice.
The overall histologic analysis of tissues derived from A12T mice revealed no
abnormalities compared with wild type mice (Figure 4-9 A). This was not wholly surprising
based on the normal skeletal architecture, normal growth rate and lifespan, and the
absence of any gross visible anomalies between the groups of mice. From the study of
HGPS mouse models, we know that a dominant mutation in the context of the human
syndrome requires homozygous expression system to be recapitulated in a mouse model.
Furthermore, in the case of WRN null mice, mice do not exhibit a premature aging
phenotype that mimics WS until the mice are bred with Terc -/- mice. This implies that
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generating a mouse model that mirrors human NGPS has not been as precise as modeling
the effect of A12T on cellular function.
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Figure 4-9
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Figure 4-9 Histologic Analysis of select BAF A12T/A12T Tissue. (A) Skin section
stained with H&E at 10x magnification in wild type and BAF A12T/A12T mice; the
subcutaneous fat and dermal thicknesses were measured. 3-5 fields were analyzed, and
statistical significance was determined by students T-test. (B) Section of epiphyseal line
of the tibia stained with H&E at 40x magnification in wild type and A12T/A12T mice; the
epiphyseal thickness was measured. 5 fields were analyzed, and statistical significance
was determined by Student’s T-test.
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Analysis of Primary Dermal Fibroblasts from BAF A12T/A12T Mice
As mentioned in the introduction to this chapter, the use of primary cells derived
from mouse models of premature aging have been informative in dissecting some of the
molecular mechanisms underlying disease etiology and progression. In order to generate
a primary fibroblast cell line from WT and A12T/A12T mice, 1mm ear biopsies were
harvested, and explant cultures were established from the outgrowth of the dermal
fibroblasts. Our hope was that the study of these cells would reveal important pathways
affected by homozygous inheritance of the BAF A12T mutation. The first parameter that
we aimed to study was the proliferation of these primary dermal fibroblasts once they were
in culture. The apparent doubling time of WT cells was approximately 25.5h, whereas the
doubling time of mutant cells was approximately 24.3h, a negligible difference in doubling
times between the two conditions. Furthermore, the growth curves were analyzed by
plating cells at equal densities and counting live cells for three days after (Trypan blue
staining). The growth curves were very similar between all the cell lines and we can
conclude from these data that there are no differences in the proliferation of A12T/A12T
fibroblasts compared to wild type.
Furthermore, since the expression of A12T results in a nuclear envelopathy (Figure
3-3), we analyzed the nuclear morphology of primary dermal fibroblasts. Cells were
analyzed by immunofluorescent staining of Lamin A and scored based on the scoring
schema described above. Greater than 50% of the A12T/A12T cells had an aberrant
nuclear morphology with a score of 2 or greater. To complement this analysis, we used
automated imaging software analysis to assess the nuclear circularity of both wild type
cells and A12T/A12T cells. The departure from circularity in A12T/A12T expressing cells
was significantly greater than wild type cells, as expected. This was an excellent proof of
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concept and solidified the data that the inheritance of homozygous A12T results in
dysmorphic nuclear envelopes.
However, as discussed in Chapter 3, nuclear envelopathy is strongly associated
with a premature cellular aging phenotype. Our next analyses were therefore focused on
whether A12T/A12T dermal fibroblasts accumulate the hallmarks of premature aging.
While there were no differences in the rates of proliferation between wild type or
A12T/A12T fibroblasts, we still aimed to analyze whether there was a fraction of senescent
cells that might contribute to a premature cellular aging phenotype. We performed SA-βgalactosidase staining on primary dermal fibroblasts and quantified the proportion of
positively stained cells. Less than 10% of the primary dermal fibroblasts exhibited SA-βgalactosidase positive staining, indicating that neither wild type nor A12T/A12T expressing
cells undergo replicative senescence. Furthermore, as discussed in Chapter 3, cells that
exhibit premature aging phenotypes usually contain an elevated of the histone variant
H3K9me3, which marks areas of SAHF (Romero-Bueno et al., 2019). We measured
H3K9me3 intensity by immunofluorescence to analyze its distribution and steady state
levels, in order to ask whether SAHF are being formed in these cells. The levels and
distribution of H3K9me3 were unaltered in the dermal fibroblasts derived from A12T/A12T
mice.
To measure the induction of the DNA damage response pathway, cells were
treated with Etoposide at a concentration of 100µM for one hour and the induction of
gamma-H2AX was monitored. Wild type and A12T/A12T fibroblasts both appropriately
induced the DNA damage response in the presence of etoposide and neither displayed
any basal DNA damage. Lastly, we assayed the accumulation of ROS in primary dermal
fibroblasts by treating cells with DCFDA. As a positive control, cells were treated with
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hydrogen peroxide for one hour prior to the assay. There was no noticeable difference
between wild type and A12T/A12T dermal fibroblasts in the basal level of ROS, but H2O2
treatment led to a marked increase in ROS levels in all cells.
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Figure 4-10
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Figure 4-10. Analysis of Growth and Nuclear Envelopathy in Primary Dermal
Fibroblasts. (A) Apparent doubling of primary fibroblasts established from the outgrowth
of dermal biopsies from two wild type mice and two A12T/A12T mice. N=15, significance
determined by students T-tests. (2) Cells were seeded at equal densities and counted
every day for 3 days by staining with Trypan Blue and counting live cells. This was
repeated in 5 independent experiments and cell number was plotted against time to
generate a growth curve. (C) Cells were analyzed by immunofluorescence of Lamin A for
nuclear morphology abnormalities. Normal nuclei were defined by a score of 1 based on
the scale defined in Molitor & Traktman 2013, and aberrant nuclei were defined by a score
>1. 50-60% of the cells expressing A12T/A12T exhibited dysmorphic nuclei compared to
wild type. Cells from four different mice WT mice and four A12T/A12T mice were analyzed.
(D) Nuclear circularity was assessed by immunofluorescence of Lamin A, and then an
automated software program assessed the nearness of the nucleus to a perfect circle,
defined as 1, and the departure from a circle defined as 0>x<1. Approximately 250 cells
were analyzed from fibroblasts cultures derived from one wild type mouse and one
A12T/A12T mouse in 2 independent experiments. Statistical significance was determined
by students T-test. (E) Using the scoring scheme defined in Molitor and Traktman 2013,
cell nuclei were assigned a score of 1-6, with 1 defined as smooth round nuclei, and 6 as
multinucleated and blebbed. WT primary dermal fibroblasts exhibited 87% normal nuclei,
whereas only 56% of A12T/A12T dermal fibroblasts had normal nuclei, and 30% had
nuclei with a score of 3 or greater.
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Figure 4-11

Figure
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4-11. Assessment of Premature Aging Hallmarks in Primary Dermal Fibroblasts. (A)
SA β-galactosidase staining of primary dermal fibroblasts were imaged by phase
microscopy and then quantified. N=3 independent experiments from cultures derived from
3 wild type mice and 3 A12T/A12T mice. (B) H3K9me3 levels in primary fibroblast nuclei
were analyzed by immunofluorescence intensity. Cultures derived from 3 WT mice and 4
A12T mice were analyzed in 3 independent experiments. (C) Cells were treated with
100uM Etoposide for 1h and then subjected to immunoblotting for γH2AX as a marker of
the induction of the DNA damage response pathway. This is representative of 3
independent experiments using cultures derived from 1 wild type mouse and 1 A12T/A12T
mouse. (D) Cells were treated with DCFDA in order to measure the accumulation of
reactive oxygen species in the cells. All cells were treated with H2O2 as a positive control
prior to DCFDA treatment. H2O2 treated cells had a fluorescence intensity of greater than
between 250-300 A.U., a massive increase compared to the untreated cells which have a
fluorescence intensity of less than 100 A.U. with no variations between wild type and
A12T/A12T mice.
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Discussion
In generating a CRISPR/Cas9 A12T/A12T mouse, we were aiming to recapitulate
some of the clinical manifestations of NGPS in mice. Taking the previous data from murine
models of HGPS and other premature aging syndromes, we hypothesized that a novel
NGPS mouse model would be a valuable tool used to elucidate the fundamental
mechanisms of disease progression in a tissue-specific, systems-based approach.
Mouse models of premature aging have been able to recapitulate some of the
clinical manifestations of the disease including skeletal abnormalities, failure to thrive,
alopecia and other severe phenotypes. NGPS patients suffer from progressive and
dramatic skeletal degeneration, scoliosis, adipolysis and alopecia. The A12T/A12T mice
that we developed do not present a premature aging syndrome. Their lifespan is
comparable to wild type C57/B6 mice, they grow and thrive appropriately, they do not have
skeletal defects or abnormalities, and at the histologic level, A12T/A12T derived tissue is
healthy and free of the hallmarks of NGPS. However, primary dermal fibroblasts derived
from A12T/A12T mice do exhibit nuclear morphology defects, and in fact almost 60% of
these cells display some amount of nuclear dysmorphia. This envelopathy, though, is not
accompanied by the induction of stress responses or the onset of replicative senescence.
Similarly to the, WRN null mouse model, the BAF A12T/A12T mice may need to
be stressed by “second hit”. Crossing A12T/A12T mice with mice that are deficient in
another gene that contributes to premature aging or that is involved in mesenchymal stem
cell maintenance or bone remodeling may begin to elucidate mechanisms of organismal
aging involving A12T/A12T expression. In the case of HGPS, a dominant disease, mice
expressing LMNA G609G/+ do not exhibit a severe phenotype compared to LMNA
G609G/G609G mice. NGPS arises from the homozygous expression of BAF A12T,
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therefore it in not possible to increase the severity of the inheritance. These complexities
between the clinical manifestation of human progeria syndromes and the parallel mouse
models aiming to recapitulate these diseases highlight the challenges of developing a
mouse model to study a disease state at the organismal level.
In Chapter 3, we hypothesized that the homozygous expression of BAF A12T
would result in an overall loss of heterochromatin, which in turn would alter gene
expression profiles through alterations in gene accessibility. We next asked whether we
could recapitulate the disease phenotype with the development of an NGPS mouse model
to assess the impact of the A12T mutation on aging at the organismal level, while also
establishing a primary cell line to assess the cellular phenotype too. The data shown in
both Chapters 3 and 4 clearly indicate that the primary effect of the BAF A12T mutation is
unlikely to be at the level of chromatin organization and architecture, and that epithelial
cells in the context of MCF-10a cells, and primary fibroblasts derived from an A12T/A12T
both do not exhibit the effects of premature aging despite exhibiting a severe nuclear
envelopathy.
In continuing to ask how BAF A12T contributes to premature aging, we shifted our
focus from epigenetic modulation to other ways that BAF A12T may be affecting the
nuclear envelope and why the clinical manifestations preferentially impact tissue of
mesenchymal origin. As we were completing our analysis of the work described in this
chapter, a publication from the Zinn-Justin lab (Samson et al., 2018) revealed a key finding
that shifted our paradigm of BAF function. Samson et al. presented the first ternary
structure of Emerin, BAF and the IgG fold of Lamin A. Residue ala12 of BAF is found on
the surface of BAF that binds to Lamin A, and indeed is buried in the interface. This
indicated to us that our assessment of BAF function would not be complete if we did not
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integrate binding to Lamin A in our future analyses. Therefore, to continue to assess how
BAF A12T affects the structure and function of the nucleus, our subsequent studies were
performed using iPSCs that carried +/+ or A12T/A12T alleles at the endogenous BANF1
locus. These isogenic, pluripotent cells can be further differentiated to different cell types
to assess the impact of the mutation.
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Chapter 5: The Assessment of BAF A12T Expression in Mesenchymal Stem
Cell Maintenance
Introduction
The use of patient-derived cells as a method to study premature aging syndromes
has been a historically powerful method to study the molecular mechanisms behind the
disease state. The ability to reprogram patient cells in to pluripotent cells provides the
opportunity to model disease development and progression through the differentiation
program. As reviewed in Carrero et al in 2016, several studies have been able to
demonstrate upon reprogramming somatic cells taken from progeria patients, there was
a reversal in age-related phenotypes reversal in age-related phenotypes including
increased telomere length, loss of senescence and a restoration of mitochondrial fitness
(Carrero, Soria-Valles, & López-Otín, 2016). The modeling done by previous labs in the
study of HGPS have helped frame and inform subsequent studies of premature aging
syndromes at the cellular level.
Human iPSCs resemble human embryonic stem cells in that they have the ability
to differentiate into all somatic cells of the body (Bellin, Marchetto, Gage, & Mummery,
2012). Studying iPSCs is particularly important in the case of premature aging, where cells
are difficult to culture and study as a result of their replicative senescence. The limitation
arising from the use of reprogrammed patient cells is the unavailability of matched control
cells with identical genetic background; therefore, the study of patient cells compared to
control cells is not a direct comparison. While this is an accepted methodology, the use of
CRISPR/Cas9 technology to generate iPSCs with a homozygous BAF A12T mutation and
a matched isogenic control is a more direct method of studying the contribution A12T to
cellular aging.
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Patients with NGPS do not begin to exhibit symptoms until approximately two
years of age, highlighting that this is not a developmental disorder but rather a
degenerative one. Patients suffer from severe osteolysis, adipolysis and craniofacial
defects indicating that tissue arising from mesenchymal origin are preferentially affected
(R. Cabanillas et al., 2011; Puente et al., 2011).
At the onset of our study of BAF and A12T’s roles at the nuclear periphery, we
initially hypothesized that the contribution of A12T to premature cellular aging would result
from alterations in chromatin organization and changes in overall gene accessibility and
gene expression. The data indicated that the impact of A12T was not on the level of
chromatin architecture. However, data from the Zinn-Justin lab indicate that Alanine 12 is
found on the surface of BAF that binds to the Ig Fold of Lamin A, and that the A12T
mutation is buried in this binding surface (Samson et al., 2018). Furthermore, since the
BAF A12T-associated progeria primarily affects tissues of mesenchymal origin, we shifted
from the use of mammary epithelial cells to performing our studies using iPSCs that carried
+/+ or A12T/A12T alleles at the endogenous BANF1 locus. These isogenic, pluripotent
cells can be further differentiated to different cell types to assess the impact of the
mutation.
Rationale
Progerias offer a pathologic model that mirrors accelerated physiologic aging. The
study of these models has been instrumental in identifying and characterizing genetic
mutations that perturb NE structure and function. The tissue-specificity of NGPS is poorly
understood, but the impact on tissues of mesenchymal origin has led to the hypothesis
that survival, proliferation or differentiation of mesenchymal stem cells (MSCs) is
perturbed. Patient fibroblasts exhibit dysmorphic nuclei, however the molecular
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mechanisms behind premature cellular aging in A12T -expressing cells is still unclear.
The homozygous expression of A12T causes dysmorphic nuclei in all cells, but the
impact of the envelopathy varies between cell types. Using isogenic WT and A12T/A12T
iPSCs, we aimed to differentiate them to induced MSCs (iMSCs). Using this model and
the data from Samson et al. 2018, we hypothesize that defective BAF-Lamin A
interactions compromise the structural network of the nuclear lamina and weaken
the nuclear envelope.
Results
Generating iMSCs and hepatocytes from iPSCs
HGPS also preferentially affects cells of mesenchymal origin, and through the
study of reprogrammed patient derived cells and genetically manipulated stem cells that
express Progerin, the cell-type specific pathologies have been attributed to stem cell
exhaustion and differentiation defects (Halaschek-Wiener & Brooks-Wilson, 2007; Scaffidi
& Misteli, 2008). NGPS preferentially affects tissues arising from mesenchymal origin (R.
Cabanillas et al., 2011). In order to ask whether the mesenchymal stem cell defects
observed in HGPS are mirrored in the case of NGPS, we sought to generate a
mesenchymal stem cell line derived from iPSCs expressing A12T. Applied Stem Cell
generated two BAF A12T/A12T cell lines (derived from ASE-9203 iPSCs) using
CRISPR/Cas9 technology to change the codon sequence encoding Alanine 12 in Exon 2
of the endogenous BANF1 gene locus. iPSCs must be cultured and passaged on Matrigel
coated dishes and do not express Lamin A, and as such, do not exhibit nuclear envelope
dysmorphia (Dan Constantinescu, Heather L Gray, Paul J Sammak, Gerald P Schatten,
& Antonei B Csoka, 2006). In order to address the tissue specificity behind NGPS, we
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differentiated iPSCs to induced mesenchymal stem cells, and to a cell type that is
unaffected by NGPS such as hepatocytes.
To generate iMSCs, iPSCs were plated on Matrigel coated dishes and cultured in
FBS-containing media for 21 days in a protocol developed from Zhang et al. who
generated iMSCs and vascular smooth muscle cells from iPSCs to study the contribution
of Progerin expression in these models (Zhang et al., 2011). After the 21st day, cells were
passaged onto dishes coated with 0.1% gelatin, and after three passages, cells were
plated on uncoated tissue culture dishes. The success of this protocol is measured by the
ability of the cells to continue to proliferate on uncoated culture dishes. When iPSCs are
cultured on Matrigel, they appear circular and grow in colonies, with no observable
differences between WT and A12T cells. When the cells transition into FBS-containing
media, they begin to grow in a tightly packed monolayer and develop a lenticular shape
until they are passaged on gelatin, where they elongate and become spindle-shaped and
maintain tight packing between the cells. Once on plastic, wild type cells maintain a similar
phenotype as when they are cultured on gelatin. However, when A12T expressing cells
are cultured on plastic, they lose the spindle shape and the cytoplasm spreads to form a
circular shaped cell. This is the first key difference that we observed between wild type
cells and A12T expressing cells (Figure 5-1 A-B).
Pluripotent stem cells do not express Lamin A, whereas differentiated cells do.
Lamin A/C is thought to play a role in the maintenance of differentiated cells. It is also
acts as an important factor in stem cell differentiation and plays a role in the differentiation
of MSCs into osteoblasts and adipocytes (Bermeo, Vidal, Zhou, & Duque, 2015; Dan
Constantinescu et al., 2006). Lamin B, is present in all cell types, and Lamin B expression
is highest in pluripotent stem cells (D. Constantinescu, H. L. Gray, P. J. Sammak, G. P.
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Schatten, & A. B. Csoka, 2006). The expression of Lamin B is required for proper
organogenesis and cells that are deficient in Lamin B have misshapen nuclei and undergo
premature cellular senescence (Y. Kim et al., 2011; Vergnes, Péterfy, Bergo, Young, &
Reue, 2004). WT and A12T iPSCs express Emerin at equal steady state levels across
differentiation. As expected, iPSCs do not express do not express Lamin A, and express
Lamin B1. Once iPSCs are differentiated into iMSCs, Lamin A steady state levels increase
and Lamin B1 levels decrease; however there is no significant difference between the
levels of Lamin A or Lamin B steady state levels between WT iMSCs and A12T iMSCs
(Figure 5-1 C).
The further characterization of the iMSCs will be discussed in upcoming sections,
however we first wanted to demonstrate that any differences we observed in A12T
expressing iMSCs were a direct result of the cell type specificity. Therefore, in order to
ask whether the phenotypes observed in A12T iMSCs are cell type specific, examined the
effect of A12T expression in a cell type that is not affecting in NGPS patients. Hepatocytes
are terminally differentiated epithelial cells of the liver which express Lamin A (Barboro,
D'Arrigo, Repaci, Patrone, & Balbi, 2010). Using a well-defined differentiation protocol
established by our MUSC colleague Stephen Duncan’s lab, WT or A12T iMSCs were
differentiated into hepatocytes (Si-Tayeb et al., 2010). Of note, when iPSCs are
differentiated into hepatocytes, they remain on a Matrigel substrate throughout
differentiation. Furthermore, induced Hepatocytes are quiescent and unable to be further
cultured once they are terminally differentiated.
When iPSCs were differentiated into hepatocytes (kindly performed by our
collaborator Ray Liu), the overall cellular morphology between wild type and A12T
expressing cells was indistinguishable. Moreover, the ability of A12T iPSCs to differentiate
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into hepatocytes and express hepatocyte specific markers was just as efficient at wild type
(Figure 4-2 A). WT iHepatocytes and A12T iHepatocytes exhibited similar steady state
levels of Apolipoprotein B (Apo B) and HNF4α, two functional markers of hepatocytes.
iHepatocytes were then subjected to SA-β-Gal staining. The great majority of WT and
A12T-expressing hepatocytes were overwhelmingly negative for SA-β-Gal staining, with
only ~10% of the population staining partially positive or positive with Blue-Gal (Figure 52 B). Lastly, we examined whether A12T-expressing hepatocytes exhibited a nuclear
envelopathy. Nuclear dysmorphia was scored as described previously. A12T expressing
hepatocytes exhibited a mild nuclear envelopathy, reinforcing the fact that A12T
expression in any cell type results in aberrant nuclear envelope architecture.
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Figure 5-1
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Figure 5-1. Principal Characterization of iMSCs. (A) Phase microscopy images at 20x
magnification of WT and A12T iMSCs in their first passage on plastic. As evidenced by
the inlaid images, WT iMSCs exhibit elongated, spindle shaped morphology, whereas
A12T expressing iMSCs exhibit lenticular shaped nuclei and a more rounded cell body.
(B) Phase microscopy images at 40x magnification p.3 on plastic. The shape of the cells
is divergent between WT iMSCs and A12T iMSCs. Where WT iMSCs are elongated and
spindle-shaped and pack in a tight monolater, A12T expressing cells are circular and the
cytoplasm is spread out. Furthermore, A12T iMSCs form clusters on the culture plastic
rather than a cohesive monolayer. (C). The steady state levels of Lamin A, Lamin B1 and
Emerin were analyzed by immunoblotting. The steady state levels of Emerin do not
change between WT and A12T expressing cells, nor did they differ between iPSC and
iMSCs. Lamin A is not expressed in iPSCs, and is expressed in high levels in MSCs,
however there is no difference in the steady state levels of Lamin A between WT and A12T
expressing iMSCs. Lamin B1 is highly expressed in pluripotent cells and diminishes in
differentiated cells. WT and A12T iPSCs express Lamin B at similar steady state levels
and Lamin B1 levels diminish after differentiation to iMSCs in both A12T and WT
expressing cells
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Figure 5-2
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Figure 5-2. Assessment of A12T Expressing Hepatocytes. WT and A12T expressing
iPSCs were differentiated into hepatocytes. (A) Immunoblot analysis of two hepatocyte
markers, Apolipoprotein B (ApoB) and HNF4α, reveals that there is no significant
difference in the steady state levels of these proteins n=4. (B) SA-β-Gal treatment of
hepatocytes was performed n=3 and cells were designated “negative”, “partial” or “full” for
Blue-Gal staining as described above. 90% of these cells exhibited no Blue-Gal staining,
indicating that BAF A12T-expressing hepatocytes do not become senescent. (C) Nuclear
envelope score was determined by using the scoring scheme from Molitor & Traktman
2014. A12T expressing hepatocytes exhibited a nuclear envelopathy compared to WT
hepatocytes as expected n=4.
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Characterizing A12T expressing iMSCs by Flow Cytometry and Differentiation Potential
Mesenchymal Stem Cells (MSCs) are multipotent stromal-like cells that are
derived from the mesoderm (Pittenger et al., 1999). They are found in a variety of tissue
including bone marrow, adipose tissue, bone, cartilage and the umbilical cord and are able
to differentiate into the associated cell types to repair damaged tissue (C. Chen & Hou,
2016; Divya et al., 2012). In 2006, the International Cellular Therapy Society established
the minimal criteria to define mesenchymal stem cells: 1) They must adhere to and
proliferate on tissue culture plastic 2) They must express CD73/CD90 and CD105 and
must not contain CD45, CD45, CD20 or CD14 and 3) they must maintain their ability to
differentiate into adipocytes, osteoblasts and chondrocytes (Dominici et al., 2006). While
MSCs are derived from the mesoderm and are defined by their ability to differentiate into
adipocytes, osteoblasts and chondrocytes, studies have also shown that they exhibit
plasticity in their potency and are able to differentiate into cells of the ectodermal layer
such as neurons, and cells of the endodermal layer such as myocytes (C. Chen & Hou,
2016; Divya et al., 2012). Importantly, mesenchymal stem cells exhibit a homing capacity,
in which they migrate to damaged tissue where they mitigate the immune response at the
site of damage, and contribute to the healing process through tissue regeneration and the
inhibition of fibrosis (Klopp, Gupta, Spaeth, Andreeff, & Marini III, 2011).
To continue our analysis of the iMSCs we generated, we sought to examine the
functional characteristics of the cells. Building on the minimal requirements of defining an
MSC, we characterized iMSCs as cells that are able to adhere to, and proliferate on, tissue
culture plastic.

By extrapolation from the literature regarding bone marrow-derived

mesenchymal stem cells, we postulated that our iMSCs should express the surface
markers CD90, CD73 and CD105, and should be negative for CD34, CD45, CD20 and
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CD14 (Dominici et al., 2006). Finally, and importantly, our iMSCs should be able to
differentiate into cells of mesenchymal lineage such as osteoblasts and pre-adipocytes.
We used commercially available mesenchymal stem cells as a positive control, this
presented a caveat because these cells are derived from the adipose tissue of patients
undergoing liposuction, and therefore, these commercial MSCs are considered hASCs,
human adipose-derived MSCs. It is important to highlight this difference, because human
mesenchymal stem cells arise from within the niche of the bone marrow or resident tissue
and are exposed to a variety of signaling molecules that inform the surface markers of
human-derived primary cells. Furthermore, conventionally MSCs are derived from the
bone marrow (BMMSCs), a site of residence of hematopoietic stem cells (HSCs),
therefore the importance of the surface markers is a method to distinguish HSCs from
BMMSCs.
We first performed flow cytometry on commercial MSCs and wild type iMSCs by
staining cells with surface marker-specific antibodies conjugated to different fluorophores:
CD90-FITC, CD73-APC and CD105-PE, while the negative surface markers were all
conjugated with –PerCP. We gated on live, individual cells to conduct our analyses and
asked whether there were variations in the staining of any of these surface markers. As
expected,

neither

the

commercial

MSCs

nor

our

iMSCs

expressed

CD34/CD45/CD20/CD14. Both commercial MSCs and wild type iMSCs stained positive
for both CD90 and CD73; however, our wild type iMSCs did not express CD105. (Figure
5-3 D). While Domincini et al. defined the three positive surface markers that must be
present in mesenchymal stem cells, other studies have shown that a subpopulation of
CD105- mesenchymal stem cells are refractory to TGF-β signaling and that have an
increased capacity for osteogenic differentiation (Levi et al., 2011).
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Building on these data, we performed lineage differentiations in which commercial
MSCs and iMSCs were cultured in adipogenic-defined or osteogenic-defined media to
generate pre-adipocytes and osteoblasts respectively. Commercial MSCs and wild type
iMSCs both effectively differentiate into pre-adipocytes and osteoblasts as assessed by
Oil-Red-O staining for adipocytes or Alizarin Red for osteoblasts (Figure 5-3 B). In fact,
wild type iMSCs differentiated into osteoblasts at a greater efficiency than commercial
MSCs, confirming the finding from Levi et al. that CD105 negative mesenchymal stem
cells function effectively as mesenchymal stem cells. Cumulatively, these data gave us
the confidence that our mesenchymal stem cell differentiation protocol was effective and
resulted in functional MSCs (Figure 5-3 B).
We therefore moved next to the differentiation and characterization of A12Texpressing iPSCs into iMSCs in order to assess the impact of A12T on mesenchymal stem
cells. We performed flow cytometry on wild type and A12T iPSCs and iMSCs in order to
observe the shift from iPSC-associated surface marker expression to iMSC-associated
surface marker expression (Figure 5-4). We found that WT and A12T iPSCs all expressed
CD90 (expected, as CD90 is a marker of stem cells) to similar levels, and they were all
negative for the expression of CD73/CD105 and CD34/CD45/CD20/CD14. When
differentiated into mesenchymal stem cells, and assessed at their first three passages on
plastic, A12T expressing iMSCs expressed CD90 to a similar level as WT iMSCs.
Whereas WT iMSCs expressed CD73, A12T iMSCs did not. Additionally, and as expected
from the data shown below (Figure 5-4), neither WT iMSCs nor A12T iMSCs expressed
CD105, or CD34/CD45/CD20/CD14. Over time, A12T iPSCs begin to express one of the
negative CD34/CD45/CD20/C14 markers (although we are unable to distinguish which
one since they are all conjugated with the same fluorophore).
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These data indicate that A12T iMSCs are have a reduced capacity to differentiate
into mesenchymal stem cells compared to WT iMSCs. This was further confirmed during
a differentiation assay in which WT iMSCs and A12T iMSCs were cultured in adipogenicdefined or osteogenic-defined media on plastic tissue culture dishes. While WT iMSCs
differentiated into pre-adipocytes and osteoblasts, A12T iMSCs all detached from the
culture surface and died (data not shown). These data suggested that A12T expressing
cells exhibited defects in differentiating into functional mesenchymal stem cells however,
we noticed that the defect occurred over time, during passaging on plastic culture dishes.
This lead us to believe that: either A12T iMSCs might functionally arrive at iMSCs but are
unable to withstand culture conditions, or are unable to differentiate into iMSCs at all. We
aimed to investigate this question further and sought to understand the etiology of the
A12T iMSC phenotype.
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Figure 5-3. Characterization of iMSC Phenotype (A) 10,000 cells were analyzed by flow
cytometry. Live, individual cells were gated on and the histograms of expression of CD90,
CD73, CD105 and CD34/CD45/CD20/CD14 were plotted. Monkey kidney epithelial cells,
BSC40s, (Bs-Black) were used as a negative control for MSCs Commercial MSCs
(LaCells-yellow)

highly

express

CD90/CD73/CD105

and

do

not

express

CD/34/CD/45/CD20/CD14 as expected. Normal, human derived bone marrow stem cells
were analyzed (Px-Purple) as well; however their expression profiles indicate that they are
CD73 negative subpopulation but they were not used for further experimentation. (B)
Absorbance of Oil Red O staining for Pre-Adipocyte staining and of Alizarin Red for
Osteoblast staining. Samples were stained on day 23 of differentiation and then stain was
solubilized and quantified by spectrophotometer at the appropriate wavelengths for the
stain. Crystal Violet staining was used to normalize for cell number, and the absorbance
was graphed. N=2 independent experiments, each performed in triplicate. Statistical
significance was determined by Student’s T-Test
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Figure 5-4
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Figure 5-4. Flow Cytometry Analysis of iPSC and iMSC Surface Markers. 10,000 cells
were analyzed by flow cytometry. Live, individual cells were gated on and the histograms
of expression of CD90, CD73, CD105 and CD34/CD45/CD20/CD14 were plotted. Monkey
kidney epithelial cells, BSC40s, (Bs-Black) were used as a negative control for MSCs (A)
iPSCs were analyzed for their surface marker expression prior to differentiation. WT iPSCs
(iPSC 197-green) and A12T iPSCs (iPSC CB6-pink & iPSC C1535-blue) both express
CD90 but do not express CD73, CD105 or CD34/CD45/CD20/CD14. (B) iMSCs were
analyzed by flow cytometry at passages 1, 2 and 3 (representative image of p.2 iMSCs).
WT iMSCs (WT-green) express CD90 and CD73. They do not express CD105, nor do
they

express

CD34/CD45/

CD20/CD14. A12T iPSCs (CB6-pink & C1535-blue) express CD90, but do not express
CD73 or CD105, nor do they express CD34/CD45/CD20/CD14.
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BAF A12T iMSCs Have Dysmorphic Nuclei
The homozygous expression of A12T in all cell types results in a dysmorphic
nuclear envelope. To begin to address the impact of A12T expression on iMSC function,
we examined nuclear envelope morphology. Cells were stained using a Vimentin antibody
as a positive marker for mesenchymal stem cells or stromal cells, and a Lamin A antibody
to delineate the nuclear envelope and were assessed by fluorescence microscopy as
described above (Figure 5-5 A).
Approximately 60% of the A12T-expressing iMSCs display some amount of
nuclear envelopathy (Figure 5-5 B). Using the scoring scheme described in Molitor &
Traktman 2014(T. P. Molitor & Traktman, 2014), the distribution of the severity of the
nuclear dysmorphia was analyzed. Wild type iMSCs displayed uniformly normal nuclei
(90%), whereas only 40% of A12T-expressing iMSCs exhibited normal nuclei. Highly
dysmorphic nuclei with scores of 3 and above were seen at a frequency of approximately
20-25% (Figure 5-5 C). The nuclear envelopathy is more severe in iMSCs than what we
observed in the MCF-10a model. Furthermore, A12T iMSCs exhibited a greater frequency
of micronuclei compared to WT iMSCs (Figure 4-6). Micronuclei are a post- mitotic
phenomenon in which whole or fragmented chromosomes that were not incorporated
during nuclear envelope reassembly are packaged into micronuclei (Luzhna, Kathiria, &
Kovalchuk, 2013). Nuclear envelopathies are thought to arise in two ways, either through
interphase tension within the nucleus or as a result of inappropriate nuclear envelope
reassembly. Therefore, the presence of a severe envelopathy in A12T iMSCs could be an
interphase phenomenon or a post mitotic phenomenon (or both), whereas the presence
of micronuclei is a result of a post mitotic defect.
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Figure 5-5
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Figure 5-5. Analysis of Dysmorphic Nuclei in A12T iMSCs. (A) WT iMSCs have
rounded, smooth nuclei when analyzed by immunofluorescence of Lamin A; in contrast,
A12T iMSCs exhibit dysmorphic nuclei that contain severe invaginations, blebs and
multinucleation (B) Cells were analyzed by immunofluorescence of Lamin A to for nuclear
morphology abnormalities. Normal nuclei were defined by a score of 1 based on the scale
defined in Molitor & Traktman 2014, and aberrant nuclei were defined by a score >1. 60%
of the iMSCs expressing A12T exhibited dysmorphic nuclei. (C) Using the scoring scheme
defined in Molitor and Traktman 2014, cell nuclei were assigned a score of 1-6, with 1
defined as smooth round nuclei, and 6 as multinucleated and blebbed. WT I MSCs
exhibited 90% normal nuclei, whereas 20-25% of A12T iMSCs had nuclei with a score of
3 or greater. These experiments were repeated in biological triplicate and statistical
significance of (B) was determined by Student’s T-test.
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Figure 5-6. Analysis of Micronuclei. WT and A12T iMSC cells were analyzed by
immunofluorescence of Lamin A to assess for the presence of micronuclei. WT iMSCs
only had an incidence of micronuclei at a rate of approximately 5%, whereas A12T iMSCs
exhibited a frequency of micronuclei of 25-35%. Data shown represent 3 independent
experiments and statistical significance was determined by Student’s T-test.
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BAF A12T Expressing iMSCs Exhibit Altered Actin Distribution and Nuclear Herniation
and Rupture
The inner nuclear envelope contains transmembrane proteins such as the LEM
domain proteins, but also SUN proteins that interact with Nesprins which, together form
the LINC complex that bridges the cytoskeleton to the inner nuclear skeleton by interacting
with Lamin A as described in Chapter 1 (Crisp et al., 2005). The connection between the
cytoskeleton and the nucleoskeleton influences many aspects of cellular structure and
function, including nuclear positioning and mechanotransduction (Tapley & Starr, 2013).
MSCs are mechanosensitive cells and their mechanotransduction and actin cytoskeleton
arrangement are regulated by shear stress (Kuo et al., 2015). Based on the morphological
differences we observed in the cells under phase microscopy (Figure 5-1 A&B), we sought
to examine the actin cytoskeleton organization in WT and A12T iMSCs. Assessment of
the actin cytoskeleton was achieved by staining cells with a Lamin A antibody and with
Phalloidin conjugated to rhodamine to visualize the nuclear lamina and the actin
cytoskeleton. We then quantified the actin fiber length (Figure 5-7 B), the classification of
actin distribution (cortical actin vs stress fibers) and whether there were changes in the
amount of actin over the nucleus. Actin fiber length corresponds to the morphological
differences we observed under phase microscopy: WT iMSCs had elongated, spindle-like
cell bodies, and as such had long, parallel actin fibers running the length of the cell. A12T
iMSCs on the other hand, exhibited shorter actin fibers that crisscrossed throughout the
cell rather than being organizing into parallel bundles. WT iMSC actin cytoskeleton was
predominantly arranged into stress fibers, with cortical actin bundles present in the cell
edges. A12T expressing iMSCs exhibited an increase in the distribution of cortical actin
as opposed to stress fibers (Figure 5-7 D). Any disruptions in cell polarity may cause
alterations in the distribution of focal adhesions and may result in the organization of the
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actin network into radial arcs that contain a dense meshwork of peripheral actin filaments
and few stress fibers (McHardy, Warabi, Andersen, Roskelley, & Roberge, 2005). We
hypothesized that the radial distribution of actin in A12T iMSCs may have altered the
proportion of actin that passes over the nucleus. The distribution of actin “on” the nucleus,
termed actin caps, play an important role in protecting it from external forces. Actin caps
are longitudinal actin fibers that run parallel with the stress fibers and terminate at focal
adhesions (Davidson & Cadot, 2021; J.-K. Kim et al., 2017). Conversely, nuclear
confinement as a result of contractile rings surrounding the nucleus and interacting with
the LINC complex, are responsible for insults to the nuclear envelope and are a direct
cause of nuclear rupture and chromatin herniation in mechanosensitive cells or cells with
compromised nuclear envelope integrity (Hatch & Hetzer, 2016). We quantified the actin
caps on the nucleus and found that there was a decrease in the distribution of actin over
the nucleus in A12T iMSCs compared to WT iMSCs (Figure 5-7 C). Taken together, the
transition of parallel stress fibers to short, radial cortical fibers and the loss of actin caps
on the nucleus in A12T expressing iMSCs, indicate that the actin network within the iMSCs
is caging the nucleus and could in turn be causing mechanical stress on the nuclear
envelope.
Next, we asked whether there were gross changes in the arrangement of the actin
cytoskeleton based on the hardness of the culture substrate. Since the diversion of the
cellular morphology between WT and A12T expressing iMSCs was dependent on whether
they were being cultured on Matrigel, gelatin or plastic, we cultured WT iMSCs on these
three substrates. We then stained these cells with rhodamine-phalloidin and measured
actin fiber length (Figure 5-7 D). Actin fiber length significantly decreased with increasing
hardness of the substrate on which the cells were cultured. This led us to postulate that
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mechanosensitive iMSCs begin to exhibit the deleterious effects of the A12T mutation
once they are subcultured on plastic and the actin cytoskeleton is shortened. Actin fiber
shortening may result in the loss of actin caps, imparting mechanical stress on the already
aberrant nuclear envelope.
Using immunofluorescence analysis of Lamin A distribution within iMSCs, we
asked whether the radial conformation of the actin cytoskeleton was causing nuclear
herniation and rupture as reported by Hatch in 2016 (Hatch & Hetzer, 2016). Cells were
defined as having undergone a rupture or chromatin herniation if the DAPI staining of the
DNA extruded beyond the Lamin A border of the nucleus. We found that 15-20% of A12T
iMSCs exhibited instances of nuclear rupture, see Figure 5-8. This was a striking finding,
because the leaking of nuclear material into the cytoplasm can trigger stress responses in
the cell, including the induction of the senescence associated secretory phenotype (SASP)
and eventual replicative senescence (Dou et al., 2017; Glück & Ablasser, 2019). The
implication that there may be an induction of replicative senescence as a consequence of
the expression of A12T in iMSCs points at a potential molecular etiology for the preferential
decay of MSCs in the context of NGPS. It also highlights a newly described role for BAF
in the context of cytoskeletal arrangement, the effects on the nuclear Lamin meshwork,
and the downstream sequelae that result from insults to this interconnected network.
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Figure 5-7
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Figure 5-7. Actin Distribution in A12T Expressing iMSCs. (A) Immunofluorescence
analysis of WT and A12T iMSCs to assess actin distribution after staining with rhodaminephalloidin and anti-Lamin A to evaluate the nuclear envelope. WT iMSC cells had long,
parallel actin fibers running the length of the cell. A12T iMSCs on the other hand, exhibited
shorter actin fibers that crisscrossed throughout the cell rather than organizing in parallel
bundles. (B) Actin fiber length was quantified and the average actin fiber length per cell of
approximately 50 cells from 3 independent experiments was plotted. Significance was
determined by Student’s T-Test. (C) We quantified the actin caps on the nucleus and found
that there was a significant decrease in the distribution of actin over the nucleus in A12T
iMSCs compared to WT iMSCs. N=3 independent experiments, statistical significance
was determined by Student’s T-Test. (D) 75% of the actin in WT iMSCs was organized
into stress fibers. Whereas only 30% of the actin in A12T iMSCs was distributed into stress
fibers, and about 50% organized into cortical actin. (E) Actin fiber length was measured
and quantified and the average actin fiber length per cell of approximately 100 cells and 2
independent experiments was plotted. Significance was determined by Student’s T-Test.
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Figure 5-8
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Figure

5-8.

Assessment

of

Nuclear

Rupture

and

Chromatin

Herniation.

Immunofluorescence of Vimentin (red), Lamin A (green) of iMSCs and DNA staining using
DAPI (blue). Rupture was defined as DAPI staining that extends beyond the Lamin A
border of the nucleus. 15-20% of A12T iMSCs exhibited nuclear rupture compared to
approximately 2.5% of WT iMSCs. n= 150 cells from 3 independent experiments and
statistical significance was determined by multiple Student’s T-Test.
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Premature Cellular Aging is a Result of Stress Signal Accumulation and Senescence
As previously mentioned, the leakage of DNA into the cytoplasm elicits a cellular
stress response that may lead to the induction of the SASP pathway and in turn increase
the incidence of replicative senescence (Campisi, 2013). Cellular senescence is defined
as a cellular effector program that can be triggered in response to various stressors
including genotoxic stress, oxidative stress, and mitochondrial dysfunction through the
induction of the p53/p21 pathway or the p16/RB pathway (Glück & Ablasser, 2019). The
activation of the SASP and the induction of replicative senescence is accompanied by the
increase in senescence-associated β-galactosidase activity (a key marker used to identify
senescent cells), as well as the hallmarks of aging described in Chapter 1 (Lopez-Otin et
al., 2013).
To ask whether the incidence of nuclear ruptures result in the induction of
replicative senescence and other cellular stress responses, we first asked whether there
was an accumulation of ROS, measured by the intensity of DCFDA as described
previously. A12T iMSCs cultured for just 1 passage on plastic exhibited the accumulation
of ROS to a greater extent than wild type iMSCs treated with H2O2. This indicates that
A12T iMSCs undergo oxidative stress, a hallmark of prematurely aged cells (Figure 5-9
A). Next, we analyzed the steady state levels of p53, to measure whether A12T iMSCs
had an increase in the induction of this stress response pathway. A12T iMSCs have a 4fold increase in the steady state levels of p53 as compared to WT controls, indicating that
iMSCs not only accumulate ROS but also p53 in response to cellular stress (Figure 5-9
B).
Lastly, we measured the presence of senescence-associated β-galactosidase in
WT and A12T iMSCs over a period of multiple passages. This was accomplished by
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treating cells with X-gal and measuring the amount of X-gal cleavage by β-galactosidase
to produce Blue-Gal: a blue colored insoluble compound visible in the cell. Cells were
classified as “negative” if they contained no blue color in the cytoplasm, “partial” if the area
of cytoplasm was less than 50% Blue-Gal, and “positive” if the area of cytoplasm was
greater than 50% Blue-Gal staining. As a positive control, wild type iMSCs were treated
with 10μM H2O2 for one week leading up to the assay. During their first passage on
plastic, only approximately 20% of A12T iMSCs exhibited any evidence of senescence.
After just one additional passage on plastic, approximately 80% of the cells exhibited
either partial or complete senescence. Of the 80%, only about half of these cells exhibited
complete senescence, and with subsequent passages both the proportion of cells
exhibiting senescence, and the ration of complete: partial senescence, increased. In
contrast, WT iMSCs maintained a proportion of non-senescent cells of greater than 80%
across the span of passages assessed. On the other hand, by passage 5, approximately
70% of the A12T expressing cells and the cells treated with H2O2 exhibited complete
senescence, and the remainder exhibited partial senescence. By this point, the iMSCs
were no longer able to be passaged. Meanwhile, WT iMSCs were able to be passaged
continually without a loss of proliferation capacity for at least 40 passages. These data
supported our hypothesis that the survival and proliferation of mesenchymal stem cells
expressing A12T is greatly diminished.
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Figure 5-9. Assessment of the Accumulation of Cellular Stress Responses and
Senescence. (A) Cells were treated with DCFDA in order to measure the accumulation
of reactive oxygen species in the cells. WT iMSCs cells were treated with H2O2 as a
positive control prior to DCFDA treatment. A12T iMSCs exhibited a DCFDA intensity level
equal to or greater than the positive control cells, indicating that A12T iMSCs were
accumulating ROS. N=3 independent experiments, statistical significance was determined
by Student’s T-Test. (B) Immunoblot analysis of p53 steady state levels between WT and
A12T iMSCs exhibited that p53 steady state levels are 4-fold greater in A12T iMSCs
compared to WT iMSCs. N=3 independent experiments. (C) SA-β-Gal staining of WT
iMSCs, WT iMSCs treated with H2O2 and A12T iMSCs across 5 passages. Cells were
classified as “negative” if they contained no blue color in the cytoplasm, “partial” if the area
of cytoplasm was less than 50% Blue-Gal, and “positive” if the area of cytoplasm was
greater than 50% Blue-Gal staining.
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A12T BAF Exhibits Defective Binding to Lamin A
Data from the Zinn-Justin lab indicate that Alanine 12 of BAF is found on the
surface of BAF that binds to the Ig Fold of Lamin A, and that the A12T mutation is buried
in this binding surface (Samson et al., 2018). By revealing the interface between the BAF
dimer and the Lamin A Ig Fold domain, Samson et al mapped several residues found on
the Lamin A Ig Fold that are frequently mutated in atypical progerias (Figure 5-10 A). Their
preliminary data indicated that there was diminished binding between Lamin A and BAF
A12T, suggesting that the complex between BAF and Lamin A/C is destabilized in the
context of NGPS and other progeroid syndromes. We posited that this data could be the
puzzle piece that tied together the phenotypes seen in the mechanosensitive iMSCs and
the etiology of the loss of the structural integrity of the nucleus. Furthermore, taking what
was shown in Chapter 1 about the biochemical analysis of BAF A12T, the previously
known functions of BAF were unaffected by the mutation. With LEM-domain binding, DNA
binding, phosphorylation by VRK1 and intracellular half-life all appearing to behave similar
to WT BAF, we were perplexed by how the mutation was affecting BAF function. The
surface on which A12T appears on the BAF dimer originally piqued our interest as a
binding surface. Previous reports had mapped that surface as being involved in histone
binding and chromatin compaction- which helped inform the hypothesis we established in
Chapter 3 (R. Montes de Oca et al., 2005). Given our data (Chapter 3) indicating that
A12T’s effect on the cell is not at the level of chromatin organization, and using this data
from Samson et al. 2018 study, we hypothesized that the loss of the BAF-Lamin A
interaction in the presence of A12T destabilizes the Lamin A meshwork within the nucleus,
causing mass cytoskeletal rearrangements which in turn cause nuclear rupture, chromatin
herniation and ultimately replicative senescence.
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To test the BAF: Lamin A interactions directly, we performed in vitro coimmunoprecipitation assays. Lysates prepared from bacteria programmed to express
recombinant GST-Lamin A Ig fold (WT, R453C or R527H) were applied to Glutathionesepharose beads, and then purified BAF WT or BAF A12T were added to the beads
containing the immobilized GST-Lamin A-IgF. After binding was allowed to occur, beads
were washed carefully and both inputs and eluates were resolved electrophoretically and
subjected to immunoblot analysis to visualize both GST-Ig Fold Lamin A and BAF.
WT BAF readily bound to GST-Lamin A WT, and as demonstrated by the ZinnJustin lab, did not bind to Lamin A R435C or R527H. These two mutant alleles are
implicated in atypical progerias that are buried in the BAF: Lamin A interface. While
Samson et al. observed diminished binding of A12T to Lamin A, in our hands we saw a
total abrogation of binding between A12T and Lamin A WT (Figure 5-10 B).
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Figure 5-10
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Figure 5-10. In Vitro Binding Assay of Lamin A with BAF. (A) Binding surface between
Lamin A Ig fold (gray) and BAF dimer (green) taken from (Samson et al., 2018).
Highlighted in red are the residues that cause atypical progeria when mutated. Highlighted
in blue are the residues on BAF that are involved in the BAF:Lamin binding interface. G47
between the BAF dimers (purple) is required for dimerization. (B) GST-tagged Ig fold of
Lamin A (either WT, R435C or R527H) was immobilized on glutathione sepharose beads
and then incubated with purified recombinant WT or A12T BAF. WT BAF readily bound
the Ig fold of Lamin A, but did not bind to the two LA-IgF mutants shown to abrogate
binding, R435C and R527H. On the other hand, A12T was unable to bind WT Lamin or
any of the mutant Lamins at all. N=4 independent experiments. (Purified BAF proteins
were prepared by Dr. Aye Mon.)
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Discussion
The study of progerias offers a pathologic model that provides insight into
accelerated physiologic aging and has been a valuable tool for characterizing the
molecular mechanisms of premature aging, specifically in the context of perturbations to
the nuclear envelope.
Patients that are affected by premature aging syndromes exhibit degeneration of
tissue derived from mesenchymal origin. Studies examining the tissue specificity in the
context of HGPS led to the hypothesis mesenchymal stem cell survival and proliferation,
and it is thought that patient MSC reservoirs are depleted as a result. We sought to identify
the molecular mechanisms behind NGPS’s tissue specificity and to understand whether
the homozygous expression of A12T preferentially impacted mesenchymal stem cells.
A12T expressing iMSC cellular morphology diverges greatly from WT iMSCs and
instead of elongated cell bodies with spindle-like morphology, they are circular with spread
out cytoplasms and lenticular nuclei. In order to understand these functional and
morphological differences, we assessed the actin cytoskeleton of these cells and found
that iMSCs exhibit changes in actin arrangement. WT iMSC actin is organized into
elongated, parallel stress fibers running the length of cell, whereas A12T iMSCs exhibit
shorter fiber length, organized in radial arcs around the nucleus. The confinement of the
nucleus by these radial bundles and loss of actin caps causes an increase in the
mechanical stress on the nucleus, and in turn results in an increased incidence of nuclear
rupture.
The downstream effects of these morphological differences and nuclear rupture
includes the leakage of DNA into the cytoplasm results the accumulation of reactive
oxygen species, increased p53 signaling and eventual complete replicative senescence.
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Knowing that these cells do not exhibit these phenotypes when cultured on Matrigel or
gelatin, we posit that the mechanosensitive nature of mesenchymal stem cells, coupled
with A12T’s effect on the nuclear envelope leads to nuclear rupture in A12T expressing
cells, where WT expressing iMSCs are able to withstand the mechanical forces.
Furthermore, BAF’s interaction with the Lamin A meshwork of the nucleoskeleton may be
a stabilizing force within the nucleus. A12T is unable to bind the Ig fold of Lamin A and in
turn destabilizes the nucleoskeletal meshwork. Since the nucleoskeleton is bridged to the
cytoskeleton through the LINC complex’s direct interaction with Lamin A, the
destabilization of the Lamin A:BAF interaction results in an inability to withstand
mechanical forces arising from the mechanotransduction of mechanical forces along the
actin network. See Figure 5-11.
Through the understanding that the mechanosensitive nature of iMSCs
predisposes these cells to nuclear deformation when cultured on hard substrates, and that
the expression of A12T in these cells exacerbates nuclear deformity and induces nuclear
rupture and DNA leakage, it became clearer why A12T iMSCs exhibit stem cell
dysfunction. While the pre-iMSCs are cultured on softer substrates such as Matrigel and
gelatin, the actin cytoskeleton exerts less force on the nuclei. Once moved to a harder
substrate, A12T nuclei are prone to catastrophic mechanical stress and as such are
unable to proliferate efficiently on plastic. Flow cytometry and differentiation assays were
performed on iMSCs that had already been subcultured on plastic, undergone nuclear
deformation by the actin cytoskeleton and may have already begun to undergo replicative
senescence. While it’s easy to dismiss these cells as not falling under the classification of
functional MSCs, it was important for us to elucidate the mechanisms underlying this
observation.
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Importantly, these data are specific to iMSCs and none of these effects are
observed in hepatocytes derived from A12T expressing iPSCs. This leads us to believe
that the effects seen are a result of the mechanosensitive nature of MSCs and that the
deleterious effects of the A12T mutation on tissue derived from mesenchymal origin in
patients are a result of the direct effect the A12T mutation has on mesenchymal stem
cells.
By elucidating the contribution of BAF to the stabilization of the Lamin A meshwork
and its novel role in mechanotransduction, we have gotten closer to understanding the
molecular mechanisms of A12T’s contribution of premature cellular aging in mesenchymal
stem cells. However, in order to strengthen these findings, we must establish whether the
loss of Lamin A binding to BAF through other mutations on the BAF binding interface
results in nuclear envelopathy and premature cellular senescence as well. Furthermore,
we would benefit from examining whether we are able to reverse these effects by moving
A12T iMSCs from a hard surface, like plastic, onto a softer substrate such as Matrigel; or
by relieving the stress imparted by the actin cytoskeleton through treatment with either a
pharmacologic agent such as Blebbistatin, or through the genetic manipulation of the LINC
complex such as depleting SUN proteins.
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Figure 5-11
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Figure 5-11. Model of A12T Contribution to iMSC Dysfunction. Pink= Matrigel,
gray=gelatin, red= actin cytoskeleton dark blue= nucleus inlay= Lamin A and BAF binding
interface (A) When WT iMSCs are cultured on varying substrates, their in-tact nuclear
envelope is able to withstand the actin rearrangement that occurs on harder substrates
and the cells do not exhibit any functional differences. (B) A12T iMSCs exhibit nuclear
envelope defects regardless of the substrate on which they are cultured, however when
they are cultured on a hard substrate such as plastic, the actin rearrangement results in
radial actin bundles caging the nucleus and including nuclear rupture and chromatin
herniation. The reason the nuclear envelope is unable to withstand these forces falls back
on to the loss of BAF-Lamin A binding in A12T expressing cells. The destabilization of this
interaction in turn destabilizes the Lamin A meshwork within the nucleus and the cells are
unable to withstand mechanical forces transduced along the actin network on a hard
substrate such as plastic. As a result, DNA leaks into the cytoplasm causing the
accumulation of cellular stress responses and ultimately replicative senescence.
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Chapter 6: Discussion
The studies emerging about the complexity and dynamic nature of the nuclear
envelope have been garnering the attention of more and more research groups in recent
years. The categorization of a subset of diseases associated with components of the
nuclear lamina, laminopathies, has elucidated the contribution of the nuclear lamina to the
maintenance of cell homeostasis, nuclear structure and function and cellular aging.
BAF is an essential protein that bridges the nuclear lamina and chromatin and
regulates nuclear structure. Phosphorylation of BAF by VKR1 regulates its interactions
with dsDNA, and LEM-D proteins and alters its subcellular localization (R.J. Nichols et al.,
2006). Molitor and Traktman demonstrated in 2014 that the depletion of VRK1 resulted in
nuclear dysmorphia in MCF-10a cells and decreased the fraction of mobile BAF (T. P.
Molitor & Traktman, 2014). Molitor and Traktman also published that the depletion of
VRK1 slowed the doubling time of breast cancer cells and reduced the instances of distal
metastases in a breast cancer model (T.P. Molitor & Traktman, 2013). Moreover, the
homozygous inheritance of a missense mutation in BAF from Alanine 12 to Threonine
results in a premature aging syndrome termed NGPS; patient-derived cells exhibit
aberrant nuclear envelope structure, thereby designating it as a laminopathy (Puente et
al., 2011). We hypothesized that the hypophosphorylation of BAF contributed to the
nuclear envelope defect observed in VRK1-depleted cells and that the discovery of the
A12T mutation could further inform the model generated by Molitor and Traktman and help
elucidate the molecular mechanisms underlying these observations.
At the onset of this study, we hypothesized that the surface on which the A12T
mutation occurred was important in chromatin condensation and histone binding (R.
Montes de Oca et al., 2005; Samson et al., 2018; Segura-Totten et al., 2002). We posited
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that the mutation had implications in chromatin structure and organization. To examine
the contribution of BAF A12T on the spatial organization within the nucleus, we generated
a model in MCF-10a cells wherein we modestly overexpress shRNA resistant 3XF-BAF
or 3XF-A12T while depleting endogenous BAF in order to approach near homozygous
expression.
We demonstrated that the expression of A12T causes a nuclear envelopathy in
MCF10a cells and sought to examine the different aspects of cellular aging such as
genomic instability, epigenetic alterations, alterations in protein synthesis, cellular
senescence, and the accumulation of reactive oxygen species (Lopez-Otin et al., 2013).
We determined there were no significant changes in the steady state levels of the nuclear
periphery proteins, histone modifications, or the substructures of the nucleus; nor were
there alterations in de novo protein synthesis. A12T expressing cells did not exhibit
accumulation of cellular stress responses, nor did we observe and variation in cell
proliferation. Furthermore, we asked whether premature aging in this model might
manifest with gross alterations at the level of euchromatin and heterochromatin
organization. Using electron microscopy and ATAC-Seq, we were unable to distinguish
changes in overall nuclear organization. The data show that there were no gross
alterations in chromatin compaction, indicating that alterations in gene accessibility and
severely altered gene expression are unlikely to be responsible for the defects seen at the
nuclear envelope and eventual premature cellular aging phenotype.
The data generated from addressing questions of premature aging in MCF-10a
cells indicates that this model does not mirror the hallmarks of premature cellular aging.
However, we learned from these analyses that while BAF A12T causes a nuclear
envelopathy, nuclear envelopathies are not sufficient to result in cellular aging and
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dysfunction. This finding presents a unique opportunity to address the contributions of
BAF to the architecture of the nuclear envelope without the cell suffering the deleterious
effects of premature aging and eventual replicative senescence.
Murine models of HGPS and other premature aging syndromes have been able to
recapitulate some of the clinical manifestations of the disease.

We theorized that

generating a novel NGPS mouse model would be a valuable tool used to elucidate the
fundamental mechanisms of disease progression in a tissue-specific, systems-based
approach. To achieve this, we contracted with Applied Stem cell to generate A12T/+ mice
using CRISPR/Cas9 technology, with the aim of mirroring the clinical manifestations of
NGPS.
While the A12T/A12T mice do not present a premature aging syndrome, primary
dermal fibroblasts derived from A12T/A12T mice exhibit nuclear morphology defects. At
the cellular level, this envelopathy, was not accompanied by cellular stress responses or
replicative senescence. The complexities between the clinical manifestation of human
progeria syndromes and the parallel mouse models aiming to recapitulate these diseases
highlight the challenges of developing a mouse model to study a disease state at the
organismal level. The reasons why some murine models are unable to recapitulate the
disease model or require more severe patterns of inheritance is unclear. While there are
most certainly differences between human and mouse physiology, it remains unknown
why the inheritance of A12T/A12T in mice does not cause a premature aging syndrome.
Unknown redundancy mechanisms in the mice may be masking the contributions of the
A12T to protect the cell and organism from its deleterious effects. Crossing A12T/A12T
mice with other mouse models of premature aging, or mice with defects in the tissues of
mesenchymal origin may aid in revealing the ways in which A12T contributes to the
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process of organismal aging and mesenchymal stem cell maintenance. Mesenchymal
stem cells are found in many tissue types and behave as the reservoir for tissue
regeneration after injury. They also exhibit homing capabilities and immuno-modulatory
functions (Pittenger et al., 1999). Therefore, while A12T expressing mice do not exhibit
defects in premature aging, we have not examined whether the expression of A12T results
in defective wound healing or tissue regeneration after injury such as bone breaks.
Additionally, harvesting bone marrow from these mice to ask whether the proportion of
BMMSCs is different over time as the mice age, or characterizing whether they exhibit
premature cellular aging similar to the iMSCs generated from iPSCs would answer the
question of cell type specificity vs species specificity as well.
Dermal fibroblasts derived from A12T/A12T mice exhibited nuclear envelope
dysmorphia but did not exhibit markers of premature cellular aging. In the same way that
stressing the mouse model with a “second hit” through genetic or injury, future studies of
the primary dermal fibroblasts with additional stress might reveal differences between WT
and A12T expressing cells that would have remained undetected in an “unstressed”
model. BAF has been shown to play an important role in the recognition and repair of
nuclear ruptures by binding to herniated chromatin and recruiting INM proteins and their
associated membranes with the help of ESCRT-III machinery (Halfmann et al., 2019;
Young et al., 2020). Using microfluidics chambers as a model for confined migration BAF
and A12T expressing dermal fibroblasts could be examined for differences in the ability to
withstand confinement and mechanical stress (how quickly it ruptures in confined spaces)
and assess the repair efficacy in A12T expressing cells.
Our initial hypothesis relied on the idea that surface of BAF on which the A12T
mutation occurs was a result of altered interactions with chromatin and histones.
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Furthermore, we posited that generating a model system for the analysis of A12T’s impact
on organismal aging, and cellular aging through an expression system that introduced
A12T in the endogenous locus would provide us with clearer insight on the disease
etiology. Moreover, the causes for the tissue-specificity of NGPS are unclear, but the
impact on tissues of mesenchymal origin led us to the hypothesis that survival,
proliferation or differentiation of mesenchymal stem cells is perturbed.
Therefore, to examine the effect of A12T expression on MSCs we transitioned from
the use of MCF-10a cells to isogenic iPSCs that carried +/+ or A12T/A12T alleles at the
BANF1 locus. W differentiated the iPSCs into induced mesenchymal stem cells (iMSCs),
or a cell type unaffected by NGPS. We were able to establish that there were no functional
defects in A12T iPSCs differentiated into hepatocytes. While A12T hepatocytes exhibit a
mild nuclear envelopathy, they express hepatocyte markers at similar levels to WT
hepatocytes, and do not exhibit cellular senescence.
We established a differentiation protocol from iPSCs to iMSCs and were able to
show that WT iMSCs were functional as stem cells and efficiently differentiated into
osteoblasts and pre-adipocytes. The first distinction we observed between WT and A12T
iMSCs was a notable morphological difference. To examine this further, we analyzed the
actin cytoskeleton using immunofluorescence. We observed that the actin cytoskeleton of
WT iMSC is organized into elongated, parallel stress fibers running the length of cell,
whereas A12T iMSCs exhibit shorter fiber length, organized in radial arcs around the
nucleus. The radial distribution of actin and confinement of that imparts mechanical stress
on the nucleus, resulting in an increased incidence of nuclear rupture and the leakage of
the components of the nucleus into the cytoplasm. The downstream effects of the leakage
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of DNA into the cytoplasm results the accumulation of reactive oxygen species, increased
p53 signaling and eventual complete replicative senescence.
The dependence of these phenotypes on substrate hardness was intriguing to us.
Knowing that these cells do not exhibit these phenotypes when cultured on Matrigel or
gelatin, we proposed that A12T’s effect on the nuclear envelope leads to nuclear rupture
in A12T-expressing, mechanosensitive iMSCs on hard substrates, whereas WT
expressing iMSCs are able to withstand the mechanical forces. Furthermore, the
publication of the ternary structure of a LEM-D protein, BAF and the IgG fold of Lamin A
revealed that Alanine 12 is buried in the of BAF-Lamin A interface (Samson et al., 2018).
Using the data from Samson et al. 2018, we pursued the hypothesis that the A12T
mutation diminishes the interaction with Lamin A, and the loss of the interaction
compromises the structural network of the nuclear lamina and weakens the nuclear
envelope.
BAF’s interaction with the Lamin A meshwork of the nucleoskeleton is a stabilizing
force within the nucleus. While WT BAF is able to bind the Ig Fold of Lamin A, A12T is
unable to bind the Ig fold of Lamin A and in turn destabilizes the nucleoskeletal meshwork.
Through the interaction of the cytoskeleton with the nucleoskeleton and in turn, Lamin A,
the destabilization of the Lamin A: BAF interaction results in an inability to withstand
mechanical forces arising from the mechanotransduction of mechanical forces along the
actin network. We were able to reveal a novel role for BAF in mechanotransduction and
the stabilization of the Lamin A meshwork within the nucleus. This observation is relevant
to one the molecular mechanisms by which the BAF A12T allele contributes to premature
cellular aging in mesenchymal stem cells.
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The elastic modulus of Matrigel is ~0.3kPa, gelatin is ~40-50kPa and tissue culture
plastic is >1MPa. The increase in substrate hardness from Matrigel to tissue culture plastic
is greater than 3,000 fold and is not physiologically relevant. While MSCs are exposed to
different niches in vivo such as bone marrow, fat and bone, the range of mechanical stress
does not begin to approach the order of MPa. For example, bone’s elastic modulus is
approximately 50 kPa, similar to the elastic modulus of gelatin; and bone marrow’s elastic
modulus is ~0.2kPa, similar to the elastic modulus of Matrigel. A12T expressing iMSCs
clearly have a lower threshold for withstanding mechanical forces applied when cultured
on plastic, however it would be interesting to examine whether these effects are rescued
when iMSCs that have been cultured on plastic are moved to softer substrates. By moving
cells onto substrates 500 fold softer (gelatin) and relieving the stress from the actin
cytoskeleton, do A12T expressing cells recover from the accumulation of stress responses
and return to a healthy state? Furthermore, since the mechanical forces are transduced
along the actin cytoskeleton, would relieving the strain of the actin cytoskeleton on the
nucleus decrease the frequency of nuclear rupture and in turn reduce the fraction of
senescent iMSCs? Inhibiting actin dynamics by treatment with Blebbistatin has been
shown to relieve the stress on the nuclear envelope and in turn improve aberrant nuclear
envelope morphology (Hatch & Hetzer, 2016). Furthermore, several studies have shown
that by depleting components of the LINC complex, relieves the tension from the actin
cytoskeleton on the nucleus. In both these ways we can ask whether the replicative
senescence observed in the iMSCs are 1) reversible 2) truly a result of the mechanical
strain imparted by the cytoskeleton.
The transduction of mechanical forces from the cell periphery to along the actin
cytoskeleton initiates a signaling cascade to modify gene expression in an effort to
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respond to the extracellular environment appropriately. Therefore, understanding the
pathways involved, such as the YAP/TAZ pathway and whether signaling is altered in the
presence of the A12T mutation would open a series of potential downstream studies of
the potential gene expression alterations in WT BAF iMSCs or A12T iMSCs in response
to mechanical stress.
Moreover, our observation that A12T does not bind Lamin A implicates the BAF:
Lamin A as a critical interaction for the structural integrity of the nucleus. To strengthen
these findings, further examination of the Lamin A-binding interface must be performed to
determine whether other mutations on the BAF binding interface results in nuclear
envelopathy and premature cellular senescence as well. Samson et al. mapped residues
on Lamin A that are buried in the BAF binding interface that are mutated in atypical
progerias. By identifying previously unknown residues on the surface of BAF that are
involved in the interaction with Lamin A, we can examine whether their mutation and leads
to the loss of the BAF: Lamin interaction, and whether, when expressed in iMSCs, results
in a nuclear envelopathy and premature cellular aging. If, however the envelopathy and
premature aging syndrome are a result of the loss of the BAF: Lamin A interaction, then
we must also assess this interaction in the primary dermal fibroblasts. Do A12T dimers
overcome the binding deficit observed in the iMSCs due to species-related differences in
the Ig Fold of murine Lamin A? While R435 and R527 are conserved in murine Lamin A
(the two residues in which mutations to Alanine are unable to bind WT BAF), other
residues in this region are not conserved. Therefore, to ask whether there is a speciesdriven difference in the BAF: Lamin A interaction, or whether the loss of binding is still
observed, we would perform binding assays between murine BAF and murine Lamin A.
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In conclusion, BAF carries out its function through its binding partners, and the
BAF dimer ties together LEM-D proteins, Lamin A and dsDNA and acts as an organizing
hub at the nuclear periphery. BAF plays extensive roles in the maintenance of the structure
and function in interphase and mitosis and this study indicates that the interaction of BAF
and Lamin at the nuclear periphery plays a central role in stabilizing the entire meshwork
of the nucleoskeleton Figure (6-1). In summary, the work done in this study has revealed
the contributions of the BAF A12T mutation to the integrity of the nuclear envelope and
has elucidated a novel role for BAF in the context of mechanosensitivity,
mechanotransduction, and the network of the nucleoskeleton and cytoskeleton. We have
also begun to understand the tissue specificity of NGPS through the study of MSCs and
have learned that A12T has deleterious effects on mechanosensitive cells but that other
cell types are more resilient in overcoming insult to the nuclear membrane morphology
(Figure 6-1). Through the study of three separate models of A12T inheritance, we have
highlighted the nuances of this mutation’s effect both at the cellular and organismal level.
Furthermore, this study has generated valuable tools for the study of BAF and A12T
outside the context of premature cellular aging. The generation of a dermal fibroblast cell
line from an A12T/A12T mouse offers a toolkit for the analysis of the roles of BAF and
A12T without suffering the consequences of premature cellular aging such as replicative
senescence.
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Figure 6-1

Figure 6-1. Summary of BAF Binding Partners. The BAF dimer creates a nuclear
organizing hub. The BAF dimer creates two binding surfaces at either pole, one that
creates a LEM-D binding saddle, and the other that binds the Ig fold of Lamin A. On either
side of the dimer BAF binds dsDNA in a sequence independent manner. BAF is
phosphorylated by VRK1 which regulates its affinity to its binding partners.
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Figure 6-2
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Figure 6-2. Summary of Models. MCF-10a cells and dermal fibroblasts from A12T/A12T
mice both exhibit nuclear envelope morphology defects without suffering deleterious
downstream consequences of premature aging. When iMSCs express A12T, they exhibit
nuclear envelope dysmorphia but also present with premature cellular aging culminating
from the accumulation of ROS and DNA damage as a result of chromatin herniation due
to nuclear rupture.
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